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SUMMARY 
 
Both mammalian and bacterial peroxidases contain novel covalent linkages. In 
the former a sulfonium linkage to a critical Met residue is thought to modify the normal 
planarity of the haem affecting the functional properties. Following on from the work of 
Metcalfe et al., 2004 which showed that such links could be engineered in ascorbate 
peroxidase, horseradish peroxidase (HRP) has been used as convenient model system to 
try and understand the structural and electronic effects of engineered covalent linkages. 
Previous work in the group (Cali, 2008) had shown that mutation of Ser167 to Met in 
HRP-C* resulted in autocatalytic cross-linking on incubation with hydrogen peroxide. 
In this thesis, two additional HRP variants, S167Y and S167W were studied and a new 
novel structural linkage discovered. 
The UV/Vis spectrum of the S167Y variant suggested a more 6-coordinate high 
spin character. The molar extinction coefficients were markedly increased, 180 mM-1 
cm-1 for S167Y and 135 mM-1 cm-1 for S167W, compared to 100 mM-1 cm-1 for the WT 
enzyme, consistent with a more 6 coordinate high spin character normally seen in lignin 
peroxidase. In contrast, the dissociation constant (Kd) of the S167W variant mutant for 
the aromatic donor BHA was hardly affected, whilst that of the S167Y variant increased 
two-fold relative to the WT, implying a significant perturbation of the aromatic donor 
binding site and / or the associated haem-linked hydrogen bonding network. 
After peroxide treatment the haem group of the S167Y variant could not be 
extracted into acid butanone in contrast to the WT. Only a proportion of the haem could 
be extracted even from the untreated S167Y variant, implying that a substantial fraction 
of the protein had formed the haem-protein linkage during folding and purification. 
These results were confirmed during reverse phase HPLC and MALDI-TOF / ESI mass 
spectroscopy measurements. The haem and protein completely co-eluted in the case of 
peroxide treated S167Y, while only ~50% of the haem was linked to the protein in the 
untreated as isolated enzyme. The MALDI-TOF and ESI mass spectrum showed that 
there was a large increase (614 Da) in the mass of the linked S167Y protein, compared 
to that of the unlinked enzyme. Unlike the sulfonium linkage obtained earlier, treatment 
with hydrogen peroxide was unnecessary to observe this increase. Interestingly, the 
100% unlinked S167Y protein could only be isolated if enzyme was prepared in the 
presence of an efficient peroxidase substrate as an antioxidant scavenger. It appears that 
a Tyr residue at position 167 is highly reactive with respect of the haem vinyl side chain 
forming a spontaneous covalent link not otherwise seen in nature. 
Pre steady-state comparison of the intermediates has shown that Compound I 
was formed essentially normally at near WT rates, however its stability was greatly 
affected in the S167Y variant (linked or unlinked), the life time being decreased to 
~0.04 s, compared to of the WT enzyme, where it was ~80 s. The substrate preference 
of the cross-linked S167Y variant was also altered. Stopped-flow measurements of the 
individual rate constants for the partial reactions of the catalytic cycle with luminol as 
reducing substrate revealed an increase in the rate of reduction of Compound I to 
Compound II (k2). 
The X-ray crystal structure of S167Y variant was solved to 1.7 Å resolution and 
the structure has been modelled and determined by x-ray crystallography. The x-ray 
structure reveals an unanticipated linkage containing an additional ring structure bonded 
to the engineered Tyr. ESI mass measurements supported this structure. 
 
V 
 
Table of Contents 
Chapter One: Introduction......................................................................................... 1 
1.1 Peroxidases: ........................................................................................................ 1 
1.2 Classification of peroxidases: .............................................................................. 3 
1.3 Mammalian peroxidase superfamily: ................................................................... 4 
1.3.1 Functional importance: ................................................................................. 4 
1.3.2 Structures of mammalian peroxidases: .......................................................... 5 
1.3.3 Active site architecture of mammalian peroxidases: ...................................... 7 
1.3.4 Spectral features of mammalian peroxidases: .............................................. 10 
1.3.5 Mechanism of action of mammalian peroxidases: ....................................... 13 
1.4. Plant peroxidase superfamily: ........................................................................... 16 
1.4.1. Class I. Peroxidases of prokaryotic origin: ................................................. 16 
1.4.2 Class II. Secreted fungal peroxidases: ......................................................... 16 
1.4.3 Class III. Classical secretory plant peroxidases: .......................................... 17 
1.5 Horseradish peroxidase: .................................................................................... 18 
1.5.1 Horseradish: ............................................................................................... 18 
1.5.2 General introduction to the enzyme: ........................................................... 18 
1.5.3 Structure of horseradish peroxidase: ........................................................... 19 
1.5.3.1 General features: .................................................................................. 19 
1.5.3.2 Haem prosthetic group: ........................................................................ 20 
1.5.3.3 The active site structure of HRP-C: ...................................................... 21 
1.5.3.3.1 Proximal region: ............................................................................ 21 
1.5.3.3.2 Distal region: ................................................................................. 22 
1.5.3.4 Calcium binding sites:.......................................................................... 24 
1.5.4 Horseradish peroxidase reaction cycle: ....................................................... 25 
1.5.4.1 Mechanism of Compound I formation:................................................. 27 
1.5.4.2 Reduction of Compound I and II: ......................................................... 28 
1.5.5 Aromatic substrate binding site: .................................................................. 30 
1.5.6 Biological roles of horseradish peroxidase: ................................................. 32 
1.5.7 Applications of horseradish peroxidase: ...................................................... 34 
1.6 Introduction of haem-protein covalent linkages into plant peroxidases: ............. 35 
1.7 The aim of the present work: ............................................................................. 38 
Chapter Two: Materials and Methods ..................................................................... 39 
2.1 Materials: .......................................................................................................... 39 
VI 
 
2.2 Generation of mutants: ...................................................................................... 39 
2.2.1 Site-directed mutagenesis: .......................................................................... 39 
2.2.2 Primer design: ............................................................................................ 40 
2.2.3 DNA amplification mutagenesis using PCR:............................................... 41 
2.2.4 Identification of correctly sized PCR product:............................................. 41 
2.2.5 Purification of PCR product:....................................................................... 42 
2.2.6 Ethanol precipitation of the purified PCR product:...................................... 43 
2.2.7 Circularization of the PCR products: .......................................................... 43 
2.2.7.1 Phosphorylation of the PCR product: ................................................... 43 
2.2.7.2 Ligation of the phosphorylated PCR product: ....................................... 43 
2.2.8 DNA Transformation into E. coli (DH5α): ................................................. 44 
2.2.9 Plasmid DNA miniprep: ............................................................................. 44 
2.2.10 Restriction enzymes analysis of miniprep plasmid DNA: .......................... 45 
2.2.11 Plasmid DNA midiprep: ........................................................................... 45 
2.2.12 Submitting DNA for sequencing: .............................................................. 46 
2.2.13 Glycerol Stocks: ....................................................................................... 46 
2.3 Protein expression and purification: ................................................................... 47 
2.3.1 Small-scale HRP-C* protein expression: .................................................... 47 
2.3.1.1 Transformation into E. coli protein expression strain W3110: .............. 47 
2.3.1.2 Culture growth: .................................................................................... 48 
2.3.1.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE): ........................................................................................................... 49 
2.3.1.3.1 Gel recipes .................................................................................... 49 
2.3.1.3.2 SDS-PAGE method: ...................................................................... 50 
2.3.2 Large scale HRP-C* protein production:..................................................... 51 
2.3.2.1 Culture growth and protein expression: ................................................ 51 
2.3.2.2 Lysis of cells and washing of protein pellets: ....................................... 51 
2.3.2.3 Folding and purification of HRP-C* protein: ....................................... 52 
2.4 UV/Vis Spectroscopic studies: .......................................................................... 54 
2.4.1 Spectral features of WT HRP-C* and the new variants: .............................. 54 
2.4.2 Haem Soret peak extinction coefficient (ε) determination: .......................... 54 
2.5 Benzhydroxamic acid binding assays: ............................................................... 55 
2.6 Reaction of enzyme with hydrogen peroxide: .................................................... 56 
2.7 Enzyme intermediates on treatment with hydrogen peroxide: ............................ 57 
2.8 Acid butanone haem extraction: ........................................................................ 57 
VII 
 
2.9 High Performance Liquid Chromatography (HPLC) analysis: ........................... 58 
2.9.1 Principles of chromatography: .................................................................... 58 
2.9.2 Distribution ratio and retention time: .......................................................... 59 
2.9.3 HPLC apparatus: ........................................................................................ 60 
2.9.3.1 Solvent delivery system: ...................................................................... 60 
2.9.3.2 Column: ............................................................................................... 61 
2.9.3.3 Detector: .............................................................................................. 62 
2.9.4 HPLC analysis of the new HRP-C* mutants: .............................................. 63 
2.10 Mass Spectrometry: ......................................................................................... 64 
2.10.1 Introduction: ............................................................................................. 64 
2.10.2 Main components of mass spectrometry: .................................................. 65 
2.10.2.1 Sample inlet system: .......................................................................... 65 
2.10.2.2 Ionization sources: ............................................................................. 66 
2.10.2.3 Mass analyzer: ................................................................................... 66 
2.10.2.4 Detector and data processing: ............................................................. 67 
2.10.3 MALDI-TOF Mass Spectrometer: ............................................................ 67 
2.10.3.1 MALDI Matrices: .............................................................................. 68 
2.10.3.2 Sample preparation in MALDI: .......................................................... 69 
2.10.3.3 Time-of-Flight analyzer in MALDI: ................................................... 70 
2.10.4 ESI Mass Spectrometer: ............................................................................ 71 
2.10.4.1 Mechanism of Electrospray ionization: .............................................. 72 
2.10.4.2 ESI spectrum appearance and Data processing: .................................. 73 
2.10.5 MALDI-TOF analysis of HRP-C* mutants: .............................................. 76 
2.10.6 Electrospray ionization of HRP-C* mutants: ............................................. 76 
2.11 Peroxidase activities under steady-state conditions: ......................................... 77 
2.11.1 Initial steady-state parameters for the oxidation of ABTS: ........................ 77 
2.11.2 Activity screening towards a panel of substrates: ...................................... 78 
2.11.3 Initial steady-state parameters with luminol as substrate: .......................... 78 
2.12 Pre steady-state kinetics measurements:........................................................... 80 
2.12.1 Introduction: ............................................................................................. 80 
2.12.2 Photodiode array experiments: .................................................................. 81 
2.12.3 Determination of k1 value: ........................................................................ 82 
2.12.4 Determination of k2 and k3 values: ............................................................ 83 
2.13 Crystallization of enzyme samples:.................................................................. 84 
Chapter Three: Generation of S167W and S167Y HRP-C* variants ..................... 86 
VIII 
 
3.1 Introduction:...................................................................................................... 86 
3.2 Design of primers: ............................................................................................. 88 
3.3 PCR products: ................................................................................................... 89 
3.4 Restriction enzyme analysis of E. coli transformants: ........................................ 90 
3.5 Sequencing of [S167Y]HRP-C and [S167W]HRP-C mutant genes: ................... 91 
3.6 Protein expression of [S167Y]HRP-C and [S167W]HRP-C mutants: ................ 91 
3.6.1 Small-scale protein expression: ................................................................... 92 
3.6.2 Large-scale protein expression, in vitro refolding and active enzyme 
purification:......................................................................................................... 93 
3.7 Conclusion: ....................................................................................................... 94 
Chapter Four: Characterisation of the new HRP-C S167 variants and evidence of 
covalent linkage ......................................................................................................... 95 
4.1 Introduction:...................................................................................................... 95 
4.2 Spectroscopic characterisation of the new S167 variants: .................................. 96 
4.3 BHA binding to WT HRP-C* and the new S167 variants: ................................. 99 
4.4 Treatment of [S167W] and [S167Y] HRP-C* variants with hydrogen peroxide:
 ............................................................................................................................. 103 
4.5 Evidence for the generation of a covalent linkage between the haem and the 
protein: ................................................................................................................. 105 
4.5.1 Pyridine haemochrome assay: ................................................................... 105 
4.5.2 Acid butanone haem extraction: ................................................................ 107 
4.5.3 High Performance Liquid Chromatography (HPLC) Analysis: ................. 110 
4.5.4 Protein analysis by Mass Spectrometry: .................................................... 114 
4.6 Crystal growth for [S167Y] HRP-C*: .............................................................. 119 
4.7 Conclusions:.................................................................................................... 120 
Chapter Five: Steady-state enzyme kinetics .......................................................... 123 
5.1 Introduction:.................................................................................................... 123 
5.2 Initial steady-state kinetics of ABTS oxidation: ............................................... 125 
5.3 Activity screening towards a panel of substrates: ............................................. 129 
5.5 Steady-state kinetics of luminol oxidation: ...................................................... 132 
5.6 Conclusion: ..................................................................................................... 134 
Chapter Six: Pre steady-state kinetic characterisation of HRP S167 variants and 
effect(s) of haem-protein covalent linkage ............................................................. 136 
6.1 Introduction:.................................................................................................... 136 
6.2 Stopped-flow rapid scan photodiode array: ...................................................... 139 
IX 
 
6.3 Pre steady-state enzyme kinetics: .................................................................... 142 
6.3.1 Determination of the rate constant (k1) for the reaction of resting enzyme with 
H2O2: ................................................................................................................ 142 
6.3.2 Auto-reduction and life time of Compound I: ........................................... 146 
6.3.2 Determination of the second-order rate constants (k2 and k3) for the HRP-C 
catalysed oxidation of luminol: .......................................................................... 147 
6.4 Conclusion: ..................................................................................................... 151 
Chapter Seven: Final discussion ............................................................................ 152 
7.1 X-ray crystal structure: .................................................................................... 155 
7.2 Finally to summarise the main results of this thesis: ........................................ 157 
References: .............................................................................................................. 159 
 
 
 
 
 
 
 
 
 
 
 
X 
 
List of Figures 
 
Chapter 1: 
Figure 1.1: Classification of haem-peroxidases. ........................................................... 4 
Figure 1.2: The overall protein fold for human MPO dimer .......................................... 7 
Figure 1.3: Schematic diagram of the caprine LPO monomer ....................................... 7 
Figure 1.4: Structure of ferriprotoporphyrin IX (haem)……………………… ............. .8  
Figure 1.5: The non-planar porphyrin ring in human MPO and its covalent attachments 
to the protein via two ester bonds and one sulfonium linkage……………… ................ .9 
Figure 1.6: The overall reaction mechanisms of mammalian peroxidases. .................. 16 
Figure 1.7: Ribbon representation of HRP-C* structure……………… .................... ..20 
Figure 1.8: Haem and catalytic residues in the active site of HRP-C…… ................... 22 
Figure 1.9: Calcium binding sites in HRP-C*…………………… ........................... ...25 
Figure 1.10: Aromatic donor molecules that can form complexes with HRP-C… ..... ..32 
 
Chapter 2: 
Figure 2.1: Simple scheme of an HPLC system, showing the main parts that make up 
the apparatus.. ............................................................................................................. 63 
Figure 2.2: Block diagram showing the main parts of a mass spectrometer. ................ 68 
Figure 2.3: The process of the formation of sample ions by MALDI source. .............. 72 
Figure 2.4: Chemical structure of the most common MALDI matrices. ...................... 73 
Figure 2.5: Diagram of a MALDI TOF-MS in (a) Linear mode and (b) Reflectron 
mode. .......................................................................................................................... 74 
Figure 2.6: Standard Electrospray ionization (ESI) spectrophotometer set up. ............ 76 
Figure 2.7: The formation of ions from droplets in ESI. ............................................. 77 
Figure 2.8: A positive ion ESI-MS spectrum of horse heart myoglobin.. .................... 79 
Figure 2.9: Sampling handling unit (SHU) of stopped flow spectrometer.. ................. 82 
XI 
 
Chapter 3: 
Figure 3.1: PCR-based whole plasmid amplification method of site-directed 
mutagenesis ................................................................................................................ 90 
Figure 3.2: Mutagenic and reference primers designed for the production of [S167Y] 
and [S167W] mutant genes, in the expression plasmid pFLAG1 ................................. 90 
Figure 3.3: 1% Agarose gel electrophoresis of WPAM PCR products. ....................... 90 
Figure 3.4: 1% agarose gel electrophoresis of BssSI digestion of DNA from 
transformed colonies for the putative pFLAG1-[S167Y]HRP-C mutant plasmid.. ....... 92 
Figure 3.5: 1% agarose gel electrophoresis of BssSI digestion of DNA from 
transformed colonies for the putative pFLAG1-[S167W]HRP-C mutant plasmid.. ...... 92 
Figure 3.6: 12% SDS-PAGE of small-scale mutant HRP-C protein expression .......... 93 
Figure 3.7: Cation exchange chromatography profile of [S167Y] HRP-C* ................. 95 
 
Chapter 4: 
Figure 4.1: UV/Visible absorption spectra of WT and the new S167 variants ............. 99 
Figure 4.2: The binding mode of BHA to resting state HRP-C* ............................... 100 
Figure 4.3: UV/Visible difference spectra resulting from titration of the S167Y (right) 
and S167W (left) HRP-C* variants with different concentrations of BHA.. ............... 103 
Figure 4.4: Change in absorption of the Soret peak obtained by titrating WT HRP-C*, 
S167Y and S167Y variants with different concentrations of BHA ............................. 103 
Figure 4.5: Repeat scan spectra collected during the reaction of [S167Y] HRP-C* with 
H2O2. ........................................................................................................................ 105 
Figure 4.6: Repeat scan spectra collected during the reaction of [S167W] HRP-C* with 
H2O2.. ....................................................................................................................... 105 
Figure 4.7: UV/Visible absorbance spectra of WT HRP-C*, treated and untreated 
S167Y variant with H2O2. ......................................................................................... 105 
Figure 4.8: UV/Visible absorbance spectra of WT HRP-C*, compared to H2O2 treated 
and untreated S167W. ............................................................................................... 105 
XII 
 
Figure 4.9: Comparison of the pyridine haemochrome difference spectra for WT HRP-
C* and the S167W variant ........................................................................................ 107 
Figure 4.10: Comparison of the pyridine haemochrome difference spectra for WT 
HRP-C* and the S167Y variant................................................................................. 107 
Figure 4.11: HPLC chromatograms of WT HRP-C* before and after treatment with 
H2O2. ........................................................................................................................ 114 
Figure 4.12: HPLC chromatograms of [S167W] HRP-C* before and after treatment 
with H2O2. ................................................................................................................ 114 
Figure 4.13: HPLC chromatograms of [S167Y] HRP-C* before and after treatment 
with H2O2. ................................................................................................................ 114 
Figure 4.14: HPLC chromatogram of [S167Y] HRP-C* folded and purified in the 
presence of ferulic acid.. ........................................................................................... 114 
Figure 4.15: Electrospray mass spectra of WT HRP-C*, [S167Y] HRP-C* and [S167Y] 
HRP-C* treated with H2O2. ....................................................................................... 119 
Figure 4.16: MassLynx auto-calculated mass from ESI-MS for HRP-C*, [S167Y] 
HRP-C* and [S167Y] HRP-C* treated with H2O2. .................................................... 119 
Figure 4.17: Selected crystals of the S167Y mutant of HRP-C*. .............................. 119 
 
Chapter 5: 
Figure 5.1: Chemical formula of ABTS and its oxidation product.. .......................... 126 
Figure 5.2: Plots depicting the initial rates (expressed as turnover numbers) against 
ABTS concentration.................................................................................................. 129 
Figure 5.3: Histogram illustrating the effects of mutations at position 167 of HRP-C* 
on kcat/Km values for the oxidation of ABTS. ............................................................. 129 
Figure 5.4: Histogram of specific activities for the oxidation of a panel of peroxidase 
substrates by Um[S167Y] and m[S167Y] HRP-C*. .................................................. 132 
Figure 5.5: Plots depicting the dependence of initial rates of luminol oxidation on 
luminol concentration during steady-state HRP-C assays. ......................................... 134 
XIII 
 
Figure 5.6: Histogram illustrating the effects of mutations at position 167 of HRP-C* 
on kcat/Km values for the oxidation of luminol. ........................................................... 134 
 
Chapter 6: 
Figure 6.1: The concentration changes in reaction participants in an enzyme-catalyzed 
reaction with time. .................................................................................................... 136 
Figure 6.2: Rapid scan absorption spectra of WT HRP-C* reaction with H2O2. ........ 142 
Figure 6.3: Rapid scan absorption spectra of S167W reaction with H2O2. ................ 142 
Figure 6.4: Rapid scan absorption spectra of UmS167Y reaction with H2O2............. 142 
Figure 6.5: Rapid scan absorption spectra of mS167Y reaction with H2O2. .............. 142 
Figure 6.6: Stopped-flow trace of Compound I formation of WT HRP-C*. .............. 144 
Figure 6.7: Stopped-flow trace of Compound I formation of [S167W] HRP-C*.. ..... 144 
Figure 6.8: Stopped-flow trace of Compound I formation of UmS167Y. .................. 144 
Figure 6.9: Stopped-flow trace of Compound I formation of mS167Y.. .................... 144 
Figure 6.10: Pseudo first-order rate constant plots for Compound I formation for WT 
HRP-C* and [S167W] HRP-C*. ............................................................................... 144 
Figure 6.11: Pseudo first-order rate constant plots for compound I formation for 
m[S167Y] and Um[S167Y] HRP-C*. ....................................................................... 144 
Figure 6.12: Stopped-flow traces of Compound I auto-reduction .............................. 147 
Figure 6.13: Stopped-flow traces of Compound II formation and reduction with 
luminol as reducing substrate.. .................................................................................. 150 
Figure 6.14: Plots of the pseudo first-order rate constants for Compound I reduction by 
luminol.. ................................................................................................................... 150 
Figure 6.15: Plots of the pseudo first-order rate constants for Compound II reduction by 
luminol. .................................................................................................................... 150 
 
Chapter 7: 
Figure 7.1: Ribbon representation for the structure of [S167Y] HRP-C* mutant. ...... 159 
XIV 
 
Figure 7.2: Five member ring linkage between Tyr167 and the haem vinyl group in the 
structure of the [S167Y] HRP-C* mutant. ................................................................. 159 
 
 
 
 
List of Tables 
 
Table 1.1: Electronic absorption spectra data of native mammalian peroxidases and 
some mutants of MPO................................................................................................. 12 
Table 2.1: Enzymatic reaction conditions for assays of WT HRP-C* and S167 variants 
with a range of substrates. ........................................................................................... 58 
Table 2.2: Layout of reservoir solutions for a 24 well VDX plate for HRP-C* variant 
crystallization. ............................................................................................................ 86 
Table 4.1: Spectrum parameters for resting state of WT HRP-C*, S167W and S167Y 
variants. ...................................................................................................................... 98 
Table 4.2: Dissociation constants (Kd) and the maximum absorbance change of the 
Soret peak (Amax) on the binding of BHA to HRP-C* and the new S167 variants. ...... 102 
Table 4.3: Spectral features of WT HRP-C* and the new S167 variants (both treated 
and untreated with 100 equivalents of H2O2) after treatment with alkaline pyridine ... 107 
Table 4.4: Acid butanone haem extraction of WT HRP-C*, [S167W] HRP-C*and 
[S167Y] HRP-C* ...................................................................................................... 109 
Table 4.5: Comparison of the molecular masses of WT, [S167W] and [S167Y] HRP-
C* treated and untreated with H2O2 ........................................................................... 118 
Table 5.1: Steady-state parameters of the oxidation of ABTS by WT HRP-C* and the 
new S167 variants. .................................................................................................... 129 
Table 5.2: Substrate activity screening of WT HRP-C* and the new S167 variants... 130 
Table 5.3: Steady-state parameters of the oxidation of luminol by WT HRP-C* and the 
new S167 mutants. .................................................................................................... 134 
XV 
 
Table 6.1: Second-order rate constants (k1) for Compound I formation by WT, 
Um[S167Y], m[S167Y] and [S167W] HRP-C*.. ...................................................... 144 
Table 6.2: Life times for Compound I of WT HRP-C*, [S167W] HRP-C*, Um[S167Y] 
HRP-C* and m[S167Y] HRP-C*. ............................................................................. 147 
Table 6.3: The pre steady-state kinetic parameters k2 and k3 obtained for WT HRP-C* 
and S167 variants, using luminol as reducing substrate. ............................................ 150 
 
 
 
 
List of Schemes 
 
Scheme 1.1: Pathways of formation and decay of reactive oxygen species.. .................. 3 
Scheme 1.2: The HRP-C ping-pong mechanism… ..................................................... 27 
Scheme 1.3: Proposed mechanism for the formation of Compound I in HRP-C.. ........ 29 
Scheme 1.4: Mechanism of Compounds I and II reduction in HRP-C by ferulic acid .. 30 
Scheme 7.1: Proposed mechanism for formation of a five member ring linkage between 
Tyr167 and 2-vinyl haem group in HRP-C*.. ............................................................ 159  
XVI 
 
Abbreviation 
 
5C-HS    Five-coordinate high spin 
6C-LS    Six-coordinate low spin 
ABTS    2,2´-azino-di-(3-ethyl-benzthiazoline-6sulphonic acid) 
BHA    Benzhydroxamic acid 
BSA    Bovine serum albumin 
DEAE    Diethylaminoethyl 
DHB    2,5-dihydroxybenzoic acid 
EDTA    Ethylenediaminetetraacetic acid 
EPO    Eosinophil peroxidase 
ESI    Electrospray ionization 
FA    Ferulic acid 
FPLC    Fast Protein Liquid Chromatography 
H2O2    Hydrogen peroxide 
HPLC    High performance liquid chromatography 
HRP    Horseradish peroxidase 
HRP-C   Horseradish peroxidase isoenzyme C 
IAA    Indole-3-acetic acid 
IPTG    Isopropyl-β-D-thiogalactopyranoside 
LPO    Lactoperoxidase 
MALDI   Matrix-Assisted Laser Desorption Ionization 
MeCN    Acetonitrile  
MPO    Myeloperoxidase 
MS    Mass spectrometry 
PCR    Polymerase chain reaction 
PNK    Polynucleotide kinase 
rpAPX    Recombinant pea ascorbate peroxidase 
RZ    Reinheitszahl number 
SA    Sinapic acid 
TBE    Tris-borate-EDTA 
TPO    Thyroid peroxidase 
WPAM   Whole Plasmid Amplification Method 
α-CHCA    α-cyano-4-hydroxycinnamic acid 
1 
 
Chapter One: 
Introduction 
 
 
 
1.1 Peroxidases: 
 
Peroxidases are a group of enzymes that catalyze oxidation-reduction reactions. They 
were among the first enzymes to be discovered, more than a century and a half ago 
(Dunford, 1991). In 1855 Schonbein observed the ability of the compound hydrogen 
peroxide (H2O2) to oxidise certain organic compounds such as guaiacol, which was 
explained later by the presence of the enzyme peroxidase. The term peroxidase was 
used for the first time in 1898, when Linossier used this term for the enzyme that he was 
isolating from pus (Azevedo et al., 2003). Peroxidases are classified as oxido-reductases 
and are given the official [EC number 1.11.1.]. Simply, the overall reaction catalysed by 
peroxidases can be expressed by the following equation: 
 
 
 
Peroxidases are widely distributed throughout the biological world. They are found in 
many plants, in many animal tissues and in micro-organisms. These enzymes carry out a 
variety of biosynthetic and degradative functions with the concomitant consumption of 
peroxide compounds as oxidant, especially H2O2. In addition, they are responsible for 
protecting cells against the accumulation of these dangerously reactive peroxide 
compounds, that form as side-products of oxygen metabolism (Poulos and Kraut, 1980; 
Arnhold et al., 2006). 
Donor + H2O2                                     oxidised donor + 2 H2O 
Peroxidase 
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Toxic molecules such as superoxide radicals, hydrogen peroxide and hydroxide radicals 
can be found in cells as side-products of metabolic reactions that involve the reduction 
of O2 (Fridovich, 1998). Oxidative phosphorylation by mitochondria is one of the major 
sources of these metabolic reactions, and results in the production of superoxide free 
radicals (Loschen et al., 1974). Several enzymes are also known to produce superoxide 
as a side-product, including aldehyde oxidase (Rajagopalan et al., 1962), cytochrome 
P450 reductase (Bosterling and Trudell, 1981) and xanthine oxidase (McCord and 
Fridovich, 1968). Therefore, the primary radical produced in biological systems is the 
superoxide radical. This undergoes conversion into many other radicals, including the 
extremely reactive hydroxyl radical. It is thus important for organisms to get rid of the 
superoxide toxic molecule quickly, so that other more dangerous oxidants (e.g. 
hydroxyl radicals) do not accumulate. This reduces the risk of cell damage that occurs 
due to oxygen radicals, such as lipid peroxidation of membrane walls (Bus et al., 1974), 
DNA damage (Halliwell and Gutteridge, 1989) and protein damage (Davies, 1987; 
Davies et al., 1987). 
 
The major defence system against superoxide involves a family of metalloenzymes, 
called superoxide dismutases, by which superoxide is converted to oxygen and H2O2 
(Fridovich, 1986). So the degradation of superoxide produces hydrogen peroxide, but 
while hydrogen peroxide is not as potent an oxidising agent as superoxide, it is still 
dangerous to the cell. Hydrogen peroxide is therefore removed by two peroxidatic types 
of enzyme, catalase and peroxidase (Fridovich, 1998). Catalases decompose hydrogen 
peroxide into water and oxygen, whereas peroxidases reduce hydrogen peroxide to 
water. Peroxidases act as electron acceptors when they have reacted with hydrogen 
peroxide, they then dissipate their oxidative potential via reaction with a variety of 
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substrates (Smith and Veitch, 1998). Thus, peroxidases are oxido-reductases, which use 
H2O2 as an electron acceptor for catalyzing a wide variety of oxidative reactions. The 
pathways of formation and decay of reactive oxygen species is shown in Scheme 1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.1: Pathways of formation and decay of reactive oxygen species. 
 
1.2 Classification of Peroxidases: 
 
Peroxidases are found in animals, plant and microorganisms, and they are classified as 
metalloenzymes. The greater proportion of them contains the ferri-protoporphyrin IX 
(haem) as a prosthetic group in their active site (Smith and Veitch, 1998). On the basis 
of their structural and catalytic properties, haem-containing peroxidases can be divided 
into two main superfamilies, the mammalian peroxidase superfamily and the plant 
peroxidase superfamily (Figure 1.1) (Welinder, 1991; Dunford, 1999a; Dunford, 
1999b). In addition, there are two further, rather indistinct groups of haem peroxidases, 
chloroperoxidases (Sundaramoorthy et al., 1995) and the di-haem cytochrome c 
peroxidases (Fulop et al., 1995). 
(Oxygen)    2O2 
2e - 
O2  +  O2 
2H+ 
Superoxide dismutase 
Hydrogen peroxide 
H2O2        +    O2 
2H2O   +   O2 
AH2 H2O2 
2H2O   +   A 
Peroxidase Catalase 
. - .- Superoxide 
anion radical 
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The primary sequences and three dimensional structures of the plant and mammalian 
peroxidase superfamilies are quite different and distinct. The most important chemical 
difference between them is in the nature of the interactions that bind the apo-protein to 
the haem prosthetic group. 
 
1.3 Mammalian peroxidase superfamily: 
 
This superfamily includes enzymes such as myeloperoxidase, MPO, (EC 1.11.1.7), 
thyroid peroxidase, TPO, (EC 1.11.1.7), eosinophil peroxidase, EPO, (EC 1.11.1.7), 
lactoperoxidase, LPO, (EC1.11.1.7) and a partial region of prostaglandin endoperoxide 
synthase (EC 1.14.99.1) (Figure 1.1). The naming of the mammalian peroxidase 
superfamily derived from the fact that its members were originally identified only in 
mammals (Hiraga et al., 2001; Zederbauer et al., 2007b). Note that, although 
glutathione peroxidase is categorized as an animal peroxidase (Churin et al., 1999), it is 
not a member of this superfamily and does not contain a haem group.  
 
1.3.1 Functional importance: 
 
The main functions of mammalian peroxidases are in host defence against infections, 
pathogenesis of microorganisms and hormone synthesis (Furtmuller et al., 2006). MPO, 
EPO and LPO play a prominent role in the immune system by exerting antimicrobial 
effects indirectly through catalyzing the hydrogen peroxide mediated peroxidation of 
halide ions, particularly chloride and the pseudo-halide thiocyanate (Harrison and 
Schultz, 1976; Klebanoff, 1991; Thomas et al., 1991; Van Dalen et al., 1997), to form 
the powerful antimicrobial agents hypohalous and hypothiocyanous acids, respectively, 
as described by the following equation where X− represents the halide or thiocyanate: 
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The products of this equation are responsible for the killing of invading pathogens and 
viruses (Belding et al., 1970; Klebanoff, 1970; Zederbauer et al., 2007b). MPO is the 
most abundant protein present in the azurophilic granules of neutrophils and in the 
lysosomes of monocytes. It represents the cornerstone of cell-mediated antimicrobial 
activity in the innate immune system of humans (Zederbauer et al., 2007b). LPO is 
found in human exocrine secretions, such as milk, tears and saliva, that represent the 
first line of protection against harmful microorganisms entering the human body 
(Thomas et al., 1991). EPO is released from activated eosinophils and plays an 
important role in eliminating tissue-invasive parasites (Gleich et al., 1989). In contrast, 
TPO has a key role in the biosynthesis of the thyroid gland hormones, thyroxin and 
triiodothyronine (Taurog, 1970). 
 
1.3.2 Structures of mammalian peroxidases: 
 
For the mammalian peroxidases, the crystal structures of MPO and LPO have been 
solved, while the structures of EPO and TPO are not yet known. The crystal structure of 
MPO became available in 1992, when Zeng and Fenna were able to determine the 
overall enzyme structure at 3 Å resolution by X-ray crystallography of the canine 
enzyme (Zeng and Fenna, 1992). After that, the X-ray crystal structure of human MPO 
at 2.8 Å and 2.3 Å resolution was obtained, and this structure has since been extended to 
1.9 and 1.8 Å resolution using data recorded at -180 oC (Fiedler et al., 2000; Blair-
Johnson et al., 2001; Capena et al., 2009). Recently, the crystal structure of caprine 
(goat) LPO at 2.4 Å resolution has been determined (Singh et al., 2008). 
_ + H2O2   +   X     +    H3O                            HOX     +    2H2O 
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Figure (1.2) shows the overall protein fold for human MPO (Fiedler et al., 2000). 
Human mature MPO is a glycosylated, cationic, dimeric molecule with a single 
disulfide bridge between the two monomers. Each symmetry related monomer (73 
kDa), contains two polypeptide chains of 14.5 and 58.5 kDa respectively, known as 
heavy and light chains. The heavy chain is composed of 467 amino acids and contains 
five intra-chain disulfide bridges, while there are 106 amino acids in the light chain with 
one intra-chain disulfide bridge. The secondary structure is largely α-helical, with very 
little β-sheet, with a total of 22 helices ranging in length from 4-29 residues (Zeng and 
Fenna, 1992; Fiedler et al., 2000).  
 
Human mature EPO (69.8 kDa) is a highly cationic, monomeric glycoprotein consisting 
of 715 amino acids. The molecule has two polypeptide chains, a 57.9 kDa heavy chain 
and a 11.9 kDa light chain, similar to the arrangement of the MPO monomer (Carlson et 
al., 1985; Olsson et al., 1985; Furtmuller et al., 2006). 
 
Human LPO is a predominantly α-helical single-chain polypeptide glycoprotein with 
molecular weight of 80 kDa. The DNA sequence of human LPO codes for a protein of 
712 amino acids with an observed 51 % similarity on basis of sequence alignment with 
both human MPO and EPO (Langbakk and Flatmark, 1989; Ueda et al., 1997). The 
complete amino acid sequence determination of caprine LPO shows that it is a single-
chain polypeptide of 595 amino acid residues including 15 cysteine residues that form 
seven disulfide bridges. From X-ray data the monomeric structure is largely α-helical 
with only two small anti-parallel β-sheets (Singh et al., 2008). Figure 1.3 depicts a 
schematic diagram of the caprine LPO molecule. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: The overall protein fold for human MPO dimer. The heavy polypeptides 
of the two halves are coloured red and blue, whereas the light polypeptides are in a 
lighter shade of the same colour. Other colour coded features include: haems (green), 
carbohydrate (orange), calcium (pink), and chloride (yellow). At the centre of the 
molecule the disulfide linking the two monomers is shown in black. This figure is 
reproduced from Fiedler et al., 2000. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Schematic diagram of the caprine LPO monomer. α-helices are 
represented as cylinders, and β-sheets are indicated by arrows. The iron atom is shown 
as a brown-coloured sphere, iodine ions are shown as purple-coloured spheres, and the 
calcium ion is shown as a grey-coloured sphere. The haem moiety is indicated in CPK 
representation (green), and the four carbohydrate chains attached to Asn95, Asn205, 
Asn241, and Asn332 are shown in ball-and-stick representation. The helices have been 
numbered. This figure is reproduced from Singh et al., 2008. 
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The gene for human TPO encodes a single-chain polypeptide consisting of 933 residues 
which has a molecular weight of approximately 100 kDa. Compared to the other 
mammalian peroxidases TPO has a C-terminal extension and is a type-1 glycosylated 
transmembrane protein (Kimura et al., 1987; Baker et al., 1994; Nishikawa et al., 
1994). In general therefore, the overall structures of the four mammalian peroxidases 
seem to have a similar core. Each monomer, or catalytic domain, of these peroxidases 
also contains one iron atom, present as a covalently bound ferri-protoporphyrin IX 
derivative, in addition to one calcium ion (Zederbauer et al., 2007b).  
 
1.3.3 Active site architecture of mammalian peroxidases: 
 
The haem group is essential to the active site of all peroxidase enzymes. This group 
consists of a ring structure, called a tetrapyrrole ring system, complexed to a central iron 
atom. The pyrrole rings are linked together by methene bridges (-CH=) to create a 
conjugated double bond system where electrons can be shared across the whole ring. 
The carbon atoms of the methene bridges are located at positions α, β, γ and δ. Each 
pyrrole ring bears a number of different side chains; four methyl groups are located at 
positions 1, 3, 5 and 8, two vinyl groups at positions 2 and 4 and two propionate groups 
are present at positions 6 and 7 (Figure 1.4) (Dunford, 1999e). 
 
One of the most important structural features of mammalian peroxidases is the nature of 
the binding of the haem group to the protein molecule. In MPO the methyl groups on 
pyrrole rings A and C of the protoporphyrin IX are modified to allow the formation of 
ester linkages with the carboxyl groups of Glu242 of the heavy polypeptide chain and 
Asp94 of the light polypeptide chain (human enzyme). In addition, the β-carbon of the 
vinyl group on pyrrole ring A forms a covalent bond with the sulfur atom of Met243 of 
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the heavy chain (human enzyme), giving rise to a sulfonium ion linkage (Figure 1.5). 
By these interactions the haem porphyrin ring is considerably distorted from planarity 
and takes on a bow-shaped structure (Fiedler et al., 2000).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Structure of ferri-protoporphyrin IX (haem). The modified Fisher 
numbering system is used to describe the overall structure (Dunford, 1999e). 
 
 
The full mode of haem binding revealed by Fiedler and co-workers (Fiedler et al., 2000) 
is so far unique to MPO. Although all other members of the mammalian peroxidase 
superfamily contain equivalents to Asp94 and Glu242 in their sequences, they lack a 
methionine at positions equivalent to 243. There is a lot of biochemical and biophysical 
evidence which confirms the presence of haem-protein ester linkages, analogous to 
those of MPO, in human LPO using Asp225 and Glu375 (Andersson et al., 1996; Rae 
and Goff, 1996; DePillis et al., 1997; Suriano et al., 2001; Colas et al., 2002), in human 
EPO through Asp93 and Glu241 (Oxvig et al., 1999), and in human TPO using Asp238 
and Glu399 (Taurog, 1999). However, the methionine at position 243 in human MPO is 
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substituted by threonine in human EPO (Sakamaki et al., 1989), whereas in human TPO 
a valine is found at this position (Kimura et al., 1987); also human LPO has been shown 
to contain a histidine at this position (Ueda et al., 1997), and in bovine LPO a glutamine 
is present (Cals et al., 1991). Thus, the sulfonium linkage from the protein to the ring A 
vinyl group is a unique feature of MPO, and the presence of this positively charged 
sulfur atom covalently attached to a pyrrole ring vinyl group may be responsible for the 
unusual spectral properties that distinguish this protein from other mammalian 
peroxidases (Fenna et al., 1995). It is important to note here that all covalent links 
between the haem and the protein lie on the distal side of the haem group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: The non-planar porphyrin ring in human MPO and its covalent 
attachments to the protein via two ester bonds [Asp94 and Glu242] and one 
sulfonium linkage [Met243]. In addition the catalytic residues His95, Arg239, and 
Gln91 are shown, the latter being important in halide binding. The figure was 
constructed by Accelrys DS visualizer using the coordinates deposited in the PDB 
(accession code 1CXP). 
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1.3.4 Spectral features of mammalian peroxidases: 
 
In the haem of haemoproteins, there are four coordination positions in a plane around 
the iron atom which are occupied by nitrogen atoms of the porphyrin, and the fifth 
coordination position at least, and possibly the sixth position also, is occupied by a 
donor group from the protein. In peroxidases, the fifth position is occupied generally by 
a nitrogen atom of the imidazole group of a histidine residue (referred to as the proximal 
histidine). Two main spin states are found for the ferri-protoporphyrin of peroxidases. 
The first has the spin moment of five unpaired electrons (spin 5/2) and is called the high 
spin state, while the second has only one unpaired electron (spin 1/2) and is called the 
low spin state (Brill and Williams, 1961). 
  
The electronic absorption spectra of haem proteins are characterised by the presence of 
two groups of intense bands. The first group, which includes Soret, α and β bands, is 
due to transitions of the π-electrons of the haem porphyrin group, while the second 
group consisting of two bands, one at about 600-650 nm (CTI) and the other at 450-500 
nm (CTII), is due to charge transfer to the high spin Fe3+ ion. The analysis of absorption 
spectra therefore allows one to establish the coordination and spin-state(s) of the haem 
iron atom, on the basis of correlation with structurally characterised proteins and model 
compounds. Both high and low spin states show typical Soret, α and β bands. The 
intensity of the α and β bands is low in the high spin state, and they are often obscured 
by the charge transfer bands, while the charge transfer bands are absent in the low spin 
state. The intensity of the α band in the low spin state is very dependent on the character 
of the fifth and sixth ligands, but the β band intensity is almost independent of the fifth 
and sixth ligands (Brill and Williams, 1961). 
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The unusual, additional, haem-protein covalent binding in mammalian peroxidases is 
responsible for their peculiar spectroscopic properties. The Soret bands of the visible 
absorption spectra of mammalian peroxidases are characteristically red-shifted with 
respect to those seen for other haem proteins, and this spectral shift has generally been 
ascribed to the influence of the protein environment on the spectral properties of the 
haem. LPO, TPO and EPO have two ester bonds in their structures between the haem 
and protein. MPO is distinctive from other mammalian peroxidases in that it forms an 
extra covalent sulfonium ion linkage between the haem and protein. This difference in 
the number of linkages that bind the protein with the haem has been interpreted as the 
major factor that contributes to the variation in optical properties between MPO and 
other mammalian peroxidases (Fiedler et al., 2000; Zederbauer et al., 2007b). 
 
Spectral analysis of LPO shows that the Soret band is fairly sharp with a maximum at 
412 nm, and the visible spectrum also exhibits maxima at 501, 542, 595, and 631 nm. 
The width and wavelength of the Soret band, as well as the wavelength of CT1 at 631 
nm are characteristic of a six-coordinate (6C) high-spin (HS) ferric haem (Eaton and 
Hochstrasser, 1967; Sievers, 1980; Zederbauer et al., 2007b). The spectral features of 
both EPO and TPO are very similar to that of LPO (Table 1.1). The absorption maxima 
of MPO are red shifted compared to other mammalian peroxidases, and are responsible 
for the characteristic green colour of the enzyme. The visible spectrum displays a Soret 
band at 428 nm, with additional maxima at 498, 570, 622 and 690 nm (Andrews and 
Krinsky, 1981; Wever and Plat, 1981). Important in this regard, it is noteworthy that 
replacement of Met243 (the residue responsible for the sulfonium linkage) in MPO 
produces an enzyme that exhibits a Soret band at 410–412 nm, considerably blue-
shifted from the 428 nm band of the native enzyme and similar to those of the other 
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mammalian peroxidases (Jacquet et al., 1994; Kooter et al., 1997a; Kooter et al., 
1999b). Similarly, the E242Q mutant of MPO, presumably lacking one of the haem-
protein ester bonds, exhibits a blue-shifted Soret band at 416–418 nm, and the mutants 
D94N and D94V, presumed to lack the other ester bond, also have a blue-shifted Soret 
band at 413-414 nm (Jacquet et al., 1994; Floris et al., 1995; Kooter et al., 1999a). 
These studies strongly suggest that the presence of one more linkage from the haem to 
the protein in MPO is responsible for its unusual spectral properties. 
 
Table 1.1: Electronic absorption spectra data of native mammalian peroxidases 
and some mutants of MPO. 
Enzyme 
Soret peak 
(nm) 
CTI 
(nm) 
CTII 
(nm) 
α band 
(nm) 
β band 
(nm) 
LPOa 412 631 501 595 542 
EPOb 413 638 500 580 542 
TPOc 412 638 496 582 547 
MPOd,e 428 690 498 622 570 
M243T MPOf 413 690 502 590 548 
D94V MPOg 413, 428 682 596 620 568 
E242Q MPOh 418 665 508 647 554 
 
a(Sievers, 1980), b(Furtmuller et al., 2006), c(Dunford, 1999c), d(Zederbauer et al., 2007b), e(Wever and Plat, 1981), 
f(Kooter et al., 1999c), g(Kooter et al., 1999a), h(Kooter et al., 1999b). 
 
 
 
It is also clearly evident that the extra haem-protein covalent linkages are important in 
maintaining the catalytic activities of mammalian peroxidases. The catalytic properties 
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of mutants of human MPO, in which residues involved in the covalent ester or 
sulfonium haem attachments were replaced, were found to be markedly different from 
those of the native enzyme. Mutation of Met243 had a huge effect on the activity of the 
enzyme, neither the M243Q nor the E242Q mutants showed chlorination activity and 
both mutants had reduced catalytic activities when substrates for single electron 
oxidation reactions were used. In addition, the D94N mutant had about 30% peroxidase 
activity while the D94V mutant had activity at even lower levels (a small percentage 
activity was observed) (Floris et al., 1995; Kooter et al., 1997a; Kooter et al., 1999a; 
Kooter et al., 1999b). 
 
1.3.5 Mechanism of action of mammalian peroxidases: 
 
Mammalian peroxidases efficiently catalyze both oxidation and halogenation cycles, 
producing oxidizing and halogenating agents. The first step of these cycles is the 
reaction of the ferric haem [Fe(III)] form of the peroxidase with hydrogen peroxide to 
form a redox intermediate called Compound I (Step 1). Compound I, which has a 
porphyrin π-cation radical and an oxygen atom coupled by a double bond to Fe (IV), 
contains two oxidizing equivalents more than the resting enzyme (Dolphin and Felton, 
1974; Marquez et al., 1994). 
 
 
 
Under physiological conditions, mammalian peroxidases are characterised by their 
ability to oxidise halides and thiocyanate into hypohalous and hypothiocyanous acids, 
respectively, with concomitant reduction of Compound I in a two-electron step back to 
Native enzyme                                     Compound I 
PorFe(III)  +  H2O2                      •+PorFe(IV)=O  +  H2O              Step 1 
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the ferric enzyme form (Step 2, where: X− represents the halide or thiocyanate and HOX 
the corresponding acid).  
 
 
 
This step along with step 1 above is the fall halogenation cycle (Figure 1.6). The 
electron donors can be arranged by the ease of oxidation as follows: SCN− > I− > Br− > 
Cl− (Arnhold et al., 2006). All haem peroxidases, including plant superfamily 
peroxidases without extra covalent haem links, can oxidise iodide and thiocyanate. The 
more difficult oxidation of bromide is catalyzed by mammalian peroxidases, but with 
less efficiency also by the plant peroxidases (Munir and Dordick, 2000). However, 
MPO Compound I is the only one that is capable of oxidizing chloride at pH 7.0 
(Marquez et al., 1994; Furtmuller et al., 1998), by a mechanism that includes a 
Compound I-chloride intermediate. At low chloride concentration, the formation of 
Compound I-chloride is rate limiting, while at high chloride concentration the transition 
back to native enzyme and the formation of the hypochlorous acid is rate controlling 
(Furtmuller et al., 2000). It has been observed that the presence of the sulfonium linkage 
in human MPO has a significant role to play in chloride oxidation. Mutation of Met243 
into Thr, Gln or Val (the corresponding residues in EPO, LPO and TPO) all had a 
dramatic effect on the overall chlorination activity. With the exception of M243T, all 
variants completely lost their chlorination activity (Kooter et al., 1999b). In addition, it 
was found that replacement of the ester residue Glu242 by Gln lead to a decrease in the 
overall chlorination and bromination activity to 20% and 24%, respectively, compared 
to wild-type recombinant MPO. The variants D94N and D94V have also been shown to 
have a chlorination activity substantially lower than that of wild-type MPO (Kooter et 
•+PorFe(IV)=O   +   X−   +   H+                        PorFe(III)  +  HOX        Step 2 
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al., 1999a; Zederbauer et al., 2005; Zederbauer et al., 2007a). Also, the peroxidative 
activity of recombinant LPO was shown to be highly dependent on the number of esters 
to the haem in the enzyme (DePillis et al., 1997). 
 
Compound I of mammalian peroxidases can also react with numerous other substrates, 
including tyrosine, tryptophan, nitrite, phenol and indole derivatives, by two 
consecutive one-electron steps to produce the ferric enzyme again. This process 
involves the formation of a second intermediate called Compound II [PorFe(IV)=O], 
and leads to the formation of substrate free radicals as shown in the following, Steps 3 
and 4. 
 
 
 
 
These two steps, in addition to the oxidation of the ferric enzyme by hydrogen peroxide 
(Step 1), are combined to form the peroxidase cycle (Figure 1.6) (Marquez and 
Dunford, 1995; Burner et al., 1999; Jantschko et al., 2002; Zederbauer et al., 2007b). 
 
Finally, in the absence of one-electron donors, a third enzyme state named Compound 
III is formed slowly. This can occur either by reaction of Compound II with hydrogen 
peroxide (Step 5) or by the fast reaction of superoxide with native enzyme (Step 6) 
(Dunford, 1999d). 
 
 
 
PorFe(IV)=O +  AH2  +  H+                      PorFe(III) + •AH  +  H2O   Step 4 
  •+PorFe(IV)=O  + AH2                        PorFe(IV)=O  +  •AH +  H+      Step 3 
Compound II 
PorFe(IV)=O  +    H2O2                           PorFe(II)O2  +  H2O           Step 5 
 Compound III 
PorFe(III)  + O2•−                        PorFe(II)O2                                 Step 6 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: The overall reaction mechanisms of mammalian peroxidases. Both 
halogenation and peroxidase cycles utilize hydrogen peroxide to oxidise the native 
ferric peroxidase to Compound I. AH2 and •AH represent substrate being oxidised and 
the formed radical product, respectively. X− represents halide or thiocyanate and HOX 
the corresponding acid. 
Native enzyme                                                      Compound I 
PorFe(III)   •+PorFe(IV)=O   
X− 
PorFe(IV)=O   
HOX 
H2O2 
Compound III 
AH2 
•AH 
H2O 
Compound II   
H2O2 H2O 
PorFe(II)O2   
AH2 
•AH  
O2•− O2•− 
Halogenation cycle 
Peroxidase cycle 
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1.4. Plant peroxidase superfamily: 
 
The second superfamily of peroxidases, the plant peroxidase superfamily, consists of 
peroxidases from plants, fungi, bacteria and yeast. This superfamily has been further 
subdivided on the basis of sequence and structural homology into three classes (Figure 
1.1) (Welinder et al., 1992). 
 
1.4.1. Class I. Peroxidases of prokaryotic origin: These include the 
intracellular enzymes in plants, bacteria and yeast, such as microbial cytochrome c 
peroxidase (EC 1.11.1.5), bacterial catalase-peroxidase (EC 1.11.1.6) and ascorbate 
peroxidase (EC 1.11.1.11). In fact, ascorbate peroxidase is not plant-specific, it has also 
been isolated and purified successfully from the bovine eye with the N-terminal 
sequence of the purified enzyme showing a very high homology to plant enzymes 
(Wada et al., 1998). Class I peroxidases are characterised by the fact that they do not 
have glycosylation, cysteine disulphide bridges, calcium ions or N-terminal signal 
sequences for secretion. It was observed that the Trp191 residue of the yeast 
cytochrome c peroxidase appears to be conserved in other Class I peroxidases 
(Welinder, 1992; Dunford, 1999b). 
 
1.4.2 Class II. Secreted fungal peroxidases: These are extracellular peroxidases 
from fungi, including Coprinus cinereus peroxidase, CiP, (EC 1.11.1.7), lignin 
peroxidase, LiP, (EC 1.11.1.14) and Mn+2-dependent peroxidase, MnP, (EC 1.11.1.13). 
Unlike the Class I peroxidases, the fungi secretory peroxidases are characterised by 
having an N-terminal signal sequence for secretion. Also, they have about 5% 
carbohydrate, two calcium ions and four conserved disulfide bridges in their structure 
(Welinder, 1992). Tyrosine residues are rare in Class II peroxidases, appearing once 
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only in lignin peroxidases, and absent from other class members. Class II peroxidases 
have an additional 40 to 60 amino acid residues at their C-termini, compared to the 
peroxidases in other classes (Welinder, 1992). 
 
1.4.3 Class III. Classical secretory plant peroxidases: The most intensively 
studied and well known enzyme in this class is horseradish peroxidase (HRP, EC 
1.11.1.7). Besides the structure of horseradish peroxidase, HRP, other known Class III 
structures are those for peanut peroxidase, PNP, (Schuller et al., 1996), soybean 
peroxidase, SoP, (Puppo et al., 1980), turnip peroxidase, TuP, (Hosoya, 1960), tobacco 
peroxidase, TobP, (Mader and Fussl, 1982) and barley peroxidase, BaP, (Henriksen et 
al., 1998b). Similarly to Class II peroxidases, the Class III peroxidases contain two ions 
of calcium, an amino-terminal signal sequence for secretion and four conserved 
disulfide bridges. In addition, they have extra helices that play a role in restricting 
access to the haem edge and binding aromatic electron donor molecules. The 
carbohydrate content in their structures ranges between 0-25% (Welinder et al., 1992). 
 
A comparison of the structures of plant peroxidase superfamily enzymes shows that all 
members contain 10 common α-helices, which can be considered as two five-helical 
structures, one the distal domain, and the other the proximal domain. Members of 
Classes I and II have one extra helix unique to their Class, whilst there are three extra 
helices found in Class III peroxidases, two of these three helices, F and F" are involved 
in the substrate access channel leading to the edge of the haem (Schuller et al., 1996; 
Gajhede et al., 1997). 
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1.5 Horseradish Peroxidase: 
1.5.1 Horseradish: 
 
The horseradish (Armoracia rusticana) belongs to the family Brassicaceae (Crusiferae). 
Horseradish is a hardy perennial herb cultivated in temperate regions of the world, 
particularly, South-Eastern Europe, Western Asia and North America. Principal 
production areas are located in the USA and, to a lesser extent, Europe. The plant grows 
up to 1.5 metres tall and is mainly cultivated for its large white root, which grows 
entirely underground to about 1 metre. The root contains a pungent, acrid and vesicating 
volatile oil. It also contains useful minerals including calcium, sodium, magnesium and 
vitamin C; the fresh root contains an average of 302 mg per 100 g vitamin C (Peter, 
2004). 
 
Horseradish is the only natural source of horseradish peroxidase. Production of the 
enzyme from horseradish roots occurs on a relatively large scale due to its commercial 
uses; it is used in diagnostic, analytical, biochemical and biotechnological applications, 
for example as a component of clinical diagnostic kits, and for immunoassays (Tijssen 
and Kurstak, 1984; Maidan and Heller, 1992; Garguilo et al., 1993; Veitch, 2004).  
 
1.5.2 General introduction to the enzyme: 
 
Horseradish peroxidase (HRP, EC 1.11.1.7), is one of the most important haem-
containing enzymes obtained from a plant source and has been studied for more than a 
century. The first observation of a reaction catalysed by horseradish peroxidase was by 
Lois Antonie Planche when he mentioned it in his note of 1810 (Veitch and Smith, 
2001; Veitch, 2004). 
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Horseradish peroxidase is not one enzyme, but a group of isoenzymes. As long ago as 
1958, five isoenzymes had been isolated from horseradish root using 
carboxymethylcellulose chromatography, called HRP A, B, C, D and E (Paul, 1958). In 
1966 seven isoenzymes were isolated and purified using DEAE-cellulose 
chromatography, where HRP-A could be further resolved into three fractions called A1, 
A2 and A3 (Shannon et al., 1966). Since then, more than 40 isoenzymes have been 
identified and they are divided into groups according to their isoelectric points. The 
acidic group contains A1, A2 and A3 isoenzymes, the neutral group contains B and C 
isoenzymes and the basic group contains D and E isoenzymes (Kay et al., 1967; Shin et 
al., 1971; Veitch and Smith, 2001). HRP-C is the most abundant isoenzyme isolated 
from horseradish root. Significant progress has been made on HRP-C structure and 
function since 1990, after a recombinant form of the enzyme, HRP-C*, was expressed 
successfully in E. coli and refolded in vitro (Smith et al., 1990). Native HRP-C enzyme 
has 18-22% carbohydrate, attached to the enzyme through eight asparagine residues 
Asn13, Asn57, Asn158, Asn186, Asn198, Asn214, Asn255 and Asn268, evenly 
distributed over the surface of protein but with some heterogeneity (Chance and 
Maehly, 1955; Welinder and Mazza, 1975; Welinder, 1976; Welinder, 1979). 
 
1.5.3 Structure of horseradish peroxidase: 
1.5.3.1 General features: 
 
HRP-C was completely sequenced in 1976 (Welinder, 1976), although the first solution 
of its three dimensional structure using X-ray crystallography was not achieved until 
1997 on the recombinant enzyme HRP-C* (Figure 1.7) (Gajhede et al., 1997). The 
enzyme has been characterised as a single polypeptide chain with 308 amino acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Ribbon representation of HRP-C* structure. Helices are shown in red 
colour while the small region of β structure is shown as a light blue arrow. The haem 
group is shown in red. The structure also has two calcium ions in green. The figure was 
constructed by Accelrys DS visualizer using the coordinates deposited in the PDB 
(accession code 2ATJ). 
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residues, folded into the 10 core α helices plus 3 extra helices and molecular weight of 
33,890 Da (Welinder, 1979). It has four disulfide bridges Cys11–Cys91, Cys44–Cys49, 
Cys97–Cys301 and Cys177–Cys209 (Welinder, 1976). Two different types of metal 
centre are found in HRP-C, which play essential roles in the structural and functional 
integrity of the enzyme; these are iron (III) protoporphyrin IX and two calcium ions 
(Haschke and Friedhoff, 1978; Shiro et al., 1986; Gajhede et al., 1997). 
 
1.5.3.2 Haem prosthetic group: 
 
HRP-C contains iron (III) protoporphyrin IX (ferri-protoporphyrin IX), i.e. a haem 
group, as a prosthetic group in its active site. In addition to the four coordination 
positions with the nitrogen atoms of the porphyrin pyrrole rings, the haem iron has two 
axial coordination sites (the fifth and sixth positions) where binding can also occur. The 
haem group is attached to the protein at the fifth position through a covalent bond 
between the iron atom and the Nε2 atom of His170 (proximal histidine). The sixth 
coordination site is essentially unoccupied in the resting state of the enzyme (Veitch and 
Smith, 2001; Veitch, 2004). Indeed, this is the only covalent link between the haem 
prosthetic group and the protein; there are no additional covalent linkages observed 
similar to those in mammalian peroxidases between the protein and porphyrin (Kooter 
et al., 1997b). Nevertheless, between the haem group and the protein there is a hydrogen 
bonding network, between the propionate groups and the amino acid side chains of 
Glu176, Ser73, Ser35 and Arg31 (Gajhede et al., 1997). 
 
The spin state of the Fe (III) in the haem group depends greatly on the orbital occupancy 
of its d-orbital electrons. The nature of this occupancy is influenced by the ligand bond 
electrons at the fifth and sixth iron atom positions (Dunford, 1999f). In HRP, the ferric 
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iron has five unpaired electrons in the d-orbital (spin 5/2) and is referred to as high spin. 
Indeed, it is reasonable to state that the dominant species of the resting state of HRP-C 
is five-coordinate high spin (5C-HS), although a small amount of six-coordinate high 
spin haem (6C-HS) can be detected. In the presence of a ligand in the sixth coordination 
site of the ferric iron, the spin state is affected due to the impact of the ligand field on 
the distribution of electrons in the d-orbital (paired or unpaired). If the ligand field is 
‘weak’, such as with a fluoride ligand, the electrons in the d-orbital are not affected too 
much and remain unpaired, and as a result the state is described as 6C-HS. However, in 
the presence of a ‘strong’ ligand like cyanide, the ligand field will force the electrons to 
be paired in the d-orbital, and therefore only one electron remains unpaired (spin 1/2), 
this state is described as 6C-LS (Dunford, 1999f; Veitch and Smith, 2001). 
 
1.5.3.3 The active site structure of HRP-C: 
 
The distal (the region of the enzyme lying above the plane of the haem when viewed in 
the usual orientation) and proximal (the region lying below the plane of the haem) 
domains of HRP-C contain residues crucial to the function of the active site of the 
enzyme (Figure 1.8) and are described in detail below. 
 
1.5.3.3.1 Proximal region: 
 
In the proximal domain, the His170 residue is considered the most important residue for 
catalysis which, as noted previously, is covalently bonded to the haem iron. In addition, 
there is the Asp247 residue, which forms a hydrogen bond via its carboxylate side chain 
with the His170 Nδ1. The strength of this interaction controls the basicity of the 
proximal histidine and also maintains the resting state haem in its five-coordinated state. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Haem and catalytic residues in the active site of HRP-C. The haem 
group (shown in red colour) is coordinated to the proximal histidine His170. The sixth 
coordination site distal to the haem group is vacant. The figure shows the location of 
important distal site residues Arg38, Phe41, His42 and Asn70. The figure was 
constructed by Accelrys DS visualizer using the coordinates deposited in the PDB 
(accession code 2ATJ). 
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It was found that the imidazole ring of His170 is tightly stacked against the side chain 
of Phe221 (Gajhede et al., 1997), and the loss of this π–π interaction leads to a 
perturbation of the haem pocket in the enzyme (Howes et al., 2001c). The role of the 
proximal histidine ligand in peroxidase function has been studied by replacing His170 
with alanine. It was observed that the reaction of H170A variant with H2O2 did not give 
any spectroscopically detectable Compound I or Compound II but resulted in the 
gradual degradation of the haem group. The activity of the mutant could be partially 
rescued by the addition of exogenous imidazole (Newmyer et al., 1996b). This has also 
been shown for other peroxidases of the plant peroxidase superfamily (Goodin and 
McRee, 1993). 
 
1.5.3.3.2 Distal region: 
 
The distal region of HRP-C contains a number of amino acid residues that have an 
essential role in catalysis; these include Arg38, Phe41, His42 and Asp70 (Figure 1.8). 
Two of these residues Arg38 and His42 are conserved in all plant peroxidases and are 
known to play a role in the acid-base catalytic cleavage of the O-O bond of peroxide 
during the process of Compound I formation. The catalytic role of the histidine residue 
in the formation of the Compound I intermediate was first proposed in 1980 by Poulos 
and Kraut (Poulos and Kraut, 1980), and then confirmed in 1993 by Erman and co-
workers when they found that the replacement of histidine by leucine caused a reduction 
of 105 fold in the rate of Compound I formation (Erman et al., 1993). 
 
It has since been shown that the rate of Compound I formation is drastically decreased 
by more than five orders of magnitude when His42 is replaced by other non-polar 
residues, such as Ala or Val (Newmyer and Ortiz de Montellano, 1995; Newmyer and 
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Ortiz de Montellano, 1995; Rodriguez-Lopez et al., 1996a). The addition of exogenous 
imidazole (2-substituted imidazoles) partially rescues both the rate of Compound I 
formation and the peroxidase activity of the H42A mutant (Newmyer and Ortiz de 
Montellano, 1996a). The catalytic activity can also be partially rescued by the 
introduction of another histidine residue in a different position as with the double 
mutant [H42A:F41H] HRP (Savenkova et al., 1996) and [H42V:R38H] HRP 
(Savenkova et al., 1998). In Chloroperoxidase, a versatile but unusual haem-containing 
peroxidase, the catalytic base used to assist in the process of O-O bond cleavage during 
Compound I formation is a glutamic acid residue rather than histidine (Sundaramoorthy 
et al., 1995). Thus, the effect of replacing His42 with glutamic acid, to give an enzyme 
that mimics in part the distal pocket of chloroperoxidase, has been investigated (Tanaka 
et al., 1996; Jennings, 1998). An intermediate rate of Compound I formation can be 
achieved with H42E, suggesting that this residue can act as an alternative proton 
acceptor, although it is only weakly basic (Veitch and Smith, 2001). 
 
The catalytic role of Arg38 in HRP-C has also been investigated through site directed 
mutagenesis. The importance of Arg38 comes from its ability to stabilise the transition 
state intermediate Compound 0 (hydroperoxide complex) during the formation of 
Compound I (Rodriguez-Lopez et al., 1996a; Rodriguez-Lopez et al., 1996b). In the 
case of the R38L mutant, the absence of the Arg residue at position 38 leads to a 
decrease in the rate of Compound I formation, but not as drastically as in the His42 
mutants (Rodriguez-Lopez et al., 1996a). Similar results were reported for the R38L 
mutant, where it was found that there was a 500-fold decrease in Compound I formation 
compared to the wild type enzyme (Smith et al., 1993). The double mutant H42E:R38S 
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proved the importance of these two residues in the catalytic reduction of H2O2, as it 
shows one of the slowest rates of Compound I formation known (Meno et al., 2002). 
 
It has been observed that the presence of the hydrogen bond between the His42 Nδ1 
hydrogen and Asn70 Oδ1 oxygen plays an important role in maintaining the basicity 
and alignment of the catalytic His42 residue, and fixes it in the correct position for 
participation in the acid-base catalytic reduction of H2O2 (Nagano et al., 1995; Nagano 
et al., 1996; Tanaka et al., 1997). Disruption of this hydrogen bond, as in N70D and 
N70V variants, leads to a presumed decrease in the basicity of His42 and decreases the 
rate of Compound I formation (Nagano et al., 1996). 
 
1.5.3.4 Calcium binding sites: 
 
Calcium ions are the most abundant metal ions found in proteins. They have the ability 
to bind to oxygen containing ligands, with a coordination number of 6 or 7. All plant 
peroxidases in Classes II and III contain two calcium binding sites, one proximal and 
the other distal to the haem plane. In HRP-C, the coordination number of each calcium 
ion is seven. The distal calcium is coordinated with oxygen-donor ligands provided 
from the side chain carboxylates of Asp43 and Asp50, the side chain hydroxyl of Ser52, 
the backbone carbonyls of Asp43, Val46 and Gly48 and the structural water molecule 
W15 (Figure 1.9). The proximal calcium is coordinated with oxygen-donor ligands 
provided from the side chain carboxylates of Asp222 and Asp230, the side chain 
hydroxyls of Thr171 and Thr225, and the backbone carbonyls of Thr171, Thr225 and 
Ile228 (Veitch and Smith, 2001; Azevedo et al., 2003). In addition, there is a hydrogen 
bond connection between the distal calcium binding site and the distal haem pocket, as 
besides coordination with calcium, W15 is also hydrogen bonded to the Oε1 of Glu64 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Calcium binding sites in HRP-C*. The haem group is shown in red with 
distal (D) and proximal (P) calcium ions shown in green. The hydrogen bonding 
linkages are shown in green colour also. The figure was constructed by Accelrys DS 
visualizer using the coordinates deposited in the PDB (accession code 2ATJ). 
W15 
W14 
P 
D 
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which in turn is hydrogen bonded to another water molecule W14. This water molecule 
and the backbone carbonyl of Glu64 are then hydrogen bonded to Asp70 Nδ2, and 
Asp70 is hydrogen bonded to the Nδ1 of the distal His42 (Figure 1.9) (Gajhede et al., 
1997). 
 
The importance of the calcium ions to the activity of the HRP enzyme is thought to be 
due to their ability to maintain the haem pocket structure and hence catalytic activity. It 
was reported that the loss of calcium from the structure of HRP-C leads to a decrease in 
both enzyme activity (about 40% reduced) and thermal stability (Haschke and 
Friedhoff, 1978), and subtle changes in the environment of the haem can be detected 
spectroscopically (Howes et al., 2001a). The importance of Glu64 to the calcium 
stabilisation of HRP-C and enzyme activity has been studied by site directed 
mutagenesis. Three mutants E64G, E64P and E64S were constructed and all exhibited 
substantially decreased enzyme activities, implying that this Glu residue is a key residue 
for the stable binding of the distal calcium, maintaining the structural integrity of the 
distal cavity (Tanaka et al., 1998). 
 
1.5.4 Horseradish peroxidase reaction cycle: 
 
HRP-C is an enzyme that catalyses the oxidation of a wide variety of organic and 
inorganic substances, with H2O2 as electron accepter (Yamazaki, 1974; Dunford and 
Stillman, 1976; Dunford, 1991; Zhu et al., 2001). The general catalytic cycle proceeds 
via a sequence of reactions which can be described by the following equations (Smith 
and Veitch, 1998; Veitch and Smith, 2001):- 
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E: HRP-C enzyme,  Porph: the haem porphyrin ring 
AH2: reducing substrate, AH: oxidation product of AH2 
 
In the first step of this cycle (equation 1) the HRP-C resting state reacts with hydrogen 
peroxide and is oxidised to a high oxidation state intermediate known as Compound I, 
in which one electron is removed from the ferric iron to give the FeIV oxyferryl centre 
and a second electron is removed from the porphyrin to give a porphyrin π-cation 
radical (Dunford and Stillman, 1976). The second step in the cycle involves a single 
electron oxidation of the substrate by Compound I. The porphyrin π-cation radical is 
reduced to give a second high oxidation state intermediate known as Compound II; the 
rate of this step of reaction is dependent on the substrate (Hasinoff and Dunford, 1970). 
Finally, in the third step, Compound II reacts with another substrate molecule from 
which an electron is extracted by the FeIV oxoferryl to regenerate the resting enzyme. 
The overall reaction of this cycle can be described in the net equation 4 (below). 
 
 
  
.
. 
. 
Compound I 
Compound II 
E (FeIII, Porph)   +    H2O2 E (FeIV=O, Porph  +)  + H2O     (1) 
E (FeIV=O, Porph  +) + AH2 
 
E (FeIV=O, Porph)     + AH       (2) 
E (FeIII, Porph)  +  AH +  H2O  (3) E (Fe
IV=O, Porph)    + AH2 
 
k1 
k2 
k3 . 
. 
.
H2O2   +   2AH2                                2H2O    +    2AH               (4) 
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The HRP-C reactions cycle can also be described as a modified ping-pong mechanism 
(Scheme 1.2) (Dunford, 1999e). 
 
 
 
 
 
Scheme 1.2: The HRP-C ping-pong mechanism. Hydrogen peroxide reacts with the 
resting enzyme to produce an intermediate named Compound I, after which the 
substrate AH2 reacts with Compound I to yield Compound II, and finally a second 
molecule of the substrate AH2 reacts with Compound II to regenerate the resting 
enzyme. 
 
 
1.5.4.1 Mechanism of Compound I formation: 
The catalytic mechanism for the formation of Compound I was initially proposed by 
Poulos and Kraut from analysis of the crystal structure of yeast cytochrome c 
peroxidase. It involves two crucial residues in the distal region, the distal His and the 
distal Arg (Poulos and Kraut, 1980). It is supposed that a similar mechanism operates in 
HRP-C, given that these His and Asp residues are conserved in all members of the plant 
peroxidase superfamily (Dunford, 1991). 
 
The mechanism of Compound I formation is considered to be a two-step process, shown 
for HRP-C in Scheme 1.3. Step 1 starts with the entry of the hydrogen peroxide 
molecule (Hα-Oα-Oβ-Hβ) into the peroxidase distal haem cavity which leads to the 
formation of a hydroperoxide complex, referred to as Compound 0; this step is a 
reversible reaction. During this step, the α-proton of the hydrogen peroxide is abstracted 
H2O2 H2O AH2 AH2 +  H2O AH AH 
HRP-C Compound I Compound II HRP-C 
. .
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by His42 and a covalent bond is formed between the haem iron and the Oα of the 
hydroperoxyl anion (-OOH), generating an iron-oxygen bond. This leads to a hydrogen 
bond between the newly protonated His42 and the β-oxygen atom of the hydroperoxide 
complex (Baek and Van Wart, 1992). 
 
In the second step of Compound I formation, the hydroperoxide complex moves 
through a transition state, where the positively charged side chain of Arg38 assists in 
stabilising the charged transition state intermediate via hydrogen bonding and 
electrostatic interaction. Heterolytic cleavage of the Oα-Oβ covalent bond occurs as one 
electron is transferred from the haem iron and another one from the porphyrin. 
Therefore, the resulting high oxidation state intermediate, Compound I, has an oxyferryl 
haem (Fe(IV)=O) and a porphyrin π-cation radical. In addition, a departing water 
molecule is formed from the remaining Oβ-Hβ leaving group of hydrogen peroxide and 
the Hα previously donated to His42 (Everse, 1998). 
 
1.5.4.2 Reduction of Compound I and II: 
 
The mechanism of Compounds I and II reduction has not been as intensively studied as 
the mechanism of Compound I formation. Site-directed mutagenesis studies have 
clearly demonstrated that the HRP-C distal residues His42 and Arg38 are also important 
in the reduction of Compounds I and II (Rodriguez-Lopez et al., 1996a; Rodriguez-
Lopez et al., 1996b). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.3: Proposed mechanism for the formation of Compound I in HRP-C. The 
α-proton of H2O2 is abstracted by His42, and the positively charged side chain of Arg38 
assists in stabilising the transition state. The scheme also includes Asn70 that forms a 
hydrogen bond with His42, a critical function affecting the rate of Compound I 
formation, reproduced from Veitch and Smith, 2001. 
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Nearly 20 years after the proposed mechanism for Compound I formation by Poulos and 
Kraut (Poulos and Kraut, 1980), a detailed mechanism for the reduction of Compounds 
I and II by a small phenolic substrate has been proposed, based on data from the 1.45 Å 
crystal structure of a ternary complex of cyanide-ligated HRP-C and ferulic acid 
(Henriksen et al., 1999). Two assumptions have been made in this mechanism: firstly 
that the orientation of ferulic acid in the pre-electron transfer complexes formed 
transiently with Compounds I and II is likely that in the ternary complex with cyanide-
ligated HRP-C, secondly, that the position of Arg38 remains undisturbed by the binding 
of any exogenous compounds during the reduction of enzyme intermediates; this is 
supported by several substrate-bound crystal structures (Henriksen et al., 1998a; 
Henriksen et al., 1999). 
 
It is generally accepted that when a substrate molecule binds to Compound I, an 
electron is transferred to the porphyrin ring via the exposed haem edge, and the π-cation 
radical disappears. In the case of ferulic acid, the proposed mechanism for Compounds I 
and II reduction is illustrated in Scheme 1.4. The carbonyl group of a proline residue 
(Pro139), which is conserved throughout the plant peroxidase superfamily (Veitch and 
Smith, 2001), acts as a hydrogen bond accepter for a structurally conserved water 
molecule, which also acts as a conduit for a proton from the hydroxyl group of ferulic 
acid to the Nε2 atom of His42. This process of proton transfer is coupled to the electron 
transfer from ferulate to the exposed haem edge. The hydrogen bond between Arg38 
and the ferulate oxygen is thought to assist the proton transfer from the ferulic acid to 
His42. As Compound II is formed the ferulic acid radical leaves the enzyme and is 
substituted by a fresh substrate molecule. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.4: Mechanism of Compounds I and II reduction in HRP-C by ferulic 
acid. The scheme is based on a 1.45 Å resolution crystal structure of the ternary 
complex of ferulic acid and cyanide-ligated HRP-C (Henriksen et al., 1999). The 
direction of proton transfer is indicated by the dotted arrows. The mechanism also 
shows the participation of Pro139 in the formation of an important hydrogen bond with 
the water molecule via its carbonyl group, reproduced from Veitch and Smith, 2001. 
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The reduction of Compound II occurs by a similar mechanism, but this time the final 
destination of both proton and electron is the ferryl-oxygen which is reduced to the 
resting ferric state. The ferryl oxygen accepts two protons, one from the substrate 
molecule and the other from the distal His42, to form a water molecule that is released 
from the haem iron (Azevedo et al., 2003). 
 
1.5.5 Aromatic substrate binding site: 
 
There is agreement that the minimal distance between the haem iron atom in HRP-C 
and the aromatic substrate is 8−11 Å, therefore excluding the metal as the binding site. 
It has been suggested that aromatic donors bind at a hydrophobic site in the vicinity of 
the exposed haem edge, a region comprising the haem methyl C8 and haem meso Cδ 
protons (Dunford, 1991; Veitch and Smith, 2001). Inactivation experiments of HRP-C 
by alkyl- and phenylhydrazines, sodium azide, cyclopropanone hydrate and nitroalkanes 
provide strong support that substrate oxidation occurs at the exposed haem edge. When 
different alkylhydrazine reagents are incubated with HRP-C and hydrogen peroxide the 
addition of the alkyl moieties is exclusively to the meso carbon of the haem edge. 
Cyclopropanone hydrate, nitromethane, and sodium azide similarly add to the meso 
carbon after being oxidised by the enzyme to radical intermediates (Ortiz de 
Montellano, 1992). 
 
In fact, substrate access to the oxoferryl centre of HRP-C Compounds I and II appears 
to be hindered by the local protein environment, an example of ‘closed’ haem 
architecture. Attempts to alter this aspect of the chemistry of HRP-C have been made by 
site-directed mutagenesis. Substituting the distal residue Phe41 by smaller amino acid 
residues such as Ala, Leu and Thr, as well as replacement of His42 with Ala and Val, 
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all resulted in an increase in substrate access to the oxoferryl centre of Compound I 
(Newmyer and Ortiz de Montellano, 1995; Ozaki and Ortiz de Montellano, 1995). 
 
On the basis of optical difference spectroscopy, hyperfine shifted NMR spectroscopy, 
and nuclear magnetic relaxation studies, it has been shown that HRP-C can bind with a 
variety of aromatic donor molecules (Figure 1.10) reversibly to form 1:1 enzyme-donor 
complexes (Critchlow and Dunford, 1972; Burns et al., 1975; Schejter et al., 1976; 
Morishima, 1978). The complexes are formed with either the resting state of the enzyme 
or with ligand bound forms, most commonly the cyanide ligated state. Spectroscopic 
and crystallographic studies have revealed a wealth of information on the site where 
these aromatic substrates are located. 
 
The X-ray structures of ferulic acid (FA) complexed with resting state HRP-C* or the 
cyanide-ligated enzyme have been solved to 2.0 Å and 1.45 Å, respectively (Henriksen 
et al., 1999). It was found that the aromatic ring of FA is almost coplanar with the haem 
group and that there are hydrogen bonding interactions between Arg38 NηH2 and the 
phenolic and methoxy oxygen atoms of FA, as well as between the phenolic oxygen and 
an active site water molecule. This active site water molecule is also hydrogen bonded 
both to the backbone oxygen of Pro139 and to the cyanide ligand nitrogen. The other 
interactions between the FA molecule and HRP-C can be defined as hydrophobic 
interactions with amino acid side chains of Phe68, Gly69, Pro139, Ala140, Phe142, 
Phe179, as well as with the C8 methyl and Cδ of the haem group (Henriksen et al., 
1999).  
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Figure 1.10: Aromatic donor molecules that can form complexes with HRP-C. 
 
 
1.5.6 Biological roles of horseradish peroxidase: 
 
In general, plant peroxidases are constitutive enzymes mainly found in the cell wall, 
vacuoles and transport organelles and rough endoplasmetic reticulum. They play an 
important role in plant physiological actions including auxin catabolism, modification 
of the cell wall, lignification, pathogen defence and wound healing (Azevedo et al., 
2003). 
 
Auxins are plant hormones that have an important role in plant growth and 
development, including the control of the elongation, division and differentiation of 
cells. One of the most important auxins produced by plants is indole-3-acetic acid 
(IAA). HRP-C is considered to be the main enzyme responsible for the catabolism of 
IAA (Campa, 1991). The ability of HRP-C to degrade the plant hormone IAA has been 
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reviewed as early as 1955 (Kenten, 1955). In contrast to most peroxidase-catalysed 
reactions, the oxidation of IAA by HRP-C has been shown to occur in the absence of 
hydrogen peroxide; for this reason authors used to refer to peroxidases in the older 
literature by the term indole acetic acid oxidases (Veitch and Smith, 2001). The 
mechanism of this oxidation is complex and has been studied experimentally in great 
detail by several groups (Campa, 1991; Dunford, 1999g). The major products of IAA 
oxidation include indole-3-methanol, indole-3-aldehyde and 3-methylene-2-oxindole, 
the latter most probably as a result of the non-enzymatic conversion of indole-3-
methylhydroperoxide. 
 
The cell wall is sometimes considered the primary site of action of plant peroxidases, as 
they play an integral role in cell wall biosynthesis. The oxidative coupling of phenolic 
monomers such as p-coumaryl, coniferyl and sinapyl alcohols can be catalyzed by HRP 
(Campa, 1991). These reactions are also essential in the biosynthesis of lignin, a 
complex and highly branched phenylpropanoid polymer that constitutes 20-30% of a 
plant cell wall. The cell wall peroxidase-catalyzed reactions are, however, not restricted 
to lignification. The synthesis of suberin, a wax that reduces water loss from cells, 
involves a peroxidase in a manner similar to that proposed for lignin biosynthesis 
(Campa, 1991; Azevedo et al., 2003). 
 
It has been reported in several plant systems, that the level of peroxidase expression and 
the isoenzyme pattern is altered by stress conditions. Peroxidases are part of the first 
line of plant defence, and increases in activity were observed upon plant exposure to 
ozone, pollution, radiation, nutritional disorders, wounding, infections, salinity and 
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aging. One of the clearest examples of this induction of HRP-C activity is the rapid 
response on wounding of horseradish leaves (Campa, 1991). 
 
1.5.7 Applications of horseradish peroxidase: 
 
HRP is one of the most widely used enzymes in vitro, as a reagent for organic synthesis 
and bio-transformation, as well as in coupled enzyme assays, chemiluminscent assays 
and immunoassays. The enzyme meets many requirements for successful use in these 
systems, such as flexibility in assay, stability, sensitivity in range of analyte detection, 
as well as availability of pure form at reasonable cost (Azevedo et al., 2003; Veitch, 
2004). 
 
One of the major applications of HRP in preparative organic synthesis is using it as a 
mild catalyst; it has the ability to catalyze a number of useful oxidative N- and O-
dealkylation reactions that are relatively difficult to carry out synthetically (Meunier, 
1991). In addition, HRP has been used in the organic synthesis of optically active 
compounds such as (S)-hydroperoxides and (R)-alcohols (Adam et al., 1995). 
Epoxidation of styrene in the presence of a mediator such as 4-methylphenol (Ortiz de 
Montellano and Grab, 1987) and selective hydroxylation of some aromatic compounds 
in the presence of oxygen and dihydroxyfumaric acid (Klibanov et al., 1981) can also be 
achieved using HRP. 
 
One of the most commercial uses of HRP is in immunoassays. The term immunoassay 
describes a wide range of assays used to detect and quantify antigens using antibodies. 
HRP-antibody conjugates have been extensively used in enzyme-linked immunosorbent 
assays (ELISA), Western blotting and immunohistochemistry assays (IHC). These are 
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the basis for many diagnostic kits, such as pregnancy testing kits. In these systems, it is 
convenient to be able to detect peroxide activity colorimetrically (Veitch and Smith, 
2001; Azevedo et al., 2003). 
 
Another commercial use of peroxidases is to detect and quantify molecules of clinical 
interest, such as glucose, uric acid and cholesterol in biological fluids (blood, plasma 
and urine). In the case of glucose, for example, it is oxidised by glucose oxidase to yield 
stoichiometric amounts of hydrogen peroxide, which are then used by HRP to oxidise 
selected substrates to give products that can be monitored easily by colorimetric, 
fluorometric or chemiluminescent methods (Veitch and Smith, 2001). One of the 
advantages of using HRP in clinical assays is that few inhibitors of the enzyme are 
found in biological fluids, thus reducing the possibility of errors. Chemiluminescent 
assays are particularly sensitive and widely used. These assays involve the oxidation of 
luminol, or a derivative, to yield 3-aminophthalate and light, with sensitivity up to 1000 
times more than when using a chromagenic substrate (Coulet and Blum, 1992; 
Nakayama and Amachi, 1999). 
 
1.6 Introduction of haem-protein covalent linkages into plant 
peroxidases: 
 
As discussed before (sections 1.2 and 1.3.3) mammalian peroxidases share a feature not 
found in the enzymes of the plant peroxidase superfamily, in that the haem prosthetic 
group is covalently attached to the protein via at least two ester linkages from the 
porphyrin. In addition, MPO has an additional sulfonium linkage between a methionine 
residue and the β-carbon of the 2-vinyl group of the porphyrin. Early studies on the 
ester linkages have indicated that they are formed autocatalytically, by reaction with 
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H2O2 (DePillis et al., 1997). Incubation of recombinant LPO, which as expressed in the 
baculovirus system has only part of the haem bound, with hydrogen peroxide led to an 
increase both in covalent haem binding and catalytic activity (DePillis et al., 1997). In 
addition, the haem group in the E375D mutant of LPO is initially only partially 
covalently bound, but exposure to H2O2 again results in complete covalent binding and a 
fully active protein (Colas et al., 2002). This provides further evidence that the 
mammalian peroxidases haem-protein ester linkages are formed by an autocatalytic 
process. Furthermore, it has been demonstrated unambiguously that the protein-haem 
ester linkages in EPO are also formed by an autocatalytic process (Oxvig et al., 1999), 
and that for TPO, exposure to H2O2 is very important for the formation of mature and 
active enzyme (Fayadat et al., 1999). 
 
More recently, efforts have been made to mimic the haem-protein covalent linkages of 
mammalian peroxidases in plant peroxidases. A glutamic acid residue has been 
introduced into the distal cavity of HRP (Colas and Ortiz de Montellano, 2004) near to 
the haem. The HRP-C* mutant F41E was found to be isolated with no covalently bound 
haem, but the haem was completely covalently bound upon incubation with H2O2. 
These results clearly show that the presence of an appropriately situated carboxylic acid 
group is sufficient for ester bond formation with the haem porphyrin (Colas and Ortiz 
de Montellano, 2004). The first information about the mechanism of formation of the 
sulfonium linkage in MPO was revealed in 2004, when a methionine residue was 
engineered close to the 2-vinyl haem group in recombinant pea cytosolic ascorbate 
peroxidase (rpAPX) (Metcalfe et al., 2004). The S160M mutant was isolated, and upon 
incubation with H2O2 a covalent sulfonium ion linkage was seen to be formed. These 
results provide the first evidence that covalent linkage formation between a methionine 
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residue and the haem vinyl group occurs as an H2O2–dependent process. They also 
identified a transient Compound I-like species as a reaction intermediate (Metcalfe et 
al., 2004). Recently, the same group have reported the introduction of a tyrosine residue 
at the same position in rpAPX (S160Y). This lead, on treatment with H2O2, to the 
formation of a haem-tyrosine covalent link (Pipirou et al., 2007b), and in addition, a 
second covalent link from the haem to Trp41, previously also seen on treatment of wild-
type rpAPX with excess of H2O2 for a long time (Pipirou et al., 2007a). Although no 
Compound I-like species was seen for the S160Y mutant, a tyrosine radical was seen by 
EPR experiments and the haem-Trp41 linkage was assumed to occur via a tryptophan 
radical. However, the importance of an, at least transient, π-cation radical to the linkage 
process was identified by experiments with cytochrome c peroxidase (CcP). Only for 
the mutant W191F was a tryptophan-haem linkage observed between the distal 
tryptophan (Trp51) and porphyrin, on treatment with excess H2O2 for a long time; the 
wild-type enzyme, which uses a Trp191 radical instead of a porphyrin π-cation radical 
showed no such tryptophan linkage under similar conditions (Pipirou et al., 2009). 
 
Recent work by another member of author’s group, Dr. Kasim Cali, has successfully 
created a covalent sulfonium linkage between the [S167M] HRP-C* mutant protein and 
the prosthetic haem group, through an H2O2-dependent activation process (Cali, 2008). 
Previously, to determine which residue in HRP-C might be in a suitable position for the 
introduction of a sulfur side chain, the X-ray structure of HRP-C* (Gajhede et al., 1997) 
was superimposed on that of MPO using the coordinations of the haem. The 
superposition revealed that the position of the methionine residue (Met243), responsible 
for the formation of the sulfonium linkage in MPO, was close to the serine residue 
Ser167 in HRP-C and close to the 2-vinyl group of the haem. This work was the first to 
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generate a haem-protein sulfonium bond in the commercially valuable HRP-C enzyme, 
but the linkage was not found to be stable indefinitely (Cali, 2008).  
 
1.7 The aim of the present work: 
 
Commercially important horseradish peroxidase (HRP: EC 1.11.1.7) is the most 
intensively studied member of the plant peroxidase superfamily. This project was 
designed to build on previous work to introduce novel haem-protein covalent linkages 
into HRP, to try to increase the stability, and possibly the activity, of the enzyme, and 
also to attempt to understand more about the mechanism of formation and the advantage 
of these linkages in mammalian peroxidases in which they naturally occur. The previous 
work involved the introduction of a sulfonium linkage into HRP-C* (Cali, 2008). Here, 
by comparison with work on rpAPX (Pipirou et al., 2007b), the current work aimed to 
introduce other covalent linkages between the haem porphyrin and protein in HRP-C, 
i.e. tyrosine and tryptophan linkages. To this end, two site-directed HRP-C* mutants at 
position 167 have been constructed, in which Ser167 was substituted by tyrosine or 
tryptophan (S167Y and S167W). The new mutant genes were generated using a PCR-
based Whole Plasmid Amplification Method of site-directed mutagenesis. The resulting 
mutant enzymes were characterised using UV/Visible spectroscopy and attempts were 
made to introduce the covalent linkage using incubation with H2O2. The presence of a 
linkage was determined using Electronic absorption spectroscopy, acid butanone haem 
extraction, MALDI-TOF and ESI mass spectrometry and HPLC methods. The results 
provide proof of the formation of a tyrosine-haem covalent linkage. The effect of this 
linkage on the activity of the enzyme was also characterised using steady-state and pre 
steady-state enzyme kinetics. 
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Chapter Two: 
Materials and Methods 
 
 
2.1 Materials: 
 
All molecular biology methods used are those described in Sambrook et al., 1989, 
unless otherwise stated. BDH, Fisher, and Sigma Aldrich supplied all chemicals used 
and all restriction enzymes and their appropriate buffers were supplied by NEB (UK) 
Ltd, unless otherwise stated. The synthesis of oligonucleotide primers and DNA 
sequencing were performed by MWG-biotech.com. 
 
2.2 Generation of mutants: 
2.2.1 Site-directed mutagenesis: 
 
Site-directed mutagenesis of recombinant horseradish peroxidase (WT HRP-C*) at 
position 167 was carried out using the polymerase chain reaction (PCR) based Whole 
Plasmid Amplification Method (WPAM) mutagenesis technique in order to construct 
two new variants [S167Y] HRP-C* and [S167W] HRP-C*. This method has been 
described previously (Veitch et al., 1997; Doyle et al., 1998). The synthetic WT HRP-C 
gene (Smith et al., 1990), cloned in the commercially available expression vector 
pFLAG1 (Doyle et al., 1998), was used as the template; the length of the resulting 
plasmid (known as pFLAG1-HRP-C) is 6.3 kb. During the PCR process, a thermostable 
and proof-reading DNA polymerase (Pfu polymerase) was used. Pfu polymerase was 
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preferred to Taq polymerase, due to the higher fidelity that it has in comparison with 
Taq polymerase (Lundberg et al., 1991; Cline et al., 1996). 
 
2.2.2 Primer design: 
 
PCR oligonucleotide primers were designed to anneal exactly ‘back to back’ at their 5’ 
termini on opposite template DNA strands. The designed primers included the 
necessary nucleotide mismatches required to generate the desired amino acid 
substitutions in the protein, in addition to silent mutations which generated a new 
restriction enzyme site in order to facilitate screening of the transformed clones. Two 
primers were designed for each mutant gene to be made and the software Webcutter1 
was used to assist in the design of the primers. This software permits the user to 
examine a given nucleotide sequence for the presence of both existing restriction 
enzyme sites and silent sites that can be introduced by exploiting natural codon 
degeneracy (see Figure 3.2). The first primer was the mutagenic primer which covered 
the area to be mutated and contained the intended base changes. The second primer was 
the reference primer which annealed to the other DNA strand. 
 
High purity, salt free (HPSF) primers were synthesized and supplied by MWG-Biotech 
in a lyophilized form. These primers were dissolved in sterile, distilled deionised water 
(ddH2O) to produce 100 μM stock primer solutions that were further diluted to produce 
10 μM working stock primers. 
 
 
                                                
1 http://www.users.unimit.it/Camelot/tools/cut2.html 
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2.2.3 DNA Amplification Mutagenesis using PCR: 
 
To generate each mutant gene, a 50 μl PCR was carried out containing 5 μl of 10x Pfu 
reaction buffer, 5 μl dNTPs (1 mM each), 1 μl template DNA (5 ng), 5 μl of 10 μM each 
of the two primers, 0.5 μl of Pfu polymerase (1.25U Promega, added after a Hot Start) 
and 28.5 μl of sterile ddH2O. The PCR tubes containing the mixture above were placed 
in a thermocycler (Perkin-Elmer GeneAmp 2400) and subjected to twenty five cycles, 
each cycle was as follows: 
 
Hot Start 95 oC for 10 minutes 
Pause for 5 minutes to add the Pfu polymerase followed by 25 cycles of 
Denaturation 95 oC for 45 seconds 
Annealing 56 oC for 1 minute 
Extension 72 oC for 17 minutes 
 
 
At the end of the 25 cycles, the thermocycler was set to automatically reduce the 
temperature down to 4 oC until the next morning. 
 
2.2.4 Identification of correctly sized PCR product: 
 
On completion of the PCR, in order to check if a PCR product was made and of the 
correct size, agarose gel electrophoresis was carried out using a DNA size marker. PCR 
products of the correct length should be 6.3 kb. This was done by preparing a 70 ml 
agarose gel containing 1% (w/v) agarose in a 1x Tris-borate-EDTA (TBE) buffer (89 
mM Tris base, 89 mM Boric acid and 2 mM EDTA, pH 8.0). 10 μl of each of the PCR 
solutions were taken and mixed with 2 μl of 6x Ficoll loading buffer (15% (w/v) Ficoll 
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400, 0.25% Bromophenol Blue and 0.25% xylene cyanol FF). The PCR samples and the 
marker were loaded on the gel. The gel was placed in a gel tank filled with 1x TBE 
buffer, and run under a constant potential difference of 60V until the blue dye 
approached the end of gel. Since the DNA is negatively charged due to the phosphate 
backbone, the samples will be separated according to their size, smallest moving 
quickest, towards the positive charged end. The gel was removed and placed into a 
staining box containing ddH2O and 20 μl of 10mg/ml ethidium bromide. The box was 
rocked for about 30 minutes, and then DNA bands were visualized under UV light by 
using a translluminator. 
 
2.2.5 Purification of PCR product: 
 
To remove the methylated template from the PCR samples, the next step was adding 1 
μl of DpnI. The mixture was incubated for two hours at 37 oC. The PCR solution was 
then made up to 150 μl with sterile ddH2O, in an Eppendorf tube. 150 μl of Phenol: 
Chloroform: Isoamylalcohol mix (25:24:1) was added, and the tube inverted several 
times until an emulsion was formed. The emulsion was centrifuged for two minutes in a 
micro-centrifuge at 13,000 rpm. The aqueous DNA-containing top layer was carefully 
transferred to another tube. To remove traces of phenol, 150 μl of chloroform was then 
added, mixed well and then centrifuged at 13,000 rpm for one minute. The top aqueous 
layer was removed and transferred to the other tube, carefully as before. 
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2.2.6 Ethanol precipitation of the purified PCR product: 
 
The DNA solution resulting from the phenol/chloroform extraction process was 
adjusted to a sodium concentration of 0.3 M by adding a volume of 3 M Na-acetate, pH 
5.2, equal to 1/9th volume of the DNA sample. 2.5 volumes of ice-cold 100% ethanol 
were added and the solution was again mixed well by shaking and then left at -20 oC for 
30 minutes. The solution was centrifuged at 13,000 rpm in a micro-centrifuge for 10 
minutes with the hinge of the tube outwards. The supernatant was carefully removed. 
500 μl of 70% ethanol was added to the pellet and the tube centrifuged again at 13,000 
rpm for 5 minutes, with hinge out as before. As far as possible the supernatant was 
carefully removed, and by leaving the lid of tube open in the filter hood the DNA was 
dried fully. 8 μl of sterile ddH2O was then added to resuspend the purified DNA. 
 
2.2.7 Circularization of the PCR products: 
2.2.7.1 Phosphorylation of the PCR product:  
 
In order to add 5’ phosphate groups to the ends of the purified linear DNA fragments, 
the DNA solution was treated with 1 μl of 10x ligase buffer and 1 μl of T4 
Polynucleotide kinase (10 units/μl) to give a total volume of 10 μl. The mixture was 
incubated at 37 oC for 2 hours. 
 
2.2.7.2 Ligation of the phosphorylated PCR product: 
 
In order to recircularize the phosphorylated linear DNA, 1 μl of 10x ligase buffer, 1 μl 
of T4 DNA Ligase (400 units/μl) and 8 μl of sterile ddH2O were added to the mixture 
from the phosphorylation process to give a final volume of 20 μl. Then the solution was 
incubated overnight at 4 oC. 
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2.2.8 DNA Transformation into E. coli (DH5α): 
 
The recircularized, mutant plasmid DNA was transformed into the E. coli DH5α strain 
(Invitrogen library efficient competent DH5α) using the heat-shock method (Sambrook 
et al., 1989). The stored competent cells, which were frozen at -80 oC, were thawed on 
ice with no external heating. After this, 10 μl of the ligated plasmid DNA was added 
into 100 μl of the competent cells, gently mixed with pipette tip, and then left on ice for 
20 minutes. The mixture was heat-shocked at 42 oC for 45 seconds in a water bath (as 
heat exchange is more efficient than in a hot-block). The sample was placed back on ice 
for five minutes for the cells to recover. 1 ml of sterile Luria-Bertani (LB) broth was 
added to the tube, and the cells were shaken at 37 oC for 1 hour to allow for the 
antibiotic resistance to be expressed. The sample was then centrifuged in a micro-
centrifuge at 7,000 rpm for 2 minutes to produce a cell pellet. Most of the supernatant 
was poured off, leaving approximately 100 μl. The cells were resuspended gently by 
pipette tip and plated onto a Luria-Bertani (LB) agar plate containing 100 μg/ml 
ampicillin; the plate was left upside down and incubated overnight at 37 oC. 
 
A transformation control was also carried out as follows: 100 μl of competent cells with 
10 ng of WT pFLAG1-HRP-C plasmid DNA was plated onto an LB agar plate 
containing 100 μg/ml ampicillin. The aim of this was to check the efficiency of the 
competent cells and to discover any potential contamination. 
 
2.2.9 Plasmid DNA miniprep: 
 
Transformed DH5α colonies obtained on the ampicillin-containing LB agar plates were 
picked and inoculated into 5 ml LB broth containing 100 μg/ml ampicillin. The cultures 
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were shaken overnight in an incubator at 37 oC. 2 x 1.5 ml of each culture was 
centrifuged in a micro-centrifuge at 7,000 rpm for two minutes. The plasmid DNA 
miniprep was then carried out using the protocol of the QIAprep® MiniPrep Kit 
supplied by Qiagen. The final DNA solution was extracted into 50 μl of 10 mM Tris, 
pH 8.5. 
 
2.2.10 Restriction enzymes analysis of miniprep plasmid DNA: 
 
7 μl of each plasmid DNA miniprep was digested in a total volume of 10 μl that also 
included 1 μl of bovine serum albumin (BSA) to a final concentration 100 μg/ml, 1 μl 
of manufacturer recommended restriction endonuclease buffer and 1 μl of restriction 
endonuclease BssSI (4 units/μl). In all cases an undigested control was also performed 
where the restriction enzyme was substituted by sterile ddH2O. The mixtures were 
incubated at 37 oC for one hour. 
 
After incubation, 2 μl of 6x Ficoll loading buffer was added to both digested and 
undigested mixtures. The samples were analysed by electrophoresis, alongside a DNA 
size marker, on a 70 ml agarose gel (1% w/v agarose) at 60 V. The gel was stained with 
ddH2O and 20 μl of 10 mg/ml ethidium bromide and shaken for 30 minutes. The stained 
gel was transluminated under UV light for DNA band identification. 
 
2.2.11 Plasmid DNA midiprep:  
 
The remaining 2 ml of a 5 ml LB broth culture, from which plasmid miniprep and digest 
showed a positive result, were used to inoculate a larger overnight culture. 250 μl of 
each positive culture was added to 50 ml LB broth containing 100 μg/ml ampicillin and 
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incubated overnight at 37 oC. Plasmid DNA midiprep was then carried out using a 
Wizard® DNA Purification System MidiPrep Kit supplied by Promega. The final DNA 
solution was extracted using 300 μl of 10 mM Tris, pH 8.5. 
 
The purity and concentration of the midiprep plasmid DNA was determined using a 
spectrophotometer and the spectral range between 220-320 nm. The purity of DNA is 
given by the ratio of A260/A280; values between 1.8 and 2 indicate that DNA is pure. The 
concentration of the DNA was determined by the following equation, as a solution of 
DNA at 50 ng/μl has an absorbance at 260 nm of 1.0. 
[DNA] = 50 * A260 * dilution factor 
 
2.2.12 Submitting DNA for sequencing: 
 
To confirm the presence of the desired mutations in the putative mutant plasmids, and to 
check for any PCR introduced error, two samples for each positive clone were prepared 
for sequencing by MWG-Biotech. The appropriate volume of midiprep DNA containing 
1 μg DNA was made up to 10 μl with 10 mM Tris, pH 8.5. One sample was sent for 
sequencing with 10 μl of 10 μM in-house forward primer (lipseq1) and the other was 
sent with 10 μl of 10 μM in-house reverse primer (lipseq5). The sequencing results 
were checked using the Seqman section of DNASTAR software, by aligning the new 
HRP-C mutant sequences with wild-type HRP-C gene.  
 
2.2.13 Glycerol Stocks: 
 
The new HRP-C mutant plasmids in E. coli DH5α were stored as glycerol stocks for 
long-term use. A colony was inoculated into 5 ml LB broth containing 100 μg/ml 
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ampicillin and incubated overnight at 37 oC. 1 ml of the culture was pipetted into a 
Nunc cryovial using sterile technique. Then 0.5 ml of sterile 50% glycerol was added, 
the tube inverted to mix and the stock stored at -80 oC. When needed, the glycerol stock 
was thawed slightly and some of the cells plated onto an LB agar plate with ampicillin 
to generate single colonies. 
 
2.3 Protein Expression and Purification: 
 
Expression of protein from the synthetic HRP-C gene cloned in the pFLAG1 expression 
vector is regulated by lacIq repression of the tac promoter, a strong promoter formed by 
the hybridisation of different regions of the trp and lac promoters (de Boer et al., 1983). 
Repression is relieved in the presence of the lactose analogue isopropyl-β-D-
thiogalactopyranoside (IPTG) and the protein is expressed in the form of misfolded 
aggregates or inclusion bodies, which require refolding to recover the active enzyme 
(Smith et al., 1990). 
 
2.3.1 Small-scale HRP-C* protein expression: 
2.3.1.1 Transformation into E. coli protein expression strain W3110: 
 
[S167Y] and [S167W] midiprep plasmid DNA (as confirmed by sequencing), as well as 
WT HRP-C DNA (used as a control), were transformed into E. coli W3110 cells. The -
80 oC stored, chemically competent W3110 cells were thawed in ice with no external 
heating. 10 μl of the DNA was taken and added into 100 μl of the competent cells. The 
mixture was gently mixed with pipette tip, and then left on ice for 20 minutes. After 
that, the mixture was heat-shocked at 42 oC for 2 minutes in a water bath, and placed 
back on ice for five minutes. 1 ml of sterile LB broth was added, and the cells were 
48 
 
 
 
shaken at 37 oC for 30 minutes to allow the antibiotic resistance to be expressed. Then 
the sample was centrifuged in a micro-centrifuge at 7,000 rpm for 2 minutes to produce 
a cell pellet. Most of the supernatant was poured off, leaving approximately 100 μl. The 
cells were resuspended gently by pipette tip, plated onto a LB agar plate containing 100 
μg/ml ampicillin, and incubated upside down overnight at 37 oC. 
 
2.3.1.2 Culture growth: 
 
Two transformed W3110 colonies were selected for each mutant HRP-C plasmid, in 
addition to one colony of WT, and were inoculated overnight in 5 ml LB broth 
containing 100 μg/ml ampicillin at 37 oC. A glycerol stock was prepared for each 
culture (section 2.2.13) and stored for future use. 50 μl of each culture was then 
inoculated into a further 5 ml LB broth containing 100 μg/ml ampicillin. The cultures 
were grown at 37 oC with vigorous shaking for 1.5 hours, then induced by adding 1 mM 
IPTG (10 μl of 500 mM stock), and grown for a further three hours. An inoculated but 
un-induced culture was also grown at the same time. 
 
Cells were harvested from 3 ml of each culture by centrifugation in a micro-centrifuge 
at 7,000 rpm for two minutes. The cells were resuspended in 500 μl of buffer solution 
containing 20 mM Tris, pH 8.0, 1 mM EDTA, 1 mM DTT and 2 M urea, by pipetting. 
The resuspended cells were sonicated for 30 seconds and then centrifuged for 15 
minutes at 13,000 rpm, and the resulting supernatant discarded. The protein containing 
pellet was resuspended in a further 500 μl of the above buffer, and the sonication step 
repeated. 500 μl of the same buffer, but supplemented with 2% Triton X-100, was then 
added and the mixture was left to stand for 10 minutes at room temperature. The 
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mixture was then centrifuged at 13,000 rpm for 15 minutes and the supernatant was 
discarded. The pellet was resuspended in 30 μl of a buffer solution containing 50 mM 
Tris, pH 8.0, 1 mM EDTA, 30 mM DTT and 10 M urea, by pipetting. The samples were 
centrifuged at 13,000 rpm for 10 minutes to remove any remaining insoluble 
(membrane) proteins. The HRP-C protein containing supernatant was removed carefully 
and stored as a 10 M urea extract at -20 oC. 
 
2.3.1.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE): 
2.3.1.3.1 Gel Recipes 
 
1) 12% Resolving Gel, 10 ml 
3M Tris, pH 8.55 1.25 ml
28% acrylamide, 1.5% bis acrylamide 4.30 ml 
20% SDS 0.05 ml 
ddH2O 1.90 ml 
0.14% Ammonium persulphate 2.50 ml 
Temed 5.00 μl 
 
2) Stacking Gel, 6 ml 
1M Tris/SDS 
0.75 ml 
(of 4.8ml 1M Tris, pH 7.0 + 0.2ml SDS) 
28% acrylamide, 1.5% bis acrylamide 0.75 ml 
ddH2O 1.50 ml 
0.14% Ammonium persulphate 3.00 ml 
Temed 7.50 μl 
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3) 1:1 sample buffer: 
SDS 1 g
Glycerol 2 ml 
bromophenol blue (0.1% w/v ddH2O) 2 ml 
1M Tris, pH 7.0 1.25 ml 
2-mercaptoethanol 2 ml 
ddH2O 2.75 ml 
 
    4) Stain solution: 10% acetic acid, 10% ethanol + 0.1% Coomassie Blue in ddH2O. 
    5) Destain solution: 10% acetic acid, 10% ethanol in ddH2O. 
 
2.3.1.3.2 SDS-PAGE Method: 
 
SDS-PAGE electrophoresis was performed using 5 μl of each of the 10 M urea extracts 
mixed with an equal volume of 1:1 gel sample buffer. Then samples were subjected to 
electrophoresis using the discontinuous buffer system through the acrylamide stacking 
gel and 12% acrylamide resolving gel. The Rainbow wide-range protein molecular 
weight marker used was from BioRad Laboratories. Electrophoresis was run first at a 
constant 30 mA until the sample reached the stacking gel, when the current was 
increased to 60 mA until the dye reached the bottom of the resolving gel. 
 
The gels were stained with stain solution for 30 minutes at room temperature with 
rocking. The gels were then washed with ddH2O and destained with destain solution 
and rocking at room temperature until the protein bands could be visually resolved from 
the background. 
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2.3.2 Large Scale HRP-C* protein production: 
2.3.2.1 Culture growth and protein expression: 
 
Solution 1) Terrific Broth (TB): 6 g tryptone, 12 g yeast extract, 4 ml glycerol and 
450 ml ddH2O were mixed in a 2 l baffled conical flask. The flask was fitted with a 
bung and then autoclaved. 
Solution 2) 10x TB phosphate: 6.27 g of anhydrous K2HPO4 and 1.17 g of KH2PO4 
were dissolved in 50 ml ddH2O using vigorous stirring, and then autoclaved. 
 
50 μl of glycerol stock of either WT HRP-C or mutant HRP-C pFLAG1 plasmid in 
W3110 E. coli were inoculated into 50 ml of LB broth containing 100 μg/ml of 
ampicillin, and shaken overnight at 37 oC. Each 5 ml of this 50 ml culture were 
inoculated into 500 ml of TB (solution 1 plus solution 2) containing 100 μg/ml of 
ampicillin. The cultures were shaken at 37 oC, and the growth rate was monitored by 
measuring the increase in light scattering at 600 nm. When the O.D. reached 0.8-1.0, the 
cultures were induced with 0.5 mM IPTG. The O.D.600 was recorded until little or no 
change was observed (approximately 4 hours); at this point all the cultures were 
harvested and centrifuged at 4,000 rpm for 30 minutes at 4 oC in a Beckman J-6B 
centrifuge. The supernatant was decanted and the cell pellets were stored at -20 oC.  
 
2.3.2.2 Lysis of Cells and Washing of Protein Pellets: 
 
All harvested cell pellets were resuspended in 200 ml 50 mM Tris, pH 8.0, 10 mM 
EDTA, 1 mM DTT, to give approximately 250 ml solution. The solution was 
transferred to a 500 ml plastic beaker, and lysozyme powder was added to give a final 
concentration of 2 mg/ml, mixed well and the extract was left for one hour on a bench at 
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room temperature until it became very viscous and stringy. The extract was then divided 
into 5 x 50 ml fractions and sonicated in a 100 ml plastic beaker with a large probe 
(CV33 probe) attached to an ultrasonic disintegrator (MSE Mod MK2), each fraction 
for 2 x 1 minutes. When the extract became thinner it was decanted into centrifuge tubes 
and centrifuged in a Beckman J2-21 centrifuge, rotor JA20, at 15,000 rpm for 30 
minutes at 4 oC; the supernatants were discarded.  
 
In each individual tube, the protein pellet was resuspended in 20 ml of 2 M urea, 20 mM 
Tris pH 8.0, 1 mM EDTA and 1mM DDT by manual homogenisation. Then 10 ml of 
the same solution supplemented with 3% Triton X-100 was added. The solutions were 
mixed well and left at room temperature for 15 minutes, then centrifuged at 15,000 rpm 
for 30 minutes at 4 oC. The supernatant was again discarded. This last step was repeated 
once more. It was repeated again for a third time, but this time without using the Triton 
X-100 part of the wash, in order to remove traces of Triton detergent that might 
subsequently affect the efficiency of the folding procedure. The HRP-C* protein pellets 
were stored frozen at -20 oC. 
 
2.3.2.3 Folding and purification of HRP-C* protein:  
 
For each variant or WT, all HRP-C* protein pellets were resuspended in 30 ml of 
freshly prepared buffer containing 50 mM Tris, pH 8.0, 6 M urea, 1 mM EDTA and 1 
mM DTT by using a homogeniser, and were left at room temperature for 15 minutes. 
They were then centrifuged at 15,000 rpm for 30 minutes at 4 oC. The concentration of 
the protein in the supernatant was determined using the Bio-Rad Bradford protein assay 
with bovine serum albumin (BSA) as a standard. The enzyme was then diluted to a final 
concentration of 2 mg/ml using more of the buffer mentioned above. The volume of the 
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protein solution was multiplied by a factor of 10 to give the final total fold volume. A 
folding solution was prepared so that after the protein solution was added, the 
concentrations would be 2.1 M urea, 50 mM Tris, pH 8.0, 8 mM CaCl2 and 0.7 mM of 
oxidised L-glutathione. The folding solution was chilled in the cold room for 30 
minutes, and then the enzyme solution was added (giving 0.1 mM DTT and 200 μg/ml 
protein), and the mixture left in the cold room (stirring) for 18 hours. At this point 6 μM 
of haemin was added, and the mixture again left in the cold room with stirring for a 
further 48 hours.  
 
The folded enzyme solution was then centrifuged in the Beckman J-6B centrifuge at 
4,000 rpm for 30 minutes to remove any misfolded protein aggregates formed. The 
solution was concentrated down to about 300 ml using a large spiral-wound Amicon 
concentrator of 30,000 Da, pre-washed with 2 M urea, and then concentrated down 
again to less than 50 ml using Millipore 30,000 Da ultrafiltration membranes in a stirred 
cell at 4 oC. The protein solution was dialysed overnight at 4 oC against 20 mM Na 
acetate solution, pH 4.3 containing 1 mM CaCl2. The aggregates formed during the 
dialysis process were removed by centrifugation at 4,000 rpm in the Beckman J-6B 
centrifuge for 10 minutes at 4 oC, and then by passing the supernatant obtained through 
a Millipore 0.22 μm Millex-GS sterilizing filter unit. 
 
Final purification of the dialysed protein solution was achieved by cation exchange 
chromatography using the Pharmacia Fast Protein Liquid Chromatography (FPLC) 
instrument. The protein was loaded onto a Mono S cation exchange column, pre-
equilibrated with 20 mM Na-acetate, pH 4.3. The purified HRP-C* enzyme was eluted 
from the column by the application of a NaCl gradient to a final concentration of 1 M. 
54 
 
 
 
The purified protein fractions were gel-filtered into 5 mM MOPS buffer, pH 7.0 using a 
PD–10 desalting column (Pharmacia). The purified HRP-C* enzyme was then frozen in 
liquid nitrogen and stored at -80 oC. 
 
2.4 UV/Vis Spectroscopic studies: 
 
All standard UV/Visible spectroscopic studies of HRP-C* enzyme samples were 
performed on a Shimadzu UV- 2401 PC spectrophotometer. The measurements were 
taken at 25 oC using quartz cuvettes. 
 
2.4.1 Spectral features of WT HRP-C* and the new variants: 
 
The UV/Vis spectra of the resting states of WT HRP-C* and the new S167 variants 
were recorded by scanning their diluted solutions in 5 mM MOPS buffer, pH 7.0; from 
250-750 nm. 
 
2.4.2 Haem Soret peak extinction coefficient (ε) determination: 
 
The pyridine haemochrome method was used to determined the molar absorption 
coefficient of WT HRP-C* and the new variants (Fuhrhop and Smith, 1975) at the haem 
Soret peak; this method measures the total haem content of the sample by forming 
pyridine-haem complexes, from extracted haem produced on treating enzyme samples 
with alkali. The difference spectrum of the reduced minus oxidised forms is used to 
calculate the concentration of the haem extracted from the enzyme and, using a known 
extinction coefficient, to determine the Soret extinction coefficient. 
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For WT and each variant, 40 μl of diluted enzyme solution was made up to 400 μl with 
5 mM MOPS buffer, pH 7.0, and the resting state Soret peak absorption recorded. The 
enzyme solution was recovered from the cuvette, diluted further to 800 μl with the same 
buffer, and then 88 μl of 1 M NaOH and 175 μl pyridine were added. The mixture was 
divided equally between two quartz cuvettes and a baseline was taken. The mixture in 
the sample cuvette was then reduced with a few crystals of sodium dithionite and a 250-
750 nm spectrum was taken. The value of A555-A542nm was recorded, and the extinction 
coefficient for each new HRP-C* variant was calculated using the published extinction 
coefficient for the reduced minus oxidised haem pyridine complex, ε555 - ε542 = 20.7 
mM-1 cm-1 (Fuhrhop and Smith, 1975), and the known Soret absorbance. 
 
2.5 Benzhydroxamic acid binding assays: 
 
Benzhydroxamic acid (BHA) binding assays were carried out on WT HRP-C* and the 
new S167Y and S167W variants in order to estimate the dissociation constant (Kd) of 
the enzyme-BHA complex. Difference spectra of the enzyme with BHA added or not 
were recorded between 350-450 nm using the following procedure. 
 
1 ml of 3 μM solution of each enzyme in 5 mM MOPS buffer, pH 7.0, was placed in 
both the sample cuvette and reference cuvette, and a baseline was taken. Then 
successive volumes (10 μl) of stock BHA solution (200 μM) were added to the sample 
cuvette and an equal volume of buffer added to the reference cuvette, and the different 
spectra were recorded. Successive volumes of stock BHA solution were added until 
saturation of the enzyme sample occurred. Addition of BHA causes an increase in the 
absorbance of the Soret peak of the HRP-C* enzyme, and when the absorbance does not 
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change with the addition of more BHA, then saturation of enzyme has occurred. All 
experiments were conducted at 25 oC. The absolute BHA concentrations in the sample 
cuvette were determined and the absorbance values were corrected accordingly to the 
dilution factor. 
 
The dissociation constant (Kd), as well as the maximum absorbance (Aω), were 
determined by fitting the data, using a weighted least-squares error minimization 
procedure, to the equation: 
 
ܣ ൌ 2ܣ߱ܮ/ሼ(ܮ +  ܭௗ + ܲ) + ሾ(ܮ + ܭௗ  + ܲ)ଶ െ 4ܲܮሿ଴.ହሽ 
 
corresponding to reversible binding of a ligand to a single site, where A is the 
absorbance change at 409 nm (Soret) for a total BHA concentration L, Aω is the 
maximum absorbance change and P is the total protein concentration (Smith et al., 
1992). 
 
2.6 Reaction of enzyme with hydrogen peroxide: 
 
In order to further characterise the new S167 HRP-C* variants, and also to attempt to 
create a new covalent linkage between the haem and the protein, enzyme samples were 
treated with differing amounts of freshly prepared hydrogen peroxide solution (DePillis 
et al., 1997; Colas and Ortiz de Montellano, 2004).  
 
Samples of the S167W and S167Y mutants were gel-filtered using a NAP–5 column 
(pre-packed disposable columns containing SephadexTM G–25 Medium, Promega) into 
50 mM Na-phosphate buffer (pH 7.0 for S167W and pH 9.5 for S167Y), and were then 
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diluted to a final concentration of 5 µM in the same Na-phosphate buffer. 0.5 mM of 
freshly diluted H2O2 was then added, and the reaction solution was incubated for two 
hours at 25 oC. After that, the H2O2 treated samples of the variants were gel-filtered 
back into 5 mM MOPS buffer, pH 7.0.  
 
The UV/Visible spectra 250-750 nm of the resting states of WT HRP-C*, treated and 
untreated variants were then taken. Pyridine haemochrome assays were performed on all 
the enzyme samples as described in section 2.4.2. 
 
2.7 Enzyme intermediates on treatment with hydrogen peroxide: 
 
Repeat scans of S167 HRP-C* variants at different times after treatment with H2O2 
were taken in order to monitor the differences in rate of formation and reduction of the 
enzyme intermediates, Compounds I and II, under steady-state conditions. This 
experiment was carried out for HRP-C* variants, where 0.5 mM of H2O2 was added to 5 
µM of each mutant in 50 mM sodium phosphate buffer (pH 7.0 for S167W and pH 9.5 
for S167Y) at 25 oC and 250-750 nm scans were taken at different times (1, 5, 10, 15, 
20, 30, 60, 90, 120, 150 and 180 minutes) after the addition of H2O2. 
 
2.8 Acid butanone haem extraction: 
 
The ability to extract the haem prosthetic group from the new S167 variants (both 
before and after treatment with H2O2) was tested using the acid butanone extraction 
technique (Fuhrhop and Smith, 1975). This experiment was to look for the formation of 
a cross-linkage between the haem and the protein as a result of the enzyme’s reaction 
with H2O2. For each 100 μl enzyme sample of WT HRP-C*, S167W or S167Y variant, 
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either treated or untreated with hydrogen peroxide, 25 μl of 2 M HCl was added (to 
denature the protein) plus 500 μl of butanone to extract the organic haem group. The 
solution was shaken well and then left on the bench to allow the separation of the 
aqueous layer below and the organic layer above; then the organic layer was carefully 
extracted. In general for WT HRP-C*, under these conditions, the haem group is 
extracted directly into the organic layer, leaving the apo-protein in the aqueous layer. 
Pyridine haemochrome analyses (section 2.4.2) were performed on the organic layer 
extracted samples and the amount of haem extracted from each of the samples was 
calculated accordingly. 
 
2.9 High Performance Liquid Chromatography (HPLC) analysis: 
2.9.1 Principles of chromatography: 
 
Chromatography is one of the most powerful analytical methods, and is used for 
separation, identification and determination of the substances in complex mixtures. This 
method is characterised by the existence of two phases, a stationary phase and a mobile 
phase. The components of the mixture (solutes or analytes) are distributed between 
these two phases, and move with the mobile phase through the stationary phase 
according to their relative affinities towards each phase. The separation is performed by 
the difference in the rate of getting each component out of the system, which is known 
as elution. A substance that is distributed preferentially in the mobile phase will elute 
from the system more rapidly than those preferentially distributed in the stationary 
phase (Done, 1978). 
 
There are two types of chromatography, based on the stationary phase. The first one is 
known as planar chromatography, in which the stationary phase is supported on a flat 
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plate or in the pores of a paper; in this type of chromatography the mobile phase passes 
the stationary phase under the effect of gravity or by capillary action. The second type is 
known as column chromatography, in which the stationary phase is packed into a 
column and the mobile phase moves under the influence of gravity, or by the effect of 
pressure. Chromatographic techniques can also be subdivided into gas or liquid 
chromatography, based upon the nature of the mobile phase, as well as solid or liquid 
chromatography depending on the form of the stationary phase (Skoog et al., 1998). 
 
2.9.2 Distribution ratio and Retention time: 
 
The relative affinity of a solute towards the stationary and mobile phases is known as a 
distribution ratio K, which is expressed as: 
K ൌ ܵ௦௧/ܵ௠௢ 
where, Sst is the concentration of solute on the stationary phase, and Smo the 
concentration of solute in the mobile phase (Skoog et al., 1996). 
 
The K value is the key to the analysis process in chromatography techniques, large 
values of K lead to slow elution for the solute, while small values lead to rapid elution. 
Therefore, the best separation occurs when the differences between the distribution 
ratios of the solutes in the mixture are large and significant. The time it takes for the 
solute to pass through the stationary phase is called the retention time tR, or in other 
words, the time it takes after sample injection for the solute peak to reach the detector 
(Skoog et al., 1996; Higson, 2004). 
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2.9.3 HPLC apparatus: 
 
High Performance Liquid Chromatography (HPLC) represents one of the most widely 
used forms of chromatography. The term ‘high performance’ relates to the ability of 
HPLC to perform high quality and selective separation of compounds in minimum 
times. In the HPLC system, the separation process is achieved by forcing the mobile 
phase to penetrate through the column under high pressure (Higson, 2004). A typical 
schematic diagram of High Performance Liquid Chromatography is shown in Figure 
2.1. In general, an HPLC apparatus consists of three main sections: solvent delivery 
system, column and detector. 
 
 
 
 
 
 
 
 
Figure 2.1: Simple scheme of an HPLC system, showing the main parts that make 
up the apparatus, reproduced from Higson, 2004. 
 
2.9.3.1 Solvent Delivery System: This is the first section in the HPLC apparatus, and is 
responsible for providing an accurate, constant flow of mobile phase when required. 
This system consists of the following key parts. 
a) Solvent reservoirs, which are usually equipped with inlet filters to remove dust 
and other particulate material; this facilitates the process of solvent pumping and 
protects the column from the possibility of blockage. 
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b) A solvent degassing unit, to remove dissolved air in the solvent; air can produce 
bubbles in the column, causing a reduction in the performance of detectors and 
disruption of elution peaks (Fifield and Kealey, 1995; Kealey and Haines, 2002). 
c) Pumps, which are responsible for forcing the mobile phase through the column 
at a controlled flow rate; this is achieved by applying a constant pressure 
(Lindsay, 1992). Most pumping systems in HPLC include (1) a range of flow 
rates from 0.1-2 ml/min., (2) non pulse flow, to remove noise from the detector, 
(3) the generation of pressure up to 4500 psi, (4) the ability to resist corrosion 
from a wide range of solvents and (5) flow reproducibility of 0.5% or better, to 
ensure adequate analytical precision (Gilbert, 1987). 
 
In the HPLC technique, liquid samples are injected directly into the flowing mobile 
phase, using highly controlled injection systems. Two types of injection system are 
available, syringe and valve. Syringe injection is more convenient than valve (Done, 
1978). Up-to-date HPLC apparatus is generally equipped with automated injection 
systems, which have the ability to automatically inject up to 100 samples. A guard 
column is also sometimes used, positioned before the separation column. This serves to 
protect the column from aggregated particulate matter in the injected samples. It is a 
short column packed with the same stationary phase as the analytical column (Kealey 
and Haines, 2002). 
 
2.9.3.2 Column: This holds the stationary phase. The columns in HPLC are usually 
constructed from stainless steel tubing, and most have lengths ranging from 10-30 cm 
with diameters ranging from 3-10 mm. These columns are packed typically with particle 
sizes of 5 or 10 μm. As a result of the need to improve and develop the efficiency of 
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HPLC, high performance micro-columns have been produced with smaller dimensions, 
ranging from 3-7.5 cm in length and 1-4.6 mm in diameter, with 3 or 5 μm particle size 
(Skoog et al., 1996).  
 
The main type of packing material for HPLC columns is micro porous particles with 
diameters from 3-10 μm. Silica is one of the most important materials that is used as a 
packing material as it can be made with highly uniform diameters. It is used to prepare 
chemically modified stationary phases with high quality separation properties. The 
particles are coated in most cases with thin organic films, which are bonded either 
chemically or physically to the surface. There are four major classes of modified silica: 
esterified silicas, Si-N functionalized silicas, Si-O-Si-C functionalized silicas and 
polysiloxane/silicone derivatized silicas. Other chemical materials that are used for 
column packing, include alumina particles, porous polymer particles, porous graphite 
carbon and ion-exchange resins (Higson, 2004). 
 
Recently, a particle size of less than 3 microns has been used for HPLC. It produces 
improved peak shapes, and reduces the retention time by a factor of ten. This is named 
ultra performance liquid chromatography (UPLC) (de Villiers et al., 2006). 
 
2.9.3.3 Detector: The detector is essential to all types of chromatography techniques. It 
is responsible for detecting the elution positions of the separated components of a 
mixture that has been subjected to a chromatographic process. The results from the 
detectors are generally displayed in the form of a chromatogram with varying peaks, 
each one of these peaks representing one component of the mixture. The main 
characteristic of any detection system is the ability to give a recognizable signal, even 
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with a minimum concentration of solute, against the background noise of the instrument 
(Done, 1978). 
 
A number of detectors are available for HPLC, and the most commonly used include 
UV-Visible absorption, fluorescence, electrochemical and refractive index detectors. By 
far the most widely used are UV-Visible detectors due to their high sensitivity and 
ability to monitor many different solutes as they elute from the column. Today, a 
variable wavelength detector (diode-array) is available for a range of 200-700 nm, 
which can display an entire spectrum as solutes exit the column (Pryde and Gilbert, 
1979; Ardrey, 2003). A fraction collector may be added after the detector; this is useful 
for collecting pure fractions accurately for further spectroscopic analysis. 
 
2.9.4 HPLC analysis of the new HRP-C* mutants: 
 
HPLC analysis was used to examine the nature of any covalent linkage between the 
haem and the protein in WT HRP-C* and the S167 variants both before and after H2O2 
treatment. All HPLC assays were conducted on the Agilent 1100 Series HPLC system 
with an analytical C4, 4µm (100 × 4.5 mm) reverse phase column, under PC control. 
The mobile phase consisted of two buffer solutions, Buffer A: 0.1% (v/v) trifluroacetic 
acid (TFA) in water, and Buffer B: 0.1% (v/v) TFA in acetonitrile (MeCN). 20 μl of a 
50 μM enzyme sample were mixed with an equal volume of 2% SDS (Metcalfe et al., 
2004) and boiled for 5 minutes at 95 oC, after which the sample was diluted to 100μl 
total volume with buffer A and injected (20 μl at a time) into the column pre-
equilibrated with buffer A. The protein/haem elution was achieved by using the 
following elution profile with a flow rate of 1 ml/min.: 0 % buffer B for 5 minutes, after 
that 0-30 % buffer B for 5 minutes, followed by 30-40 % buffer B for 5 minutes, and 
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then 40-100 % buffer B for 45 minutes. The haem group was monitored at 400 nm 
while the protein was monitored at 280 nm. 
 
2.10 Mass Spectrometry: 
2.10.1 Introduction: 
 
Mass spectrometry (MS) is a widely used analytical technique, in which the atoms or 
molecules of a sample are treated to form gaseous ions; these ions are then separated 
according to their mass-to-charge ratio (m/z) (Farmer, 1963). MS is characterised by 
high sensitivity, as very small amounts of analyte (picogram) are sufficient to provide 
information with high accuracy and precision (Ardrey, 2003). MS has been successfully 
applied to a wide range of research studies in organic chemistry, to determine the 
molecular weight and structure of organic compounds (Johnstone and Rose, 1996), and 
in inorganic and organometallic chemistry, to identify and determine complexes and 
compound components (Henderson and McIndoe, 2005). Furthermore, this technique 
has been used extensively in the field of biochemistry and biotechnology, to 
characterise a wide variety of bio-molecules such as sugars, oligonucleotides, peptides 
and protein molecules (Fountoulakis and Langen, 1997; Roepstorff, 1997; Mo and 
Karger, 2002). Currently, MS plays a significant role in determining the amino acid 
sequences of peptides and proteins, in addition to identifying the location of disulfide 
bridges in proteins (Hunt et al., 1988; Carr et al., 1991). MS has a lot of applications in 
the pharmaceutical industry, where it is invaluable for drug discovery and drug 
metabolism studies (Korfmacher, 2005; Ackermann et al., 2008), and has important 
medical applications, in respiratory and blood gas analysis, lipid analysis and in 
studying the fate of pesticide and insecticide metabolism (Milne, 1991).  
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2.10.2 Main components of mass spectrometry: 
 
MS consists of the following main parts: inlet system, ionization source, mass analyzer 
and detector, Figure 2.2. These fundamental parts are usually maintained under high 
vacuum in order to protect the system from the effects of air molecules, which would 
hinder and disrupt the mass spectra of samples by colliding with the gaseous ions, and 
also cause damage to some parts of the instrument such as the ionization source and 
detector (Kealey and Haines, 2002). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Block diagram showing the main parts of a mass spectrometer. 
 
 
2.10.2.1 Sample Inlet System: The sample inlet represents the first part of the mass 
spectrometer instrument. It facilitates the controlled introduction of gaseous or 
vapourized liquid samples via a molecular leak, and solid samples via a heated probe. In 
fact, there are three inlet systems commonly used for introducing samples for 
ionization: these are batch, direct probe and chromatographic type inlet. Each one of 
these systems has high efficiency and are used for experiments depending on the nature 
of sample to be analyzed (Kealey and Haines, 2002; Higson, 2004). 
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2.10.2.2 Ionization Sources: The main function of this part is to produce as many ions 
as possible from the neutral particles of sample, and to form an ion beam that is suitable 
to enter into the analyzer. A variety of ionization sources are used for MS, the choice 
depending on the nature of the sample and the type of information desired. For example, 
electron ionization and chemical ionization sources are suitable for gas phase ionization, 
whilst fast atom bombardment, secondary ion mass spectrometry, electrospray and 
matrix assisted laser desorption ionization sources are used to ionize condensed phase 
samples. The principle of how most of these ionization sources work is the exciting of 
the neutral sample molecule which then ejects an electron to form a radical cation (M+.). 
Suitable ionization sources must also be characterised by possession of a stable ion 
beam that has sufficient intensity for accurate measurement. In addition, ionisation 
sources are designed to produce as low as possible an intensity of background ions 
which do not originate from the sample, and they should not exhibit mass 
discrimination (Elliot, 1963; Roboz, 1968). 
 
2.10.2.3 Mass Analyzer: The sample ions, which are formed in the ionisation source, 
are then accelerated into the next part of the mass spectrometer, known as the mass 
analyzer, by applying an electric field. Within the mass analyzer, the ions are separated 
according to differences in their mass-to-charge (m/z) ratios. Ions formed from neutral 
sample molecules will have different masses, and therefore when accelerated towards 
the analyzer region, they will enter with a range of velocities; the greater the mass of the 
ions the slower they travel, hence ions with smaller mass will arrive and enter the 
analyzer first (Higson, 2004). Several forms of mass analyzers are available to achieve 
the separation process of the ions according to their m/z value. The selection of mass 
analyzer depends on the following properties: (1) resolution, (2) mass range, (3) scan 
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rate and (4) detection limits required. Commonly used mass analyzers include 
quadrupole filter, magnetic sector, time-of-flight, ion cyclotron resonance and 
quadrupole ion trap analyzers (Chapman, 1993; Bramer, 1998). 
 
2.10.2.4 Detector and Data Processing: This is the last component of the mass 
spectrometer. Once the process of separation of the ions according to their m/z ratios in 
the analyzer region is completed, ion current of varying intensity reaches the detector. 
The detector monitors this ion current, amplifies it, and then transmits a signal into the 
data processing system, whereby the signal is processed and recorded in the form of a 
mass spectrum. The spectrum output is plotted as m/z values of the ions against their 
intensities. Important information can be obtained from this spectrum, such as the 
number of components, the molecular mass of each component and the relative 
abundance of the various components in the sample. The most common detectors 
include the photomultiplier, electron multiplier and micro-channel plate detectors, and 
are used to suit the type of analyzer (Bramer, 1998; Ashcroft, 2002; Polce and 
Wesdemiotis, 2002). 
 
2.10.3 MALDI-TOF Mass Spectrometer: 
 
Matrix-Assisted Laser Desorption Ionization (MALDI) is a soft ionization technique 
used in MS, which is characterised by high accuracy and sensitivity. The technique was 
developed in 1988 by Hillenkamp and Karas for protein analysis (Karas and 
Hillenkamp, 1988), and recently it has become one of the most widely used techniques 
for the analysis of bio-molecules. It is used mainly for rapid measurement of the 
molecular weights of peptides, proteins, lipids, oligonucleotides, oligosaccharides and 
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other bio-molecules, with an accuracy of up to 0.01% of the actual molecular weight of 
the sample (Johnstone and Rose, 1996). 
 
MALDI-MS is based on exposing the sample to be analyzed, mixed with an excess of 
matrix compound, to a short period of bombardment by intense pulses of laser light, 
usually a pulsed nitrogen laser at a wavelength of 337 nm (Figure 2.3) (Polce and 
Wesdemiotis, 2002). The matrix is characterised by its high absorbance of laser light 
energy, which is transformed into excitation energy and leads to the ionization of the 
analyte. Experience has shown that the best and most reliable results can be obtained 
when the molar ratio of sample to matrix ranges from 1:100 to 1:50,000. Indeed, the 
matrix plays an essential role in the generation of intact ions from the analyte, as it 
assists in efficiently providing controllable energy to the sample, minimizing the 
possibility of decomposition (Hillenkamp et al., 1991; Lewis et al., 2000). 
 
 
 
 
 
 
Figure 2.3: The process of the formation of sample ions by MALDI source, 
reproduced from Polce and Wesdemiotis, 2002. 
 
2.10.3.1 MALDI Matrices: 
 
Matrices that are used in MALDI-MS analysis should have the following properties: (1) 
high electronic absorption at the laser wavelength used, (2) good vacuum stability, (3) 
low vapour pressure and (4) good solubility in solvents that also dissolve the analyte 
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sample (Montaudo et al., 2002). The most commonly used matrices are 2,5-
dihydroxybenzoic acid (DHB) which is usually used for the analysis of glycopeptides, 
glycoproteins, small proteins and oligonucleotides, 3,5-dimethoxy-4-hydroxycinnamic 
acid (sinapic acid or SA) which is commonly used for peptides and proteins, and α-
cyano-4-hydroxycinnamic acid (α-CHCA) which is mainly used for the analysis of 
peptides, glycopeptides and small proteins (Figure 2.4) (Lewis et al., 2000). 
 
2.10.3.2 Sample Preparation in MALDI: 
 
The sample-matrix preparation is crucial to the quality of the spectrum obtained in 
MALDI-MS, as it strongly affects detection sensitivity, selectivity and mass resolution 
in the analysis of peptides and proteins. The most frequently used preparation method 
currently is the dried-droplet method. It is quite a simple and fast method, in which 
initially a saturated solution of a suitable matrix is prepared in water/organic solvent 
(usually either ethanol or acetonitrile). Appropriate amounts of this matrix solution are 
then mixed with the analyte dissolved in identical solvent(s) to give a mixture with a 
matrix to sample ratio of about 5000:1. After this, an aliquot of the mixture is 
transferred onto the MALDI target and allowed to dry at room temperature. The sample 
is then is ready to be loaded into the MALDI-MS instrument and analyzed (Hillenkamp 
et al., 1991; Lewis et al., 2000). 
 
 
 
 
 
 
  
Figure 2.4: Chemical structures of the most common MALDI matrices. 
Sinapic acid (SA) α-CHCA DHB 
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2.10.3.3 Time-of-Flight analyzer in MALDI: 
 
Time-of-Flight (TOF) analyzers are typically suited for use with MALDI-MS because 
of their theoretically unlimited mass range, high ion transmission and temporal 
separation of ions (Lewis et al., 2000). TOF is characterised by its ability to produce 
high mass accuracy and high mass resolution. In MALDI TOF-MS, a packet of ions is 
produced by firing a laser onto the matrix-sample mixture, which is then accelerated by 
a fixed electric potential (V). The resulting velocity of the ions is characteristic of their 
m/z ratio. After the ions leave the acceleration region they then enter a field-free flight 
region known as a drift tube. They travel through the drift tube and reach the detector at 
different times depending on their initial velocity. The signal resulting from the detector 
is recorded as a function of time and displayed as a mass spectrum, on which the square 
of the flight time is proportional to the m/z ratio, as shown in the following equation: 
݉/ݖ ൌ 2Vݐଶ/݈ଶ 
where, m is the mass of the ion, z is the number of charges, V is the accelerating 
voltage, t is the ion flight time, l is the length of the flight tube. Since the V and l values 
are known, the m/z ratio can be calculated from the equation above (Chapman, 1993; 
Lewis et al., 2000; Montaudo et al., 2002). 
There are two kinds of TOF analyzers which can be used to detect the ions through the 
drift tube; these are linear mode and reflectron mode (Figure 2.5). Higher sensitivity, 
particularly at high molecular mass, is achieved in linear mode, whilst higher resolution 
is obtained in reflectron mode, as the reflector (ion mirror) serves to increase the flight 
time of the ions and hence their separation. In linear mode, resolution is around (500–
800) and only a short lifetime (1 μs) for the ion is required, even in the case of a 
metastable decay on the flight path. In reflectron mode, resolution is typically around 
1000–2500 (Hillenkamp et al., 1991; Montaudo et al., 2002). 
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Figure 2.5: Diagram of a MALDI TOF-MS in (a) Linear mode and (b) Reflectron 
mode, reproduced from Hillenkamp et al., 1991. 
 
2.10.4 ESI Mass Spectrometer: 
 
Electrospray ionization (ESI) has emerged as a powerful MS technique for the analysis 
of large and fragile polar molecules. Since it was first used by Yamashita and Fenn in 
1984 (Yamashita and Fenn, 1984), this technique has become one of the common ways 
to measure the molecular weight of bio-molecules, particularly peptides and proteins. 
The principle of ESI is the formation of multiply charged ions from an analyte, with 
produced ions having one, two, three or more charges; therefore the corresponding m/z 
ratios will vary relative to the number of charges (z) carried by each ion. In this 
technique, large molecules such as proteins can be protonated or deprotonated at several 
sites, giving ions with an upper limit of m/z value not exceeding a few thousand. This is 
of significance as a mass spectrometer measures the m/z ratio of an ion, and the mass 
range of an instrument may therefore be effectively extended by a factor equivalent to 
the number of charges caused to reside on the sample molecule. Thus, massive 
molecules, even those with a molecular weight in excess of a hundred thousand, can be 
analyzed (Johnstone and Rose, 1996). 
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2.10.4.1 Mechanism of Electrospray Ionization: 
 
Electrospray ionization occurs by three main steps: (1) formation of charged droplets, 
(2) desolvation of the droplets and (3) formation of gas-phase ions from the sample. 
During standard ESI (Figure 2.6), the sample is dissolved in a polar, volatile solvent and 
introduced into the instrument by a syringe pump in a region of atmospheric pressure 
(Ashcroft, 2002). The analyte solution is then passed through an electrospray capillary 
tube at a flow rate ranging between 1 μl/min to 1 ml/min, while a strong electric field is 
applied to the tip of the capillary. Typically, the potential difference between the 
capillary tip and a nearby counter-electrode is 3-4 kV. The sample emerging from the 
tip is charged by the field and hence dispersed into a mist of highly charged droplets, a 
process that is assisted by the co-axial flow of a nebulising gas, usually nitrogen, 
flowing around the outside of the capillary. The charged droplets then undergo a 
desolvation process during their passage across the front of the ionization source, 
assisted by a warm flow of nitrogen gas that is known as the drying gas. As a result of 
the removal of the solvent, the droplets decrease in size until they reach the Rayleigh 
instability limit; at this point a Coulombic explosion occurs and several even smaller 
droplets are formed. A series of solvent evaporation, droplet contraction and Coulombic 
explosions is repeated until gas-phase ions of the sample are produced (Figure 2.7), 
which are eventually transferred through a sampling cone under high vacuum towards 
the analyzer of the mass spectrometer (Fenn et al., 1989; Ashcroft, 2002; Polce and 
Wesdemiotis, 2002; Prokai, 2002; Ardrey, 2003). 
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Figure 2.6: Standard Electrospray Ionization (ESI) spectrophotometer set up, 
reproduced from Ashcroft, 2002. 
 
 
 
 
 
 
 
Figure 2.7: The formation of ions from droplets in ESI, reproduced from Polce and 
Wesdemiotis, 2002. 
 
2.10.4.2 ESI spectrum appearance and Data processing: 
 
As discussed before, ESI produces multiply charged ions, either by protonation in 
positive ionization mode, [M+zH] +z, or deprotonation in negative ionization mode, [M-
zH] -z, from molecules that have multiple sites. The choice between negative or positive 
ionization modes would depend on the nature of the sample. Peptides and proteins are 
usually analyzed under positive ionization conditions, while saccharides and 
oligonucleotides are analyzed under negative ionization conditions. The analysis of 
[M+zH] +z 
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multiply charged (both protonated and deprotonated) ions has been accomplished using 
most types of analyzers, such as quadrupole, magnetic sector, ion taps and time-of-flight 
(Prokai, 2002). An ESI mass spectrum usually appears as a series of ion peaks of 
different m/z values, each of which represents a different charged state for the same 
analyte (Fenn et al., 1989). The molecular weight of the sample can be determined from 
the spectrum, using the fact that adjacent peaks in the multiply charged series are 
different only by one charge. A typical ESI-MS spectrum, of horse heart myoglobin, is 
shown in Figure 2.8; in this spectrum, the m/z values recorded for multiply charged ions 
range from 616.35 to 1413.87 (Ardrey, 2003). Each peak observed in this spectrum 
represents the intact molecule of the analyte carrying an unknown number of charges, 
and the same number of protons. The value above each peak represents the molecular 
weight of the intact analyte divided by the charge number it carries (Ardrey, 2003).  
 
The m/z value of an ion is related to the molecular weight of the analyte and can be 
expressed by the following equation:  
݉/ݖ ൌ  (MW +  nHା)/n 
where m/z = the mass-to-charge ratio, MW = the molecular mass of the analyte, n = the 
integer number of charges on the ion and H = the mass of a proton = 1.008 Da. 
When the number of charges on an ion is known, then it is possible to calculate the 
molecular weight of the sample from one peak by using the equation. However, because 
the value of n is not known, this makes one peak insufficient to determine the molecular 
weight of the analyte. But if two adjacent peaks are examined, both unknown 
parameters (number of charges and molecular weight of analyte) can be solved from a 
pair of simultaneous equations (Johnstone and Rose, 1996; Ardrey, 2003). For example, 
if the ions appearing at m/z 848.62 in the horse heart myoglobin spectrum (Figure 2.8) 
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have "n" charges, then the ions at m/z 808.28 will have "n+1" charges, and the above 
equation can be written for these two ions as: 
848.62 ൌ  (MW +  nHା)/n     and    808.28 ൌ  ሾMW +  (n + 1)Hାሿ /(n + 1) 
These simultaneous equations can be rearranged to exclude the MW term: 
n(848.62)  െ  nHା ൌ  (n + 1) 808.28 െ  (n + 1)Hା  
n(848.62)  ൌ  n(808.28) + 808.28 െ  Hା 
n(848.62 െ  808.28)  ൌ  808.28 െ  Hା  
n ൌ  (808.28 െ  Hା) / (848.62 െ  808.28) 
n ൌ  807.272 /40.34 ൌ  20  
Putting the value of n back into the equation: 
848.62 ൌ  (MW +  nHା)/ n 
848.62x 20 ൌ  MW +  (20 x 1.008) 
MW ൌ  16972.4 െ  20.16 
MW = 16952.24 Da 
 
 
 
  
 
 
 
 
 
 
 
Figure 2.8: A positive ion ESI-MS spectrum of horse heart myoglobin, reproduced 
from Ardery, 2003. 
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2.10.5 MALDI-TOF analysis of HRP-C* mutants: 
 
For MALDI–TOF MS analysis, 5 μl of a 50μM of WT HRP-C*, S167W or S167Y 
variant (either treated or untreated with hydrogen peroxide) were mixed with an equal 
volume of 25 mg/ml matrix solution (α-cyano-4-hydroxycinnamic acid dissolved in 1:1 
MeCN and ddH2O). 1 μl of the final solution with matrix was applied to the sample 
target plate and allowed to dry and crystallise at room temperature. The analysis of 
sample was performed by the MALDI-TOF machine (Waters Corporation), pre-
calibrated with protein samples of high purity and known molecular weight. The sample 
was loaded under high vacuum, the laser fired (the energy of the laser was at 60% on 
medium range) and the detector placed in a linear mode. The data processing was 
achieved automatically using MassLynx V4.0 to calculate the mass of each enzyme 
sample. 
 
2.10.6 Electrospray Ionization of HRP-C* mutants: 
 
For ESI-MS analysis, HRP-C* proteins were analysed under positive ionisation 
conditions. 100 μl samples of WT-HRP-C*, S167W or S167Y variant (either treated or 
untreated with hydrogen peroxide) were dialysed overnight in the cold room (4 oC) 
against ddH2O, then mixed with an equal volume of 0.1% (w/v) formic acid in 50:50 
methanol and water. The final solution was directly injected at a rate of 15 μl/min into a 
Micromass Hybrid Q-TOF ultima machine (Waters Corporations), pre-calibrated with 
sodium iodide with m/z values range of 100-3000 Dalton. The dissolvation temperature 
was 400 oC and desolvation gas flow was 396 l/hr. Data processing and analysis of the 
resultant spectrum data was achieved automatically using MassLynx V4.1 to determine 
the mass of each protein sample. 
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2.11 Peroxidase activities under Steady-State Conditions: 
2.11.1 Initial steady-state parameters for the oxidation of ABTS: 
 
For WT HRP-C* as well as each of the S167 variants, initial steady-state parameters for 
peroxidase activity were determined using the substrate 2,2’-azino-bis (3-
ethylbenzthiozoline-6-sulphonic acid) (ABTS), which is oxidised to a green radical 
product in the presence of peroxidase and hydrogen peroxide (H2O2). 
 
Reactions were carried out in a citrate-phosphate buffer, pH 5.0, containing 51 mM 
disodium hydrogen orthophosphate and 24 mM citric acid. The assay reactions were 
initiated by the addition of substrate, hydrogen peroxide and then enzyme to a cuvette, 
giving final concentrations of 1 mM H2O2, 3 nM enzyme and 0.1-3 mM ABTS in 1 ml 
total final assay volume. All assay reagents were prepared in the assay buffer. 
 
The formation of the green radical product, as a function of time, was measured at 25 oC 
by monitoring the change of absorbance at 414 nm for 60 seconds. Three independent 
measurements were made for each substrate concentration. The initial rates (μmol.min-
1.ml-1) were determined using ε414 = 36.8 mM-1 cm-1 (Childs and Bardsley, 1975) and 
then converted to turnover number (s-1) using enzyme concentration. The Km and kcat for 
ABTS were determined by fitting the data obtained to the Michaelis-Menten equation 
using the statistical analysis software SigmaPlot for Windows V4.01 (SPSS UK Ltd,). 
Hydrogen peroxide concentration was determined by measuring the absorbance of a 
dilution of the stock solution at 240 nm, and using the extinction coefficient ε240 = 39.4 
M-1 cm-1 (Nelson and Kiesow, 1972). 
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2.11.2 Activity screening towards a panel of substrates: 
 
WT HRP-C* enzyme and the S167 variants were also screened against a range of 
peroxidase substrates, in order to determine their specific activities. The assays were 
carried out in phosphate-citrate buffer, pH 5.0, containing 51 mM disodium hydrogen 
orthophosphate and 24 mM citric acid at 25 oC. The individual conditions for each 
substrate are given in Table 2.1. The reactions were initiated by the addition of enzyme, 
at suitable concentration, to the other reagents. The dilute stock enzyme solutions were 
prepared in 5 mM MOPS buffer, pH 7.0, containing 0.2 mM CaCl2 and 0.2 mg/ml BSA, 
to promote enzyme stability. 
 
2.11.3 Initial steady-state parameters with luminol as substrate: 
 
Steady-state kinetic constants for luminol oxidation by WT HRP-C* and S167 variants 
were obtained by measuring the absorbance change at 400 nm for 60 seconds. The 
assays were carried out in a citrate-phosphate buffer, pH 5.0, as described in section 
2.11.2 using 1 mM H2O2, 20 nM enzyme and 0.1−5 mM luminol in 1 ml total assay 
volume. The initial rates (μmol.min-1.ml-1) were determined using ε400 = 4.5 mM-1 cm-1 
and then converted to turnover number (s-1). Kinetic parameters Km and kcat for luminol 
were determined by fitting the data obtained to the Michaelis-Menten equation. 
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Table 2.2: Enzymatic reaction conditions for assays of WT HRP-C* and S167 
variants with a range of substrates. The assays were carried out in phosphate-citrate 
buffer, pH 5.0, containing 51 mM disodium hydrogen orthophosphate and 24 mM citric 
acid at 25 oC using enzyme concentrations as shown below, 1 mM H2O2 (with the 
exception of point 2 below) and the different concentrations of substrates as shown 
below, in a final volume of 1 ml at 25 oC. The enzyme solutions were diluted in 5 mM 
MOPS buffer, pH 7.0, containing 0.2 mM CaCl2 and 0.2 mg/ml BSA. 
  
Substrate [Substrate] [Enzyme] Extinction coefficient 
ABTS 0.3 mM 0.5 nM aε414 = 36.8 mM-1 cm-1 
Ferulic acid 50 µM 0.25 – 0.5 nM bε310 = 8.68 mM-1 cm-1 
Caffeic acid 70 µM 0.2 – 0.25 nM cε320 = 10.4 mM-1 cm-1 
p-Cumaric acid 76 µM 0.1 – 0.25 nM dε308 = 12 mM-1 cm-1 
Potassium ferrocyanide 2 mM 2.5 – 5 nM eε420 = 1.06 mM-1 cm-1 
Guaiacol 5 mM 1 nM fε470 = 26.6 mM-1 cm-1 
Pyrogallol 20 mM 1 nM gε430 = 2.47 mM-1 cm-1 
o-Phenylenediamine 0.2 mM 0.5 nM hε450 = 11.1 mM-1 cm-1 
Chlorpromazine 2.2 mM 50 nM iε525 = 12.1 mM-1 cm-1 
Luminol1 0.5 mM 20 nM jε400 = 4.5 mM-1 cm-1 
Orange I2 50 µM 1 nM kε480 = 15.2 mM-1 cm-1 
Orange II2 50 µM 0.75 µM lε480 = 15.2 mM-1 cm-1 
 
a(Childs and Bardsley, 1975), b(Abelskov et al., 1997), c and d(Rasmussen et al., 1995), e(Hasinoff and Dunford, 1970), f and 
h(Bovaird et al., 1982), g(Chance and Maehly, 1955), i(Reilly and Aust, 1997), j(Cali, 2008), k and l(Coen, 2001). 
 
 
 
 
1 0.01772 gm of luminol was dissolved in 1 ml DMSO solvent, then 9 ml of ddH2O were added to this 
solution along with 200 µl of 1 M NaOH (to completely dissolve the luminol). 
2 The assay was carried out in 5 mM borate-phosphate buffer, pH 8.0, µ = 50 mM, using 0.1 mM of H2O2. 
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2.12 Pre steady-state kinetics measurements: 
2.12.1 Introduction: 
 
Stopped flow spectroscopy provides a way of monitoring fast reactions that have an 
accompanying spectral change. It was developed by Britton Chance in the 1950s and it 
is considered an efficient way of measuring the transient absorbance changes which 
occur when an enzyme reacts rapidly with substrate (Gutfreund, 1999). The method 
allows the measurement of pre steady-state rate constants for the formation of enzyme 
intermediates, which is impossible under normal steady-state kinetics. Pre steady-state 
kinetics describes the phase of an enzyme-catalysed reaction where enzymatic 
intermediates are accumulating, processes that may be completed typically within 
milliseconds. Therefore stopped flow spectroscopy is an extremely useful technique 
characterised by the ability to achieve a very rapid mixing of reagents and timely data 
collection (Cornish-Bowden, 2004). 
 
The sampling handling unit (SHU) of the stopped flow system used (Applied Photo 
Physics SX18MV) (Figure 2.9) is composed of two syringes, one holds the enzyme 
sample and the other holds the substrate under investigation. Computer controlled 
pneumatic ram drivers load reactants from these syringes into a mixing chamber. Once 
the mixed solution has passed through the mixing chamber it forces back a ‘stopping’ 
syringe, which triggers a micro switch, stopping the rams and triggering the 
spectroscopic measurements of the reaction. This process takes approximately 2 ms and 
is known as the dead time; the dead time is thus essentially the age of the reaction as it 
enters the optical cell. The system is able to measure either rapid change in absorbance 
at a single wavelength or across a range of wavelengths (using a photodiode array, see 
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below). The changes in absorption are measured using a spectrophotometer equipped 
with a xenon light source and a photomultiplier. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Sampling handling unit (SHU) of Stopped Flow spectrometer. The SHU 
is shown fitted with the sequential (double) mixing option. This option equips the SHU 
with 4 drive syringes and 2 pneumatic drives rams. The standard single-mix system is 
equipped with 2 drive syringes and 1 pneumatic drive ram2.  
 
2.12.2 Photodiode array experiments: 
 
The photodiode array (PDA) of the Applied Photophysics stopped flow system used, 
uses a xenon light source to perform rapid UV-Visible spectral scans of the contents of 
the optical cell. The array has the ability to perform spectral measurements over the 
range of 300-735 nm, and enables repeat scans down to every 1.28 ms (this is known as 
the integration time). Repeat scans obtained were analysed using the global analysis 
                                                
2 The picture is adopted from Applied Photophysics, hardware user guide of the SX20 stopped flow 
system. 
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software, Pro-Kinetics V1.05, to model the presence of possible transient species in the 
enzymatic reaction.  
 
Samples of WT HRP-C* and variants were exchanged from MOPS storage buffer, 
using a NAP-5 column (containing Sephadex G-25 Medium, Pharmacia) into 10 mM 
Na-phosphate buffer, pH 7.0, and then diluted to 4 µM with the same buffer. A 40 µM 
H2O2 solution was also prepared using the phosphate buffer. Enzyme and peroxide 
solutions were placed into the two driving syringes and mixed giving final 
concentrations of 2 µM enzyme and 20 µM H2O2. Rapid scan optical spectra were 
recorded in a logarithmic manner from 1.28 ms to 1000 ms. 
 
2.12.3 Determination of k1 value: 
 
The Compound I formation rate constant k1 for the reaction of WT HRP-C* or variant 
(both before and after treatment with hydrogen peroxide) with H2O2 was determined 
under pseudo first-order conditions using the stopped flow spectrophotometer. All 
measurements were conducted at 25 °C in 10 mM sodium phosphate buffer, pH 7.0.  
 
Stock enzyme samples were exchanged from MOPS buffer, using a NAP-5 column 
(containing Sephadex G-25 Medium, Pharmacia) into 10 mM phosphate buffer, pH 7.0, 
and diluted to the desired concentration with more buffer. A constant concentration of 
enzyme ranging between 1-1.5 µM was used with variable concentrations of H2O2 
ranging between 5-15 µM. Three independent determinations were made for each 
hydrogen peroxide concentration and the mean was taken. The changes in absorbance in 
the optical cell were monitored at 395 nm, the isosbestic wavelength for Compound I 
and Compound II (Smith et al., 1992). By following the decrease in absorbance at 395 
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nm, the pseudo first-order rate constant (kobs) at each H2O2 concentration was obtained 
by single exponential decay fit of the trace. The kobs obtained were then plotted against 
H2O2 concentration and the resultant curve fitted by a weighted least square, linear 
regression analysis using SigmaPlot software. The gradient of the plot is the second-
order rate constant k1. 
 
The auto-reduction of Compound I was also monitored, at 412 nm, by stopped flow 
spectroscopy. Upon stopped flow mixing of enzyme and H2O2, using final 
concentrations for H2O2 and enzyme of 2 µM and 20 µM, respectively, the traces 
obtained were biphasic in nature. The traces were recorded and fitted to a double 
exponential function and the pseudo first-order rate constant (kobs) were obtained. The 
life time of the Compound I intermediate was determined as the reciprocal of the kobs 
obtained. 
 
2.12.4 Determination of k2 and k3 values: 
 
The Compound I reduction, or Compound II formation, rate constant k2 and Compound 
II reduction rate constant k3 of the reaction of WT HRP-C* or variant with luminol as 
reducing substrate, were determined by monitoring the change in absorbance at 424 nm 
under pseudo first-order conditions using the stopped flow spectrophotometer. Pre-
preparation of Compound I was by mixing 3 μM of enzyme sample with 2.7 μM of 
H2O2, which was then reacted with variable concentrations of luminol ranging from 10 
– 50 μM. All measurements were carried out at 25 °C in 10 mM sodium phosphate 
buffer, pH 7.0. Stopped flow traces from these experiments were biphasic; an initial 
increase in absorbance was detected corresponding to the formation of Compound II, 
followed by a decrease in absorbance corresponding with the reduction of Compound II. 
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The traces were fitted to a double exponential function using the curve fitting 
application in the Pro-Data Viewer software (Applied Photo-Physics) to determine the 
pseudo first-order rate constants (kobs) for the first and second phases at the same time. 
After that, the rate constants k2 and k3 were calculated, by a weighted least square 
regression analysis using SigmaPlot software, from the slope of a graph of the pseudo 
first-order rate constants (kobs) against luminol concentration. 
 
2.13 Crystallization of enzyme samples: 
 
In order to determine X-ray crystal structures for the HRP-C* variants, the hanging drop 
vapour diffusion method (in which a drop of protein is brought gradually to super-
saturation by loss of water from the droplet to the larger reservoir that contains a 
polyethylene glycol solution) was used to grow crystals as previously reported for WT 
HRP-C* (Henriksen et al., 1999). Concentrated samples of HRP-C* variants were 
prepared by concentration to about 10 mg/ml using an Amicon YM-30 (30,000 Da) 
Centricon at 4 oC. A saturated solution of ferulic acid (FA) in isopropyl alcohol was 
also prepared, as well as 1 M calcium acetate, 1 M sodium cacodylate and 50% (w/v) 
polyethylene glycol 8000 (PEG 8000) solutions. 
 
Crystals were grown in a mixture of equal amounts (2 μl) of enzyme variant and 
reservoir solution, plus 1 μl of saturated FA in isopropyl alcohol, in a hanging drop, by 
vapour diffusion in a 24 well VDX plate (Hampton Research). The drops were 
equilibrated against reservoir solution with different concentrations of polyethylene 
glycol 8000, calcium acetate and sodium cacodylate in a 1 ml final solution, as shown in 
Table 2.2. The VDX tray was left in the fridge at 4 oC. 
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Table 2.2: Layout of reservoir solutions for a 24 well VDX plate for HRP-C* 
variant crystallization. Each well contained a different concentration of polyethylene 
glycol 8000, Ca acetate, and Na cacodylate, in 1 ml final solution.  
 
A1 
5% PEG 8000 
0.1M Ca acetate 
0.1M cacodylate
A2 
10% PEG 8000 
0.1M Ca acetate 
0.1M cacodylate
A3 
15% PEG 8000 
0.1M Ca acetate 
0.1M cacodylate
A4 
20% PEG 8000 
0.1M Ca acetate 
0.1M cacodylate
A5 
25% PEG 8000 
0.1M Ca acetate 
0.1M cacodylate 
A6 
30% PEG 8000 
0.1M Ca acetate 
0.1M cacodylate
B1 
5% PEG 8000 
0.2M Ca acetate 
0.1M cacodylate
B2 
10% PEG 8000 
0.2M Ca acetate 
0.1M cacodylate 
B3 
15% PEG 8000 
0.2M Ca acetate 
0.1M cacodylate 
B4 
20% PEG 8000 
0.2M Ca acetate 
0.1M cacodylate 
B5 
25% PEG 8000 
0.2M Ca acetate 
0.1M cacodylate 
B6 
30% PEG 8000 
0.2M Ca acetate 
0.1M cacodylate 
C1 
5% PEG 8000 
0.1M Ca acetate 
0.2M cacodylate
C2 
10% PEG 8000 
0.1M Ca acetate 
0.2M cacodylate 
C3 
15% PEG 8000 
0.1M Ca acetate 
0.2M cacodylate 
C4 
20% PEG 8000 
0.1M Ca acetate 
0.2M cacodylate 
C5 
25% PEG 8000 
0.1M Ca acetate 
0.2M cacodylate 
C6 
30% PEG 8000 
0.1M Ca acetate 
0.2M cacodylate 
D1 
5% PEG 8000 
0.2M Ca acetate 
0.2M cacodylate
D2 
10% PEG 8000 
0.2M Ca acetate 
0.2M cacodylate 
D3 
15% PEG 8000 
0.2M Ca acetate 
0.2M cacodylate 
D4 
20% PEG 8000 
0.2M Ca acetate 
0.2M cacodylate 
D5 
25% PEG 8000 
0.2M Ca acetate 
0.2M cacodylate 
D6 
30% PEG 8000 
0.2M Ca acetate 
0.2M cacodylate 
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Chapter Three: 
Generation of S167W and S167Y HRP-C* variants 
 
 
3.1 Introduction: 
 
The main aim of the described work was to introduce novel covalent linkages between 
the haem porphyrin and protein of HRP-C, similar to those found in myeloperoxidase 
and other mammalian peroxidases (Fiedler et al., 2000). It has previously been reported 
that mutation of Ser160 to Met or Tyr (S160M or S160Y) in recombinant pea ascorbate 
peroxidase (rpAPX) results in a covalent linkage between the haem 2-vinyl and the 
protein on treatment with H2O2 (Metcalfe et al., 2004; Pipirou et al., 2007b). in 
addition, the distal tryptophan of APX (Trp41) can form a covalent bond to the haem if 
the protein is incubated for a long time with H2O2 (Pipirou et al., 2007a); a result 
replicated for the W191F mutant of CcP where a link is formed between the distal 
tryptophan, Trp51, and the haem (Pipirou et al., 2009). 
 
Previously in this laboratory, the position 167 has been identified in HRP-C as the 
closet to the 2-vinyl of the haem (Cali, 2008). Work on the subsequently engineered 
[S167M] HRP-C* mutant showed that, upon incubation with H2O2, a sulfonium linkage 
was formed between the introduced methionine and the haem (Cali, 2008). Based on 
this work, and the work on rpAPX, it was decided to engineer two new mutants in HRP-
C*: [S167Y] and [S167W] HRP-C*. 
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The process of replacement of an amino acid by another one in a protein requires the 
changing of the particular codon that codes for the original amino acid residue to the 
codon of the desired replacement amino acid in the expression vector used. This 
manipulation in the gene or cDNA of the protein of interest is known as site-directed 
mutagenesis, and is the basis for much of the protein structure/function studies 
performed today. Indeed, this technique has been, and is still being, used to investigate 
the structure/function of plant peroxidases, in particular HRP-C, and has led to the 
understanding of the critical role(s) played by the distal and proximal haem pocket 
amino acid residues Arg38, His42 and His170 in peroxide binding and catalysis 
(Newmyer and Ortiz de Montellano, 1995; Newmyer and Ortiz de Montellano, 1996a; 
Rodriguez-Lopez et al., 1996a; Newmyer et al., 1996b; Rodriguez-Lopez et al., 1996b), 
as well as the functional importance and role(s) of other amino acid residues, such as 
Phe41, Glu64 and Asn70 in the substrate binding site, calcium binding sites etc. (Smith 
et al., 1992; Smulevich et al., 1994; Tanaka et al., 1998; Heering et al., 2002). 
 
In this work, mutant genes encoding HRP-C variants S167W and S167Y were produced 
using a PCR-based Whole Plasmid Amplification Method (WPAM). This method 
(Figure 3.1) has already been successfully employed in the generation of a range of 
peroxidase mutants (Veitch et al., 1997; Doyle et al., 1998) and has proved to be 
efficacious, economical and specifically does not require the presence of a unique 
restriction enzyme site near the point of mutation. The template used in this work was 
the ampicillin resistant (AmpR) expression vector pFLAG1-HRP-C, which contains a 
synthetic HRP-C gene (Smith et al., 1990). This vector allows the expression of HRP-C 
recombinant enzyme in E. coli under the control of the tac promoter; it also contains a 
copy of the lacIq repressor gene to ensure extra tight regulation of expression. The gene 
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is present in this vector between an Nde I site and a non-functional Bam HI/ Bgl II 
hybrid site (Figure 3.1). 
 
3.2 Design of Primers: 
 
Two oligonucleotide primers for the production of each mutant gene (Figure 3.2) were 
designed, to incorporate the necessary changed deoxynucleotide(s) required to generate 
the required amino acid substitution in the enzyme, as well as additional silent 
mutations to produce a new restriction enzyme site in order to facilitate transformant 
screening. These designed primers were synthesized by MWG-Biotech. For the S167Y 
mutant, the mutagenic primer contained a TAT codon, which encodes the amino acid 
tyrosine, instead of a TCC codon which encodes the amino acid serine. Also, correct 
ligation will lead to the formation of a new restriction site for the restriction enzyme 
BssSI, through the replacement of T at position 591 in the WT plasmid by C. It is 
important to mention here that the WT expression vector already has two restriction 
sites for BssSI at positions 1666 bp and 3049 bp, respectively. For the S167W mutant, 
the mutagenic primer contained the codon TGG, which encodes for the amino acid 
tryptophan, instead of the TCC codon (serine). The new introduced restriction site for 
the enzyme BssSI was the same as for the S167Y mutant. The reference primer used 
was the same for both S167Y and S167W. 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: PCR-based Whole Plasmid Amplification Method of site-directed 
mutagenesis (Doyle et al., 1998).  
HRP-C synthetic gene 
pFLAG1-HRP-C 
        6.3 kb 
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AmpR 
Bam HI/ Bgl II 
tac 
lac Iq HRP-C synthetic gene 
  
For [S167Y]HRP-C gene 
Original WT sequence of the HRP-C gene: 
5’-AATCGCTCGAGTGACCTTGTGGCTCTGTCCGGAGGACACACATTTG-3’ 
 
Engineered sequence to give [S167Y]HRP-C gene: 
5’-AATCGCTCGAGTGACCTC*GTGGCTCTGTA*T*GGAGGACACACATTTG-3’ 
 
 
Mutagenic primer: 5’-C*GTGGCTCTGTA*T*GGAGGACAC-3’ Tm = 62 oC 
Reference primer:  5’-AGGTCACTCGAGCGATTCAG-3’  Tm = 62 oC 
 
 
For [S167W]HRP-C gene 
Original WT sequence of the HRP-C gene: 
5’-AATCGCTCGAGTGACCTTGTGGCTCTGTCCGGAGGACACACATTTG-3’ 
 
Engineered sequence to give [S167W]HRP-C gene: 
5’-AATCGCTCGAGTGACCTC*GTGGCTCTGTG*G*GGAGGACACACATTTG-3’ 
 
 
Mutagenic primer: 5’-C*GTGGCTCTGTG*G*GGAGGACAC-3’ Tm = 62 oC 
Reference primer:  5’-AGGTCACTCGAGCGATTCAG-3’  Tm = 62 oC 
 
Figure 3.2: Mutagenic and reference primers designed for the production of 
[S167Y]HRP-C and [S167W]HRP-C mutant genes, in the expression plasmid 
pFLAG1.  
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3.3 PCR Products: 
 
PCRs were carried out for both HRP-C mutants, according to the conditions described 
in section 2.2.3, using an annealing temperature of 56 oC and Pfu polymerase. A proof 
reading polymerase was essential due to the large size of the DNA products expected, 
i.e. 6.3 kb. Agarose gel electrophoresis is the standard method used for separating DNA 
molecules of different lengths. Therefore, the PCR products obtained for both HRP-C 
mutants were checked by running a portion of the reaction mixture on a 1% agarose gel 
(Figure 3.3). It can be seen that only a linear DNA fragment of 6.3 kb was produced for 
both mutants, in quantities sufficient for the continuation of the WPAM site-directed 
mutagenesis method. 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 3.3: 1% Agarose gel electrophoresis of WPAM PCR products, where M: 
DNA size marker (Promega, 1 kb DNA Ladder), (a) [S167W]HRP-C DNA and (b) 
[S167Y]HRP-C DNA. 
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Next, the DNA template WT pFLAG1-HRP-C was removed from the PCR samples by 
using DpnI, and the samples purified using phenol/chloroform extraction and ethanol 
precipitation (see sections 2.2.5 and 2.2.6). After that, the 5’ termini of the linear, 
purified PCR products were phosphorylated using T4 polynucleotide kinase and the 
DNA re-circularized using T4 DNA ligase, to give circular pFLAG1-HRP-C mutated 
plasmids (section 2.2.7). 
 
3.4 Restriction enzyme analysis of E. coli transformants: 
 
The ligation mixtures for both mutants were transformed into DH5α E. coli cells and 
selected on ampicillin agar plates. The resulting colonies had DNA extracted which was 
then screened by restriction enzyme digest with BssSI (section 2.2.10), along with WT 
pFLAG1-HRP-C DNA as a control. This was to confirm the presence of the desired 
nucleotide changes and correct ligation as a new site for this enzyme should have been 
introduced. However, WT pFLAG1-HRP-C DNA already has two restriction sites at 
position 1666 bp and 3049 bp, which when digested will give two bands on a gel with 
sizes 1383 bp and 4812 bp, respectively. For the mutant plasmids the new restriction 
site has been inserted at position 591 bp, and so BssSI digestion should give three bands 
on a gel, of 1075 bp, 1383 bp and 3737 bp, respectively. 
 
The results for DNA from [S167Y] and [S167W] putative mutant colonies, digested 
with BssSI, are shown in Figures 3.4 and 3.5. Seven colonies have the correct restriction 
pattern for the [S167Y] HRP-C mutant (Figure 3.4) and four colonies have the correct 
restriction pattern for the [S167W] HRP-C mutant (Figure 3.5). These results 
demonstrate the success of the site-directed mutagenesis method used at 58% and 44%, 
respectively. In Figure 3.4 there can be seen an unexpected extra DNA band for
  
 
 
 
 
 
  
 
 
 
 
 
 
Figure 3.4: 1% agarose gel electrophoresis of BssSI digestion of DNA from 
transformed colonies for the putative pFLAG1-[S167Y]HRP-C mutant plasmid. 
M: DNA size marker (Promega, 1 kb DNA Ladder). 
 
 
 
 
 
 
 
  
 
 
 
Figure 3.5: 1% agarose gel electrophoresis of BssSI digestion of DNA from 
transformed colonies for the putative pFLAG1-[S167W]HRP-C mutant plasmid. 
M: DNA size marker, WT: WT pFLAG1-HRP-C plasmid digested with BssSI. 
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colonies 2, 5, 7, 10, 11, and 12 at approximately 2.5 kb. This is assumed to be due to 
star activity. 
 
3.5 Sequencing of [S167Y]HRP-C and [S167W]HRP-C mutant 
genes:  
 
Plasmid DNA from two colonies of each mutant was submitted for DNA sequencing in 
order to confirm the expected mutations and the absence of any errors that may have 
occurred during the PCR procedure. The results obtained were analysed using the 
Seqman module of DNASTAR Lasergene software, by alignment with the sequence of 
WT pFLAG1-HRP-C. For both mutants, one sample contained the correct sequence 
without any error and the other sample had an error in the gene sequence. The colony 
containing the DNA that had the correct mutant gene sequence was selected for further 
work. 
 
3.6 Protein expression of [S167Y]HRP-C and [S167W]HRP-C 
mutants: 
 
Recombinant protein expression of HRP-C has been a major focus of researchers since 
the beginning of 1990s, and therefore a number of different expression systems have 
been developed (Veitch, 2004). Among these systems, expression in E. coli has proved 
to be the most valuable, as it is relatively low-cost and easy to obtain mutant proteins 
compared to other systems. In addition, the recombinant enzyme from E. coli 
expression is obtained in a non-glycosylated form, which helps in X-ray crystallization 
studies (Veitch and Smith, 2001; Veitch, 2004). However, the protein is expressed as 
non-active and in insoluble inclusion bodies and so in vitro refolding is needed. 
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3.6.1 Small-scale protein expression: 
 
Both mutant plasmids were transformed into E. coli W3110 cells for high protein 
expression from the tac promoter after induction with 1 mM IPTG. Expression of 
protein and production of protein extracts were performed as in sections 2.3.1.1 and 
2.3.1.2. The products of the expression were analyzed by SDS-PAGE on a 12% gel. 
This revealed that the size, 34 kDa, and expression levels of each new mutant were 
similar to those of the WT enzyme (Figure 3.6). In the absence of the inducer (IPTG), 
there was no detectable expression. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: 12% SDS-PAGE of small-scale mutant HRP-C protein expression. The 
figure shows that both new mutants have size approximately 34 kDa, which is 
comparable to the size of WT HRP-C*. a1 and b1: S167Y mutant induced with IPTG 
while a2 and b2 are without IPTG, c1 and d1: S167W mutant induced with IPTG, c2 
and d2 without IPTG, e1 WT induced with IPTG and e2 without IPTG. M: protein size 
marker (SigmaMarkerTM, Wide Range, 6.5-200 kDa). 
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3.6.2 Large-scale protein expression, in vitro refolding and active 
enzyme purification: 
 
Large-scale protein expression, in vitro folding and purification were achieved for both 
new HRP-C variants, as well as for WT enzyme, using a slightly modified form of the 
method previously described by Smith and co-workers (Smith et al., 1992); an 
alteration in the refolding procedure of the protocol (section 2.3.2.3) involved the 
addition of haem to the folding solution only after 18 hours of the process of refolding 
with the process then continuing for another 46 hours. This alteration has been shown to 
give a small, but significant, increase in enzyme yield (Cali, 2008). 
 
The final active enzyme was purified after refolding and concentration using the Fast 
Protein Liquid Chromatography (FPLC) instrument and cation-exchange 
chromatography on a Mono S column (section 2.3.2.3). The FPLC elution profiles 
obtained for the variants [S167Y] and [S167W] HRP-C* were consistent with those 
obtained from the purification of WT HRP-C* (Figure 3.7), indicating that there was no 
significant variation in the folding of the new mutants, compared to the WT enzyme. 
Yields of the mutant enzymes were also similar to WT enzyme, at approximately 9 
mg/L E. coli. 
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Figure 3.7: Cation exchange chromatography profile of [S167Y] HRP-C*. Active 
enzyme was purified using FPLC and cation exchange column Mono-S HR 10/10. 
Elution was achieved with a linear NaCl gradient of 0-1 M. The enzyme eluted as a 
single sharp peak at 160 mM NaCl, the same salt concentration as for the WT enzyme 
and S167W mutant. 
 
3.7 Conclusion: 
 
The PCR-based Whole Plasmid Amplification Mutagenesis method was successfully 
used to construct two HRP-C mutant genes, S167Y and S167W. The expected sequence 
changes in the HRP-C gene were confirmed by restriction enzyme screening as well as 
DNA sequence analysis, and no unexpected changes were detected. Both mutant 
proteins have been expressed in E. coli and SDS-PAGE analysis showed that the protein 
had the expected mass of 34 kDa. Finally, the purified variants [S167Y] and [S167W] 
HRP-C* were obtained in good yield after in vitro refolding and cation-exchange 
chromatography on an FPLC machine.  
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Chapter Four: 
Characterisation of the new HRP-C S167 variants 
and evidence of covalent linkage 
 
 
4.1 Introduction: 
 
Despite considerable efforts made by a lot of researchers, the mechanism of formation 
of the haem-protein covalent linkages in mammalian peroxidases, and their functional 
advantage(s) remain unclear. In the last ten years, efforts have focused on introducing 
these bonds into plant peroxidases. Site directed mutagenesis of plant peroxidases, 
which lack these linkages and belong to a different peroxidase superfamily, has been 
used to study the effect of both the esters and sulfonium linkages of MPO in a simpler 
system, where fundamental parameters can be more easily measured and the effects, 
whether electronic or structural, determined. As mentioned before (section 1.6), new 
haem-protein covalent bonds have been successfully created in rpAPX and CcP, where 
it has been unambiguously demonstrated that creation of these linkages lead to a 
profound impact on the spectroscopic and functional properties of these enzymes 
(Metcalfe et al., 2004; Pipirou et al., 2007a; Pipirou et al., 2007b; Pipirou et al., 2009). 
 
Recent work by another member of the group, Dr. Kasim Cali, highlighted position 167 
in HRP-C as close enough to the haem to form a haem-protein bond in the site-directed 
HRP-C* mutant S167M. Dr. Cali concluded from UV/Visible spectroscopy studies and 
HPLC and MS analysis that a sulfonium linkage between the protein and the porphyrin 
of the haem prosthetic group was auto-catalytically generated in this mutant after 
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treatment with hydrogen peroxide. However, he also found that this linkage was 
unstable and that after a short time it broke to yield a modified haem species (Cali, 
2008).  
 
In this study, and building on the previous work, two new site-directed HRP-C* mutants 
S167W and S167Y have been constructed, and protein expressed, refolded and purified 
(Chapters 2 and 3). This chapter describes the initial characterisation of these new 
variants, the effect of treatment of these variants with hydrogen peroxide and the 
evidence for the creation of a new covalent linkage between the haem and the protein. 
 
4.2 Spectroscopic characterisation of the new S167 variants: 
 
Spectroscopic techniques are a particularly useful probe for understanding the electronic 
properties of the haem of the peroxidases. The UV/Vis spectrum of wild-type HRP-C is 
characterised by the presence of a Soret peak at 403 nm as a result of π-π* transitions, 
with a strong shoulder at about 380 nm. Charge-transfer bands (CTI and CTII) at 642 
and 498 nm are also present and are due to partial transfer of electronic charge between 
the porphyrin and the iron (Dunford, 1999f). The iron in the resting state of HRP has six 
co-ordination sites: four positions are located in the plane of the haem iron atom and are 
occupied by the nitrogen atoms of a porphyrin group, the fifth co-ordination site is 
occupied by the proximal imidazole side chain of His170 residue, and the sixth position 
is vacant. Therefore, HRP-C is substantially a five coordinate high spin ferric haem 
iron. There are no additional cross-links between the side chains of the haem group and 
the protein. 
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The spectral features of the S167Y and S167W variants indicate small but significant 
electronic differences in the haem environment when compared to wild-type 
recombinant enzyme, Figure 4.1 and Table 4.1, the most obvious being the absence of 
the shoulder at 380 nm in the spectrum of the S167Y variant. This suggests a loss of 5-
coordinate character of the haem iron and conversion to a 6-coordinate high spin form. 
The intensity of the shoulder at 380 nm is also much weaker in the S167W variant, 
suggesting that about 50% of the haem iron is converted from 5-coordinate high spin 
form to 6-coordinate high spin form. The Soret peak of S167W has also slightly red 
shifted to 404.  
 
The spectra also show that the CTII band for both the S167W and S167Y variants is 
496 nm, very slightly blue shifted when compared to the WT CTII band at 498 nm. 
However, there are more significant differences for the CTI band: being 636 nm for 
S167Y, 638 nm for S167W compared to 642 nm for WT. All these features are 
consistent with an increase in 6-coordinate character for the new variants. Also, 
consistent with this, there are significant increases in the molar extinction coefficients of 
both mutant variants, 180 mM-1 cm-1 for S167Y and 135 mM-1 cm-1 for S167W 
compared to 100 mM-1 cm-1 for the WT enzyme, implying a significant electronic effect 
especially for the S167Y variant. The large increase in molar extinction coefficient for 
the S167Y variant could be attributed to the resonance effect of the aromatic ring of the 
tyrosine residue as well as the auxochromic effect of the hydroxyl group. 
 
The most convenient measurement of peroxidase purity is given by the Reinheitszahl 
number (RZ), which is the ratio of the absorbance of the enzyme at the Soret peak and 
280 nm. RZ values between 3 and 3.4 are generally considered optimal for WT HRP-C 
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(Dunford, 1999f; Veitch and Smith, 2001). However, the reduction in the value of RZ 
for the S167W variant is reasonable as the addition of another tryptophan residue in the 
structure of enzyme will contribute to an increase in the absorbance at 280 nm, there is 
therefore no reason to suggest that the [S167W] HRP-C* sample is less pure. 
 
 
 
 
 
 
Table 4.1: Spectrum parameters for resting state of WT HRP-C*, S167W and 
S167Y variants. 
 
Enzyme Shoulder (nm) 
Soret peak 
(nm) 
CTII 
(nm) CTI (nm) 
Extinction 
coefficient 
mM-1 cm-1 
RZ1 
WT HRP-C* 380 403 498 642 100 ± 5 3.4 
S167Y very weak  403 496 636 180 ± 2 3.3 
S167W weak 404 496 638 135 ± 1 2.7 
 
1 Reinheitszahl number 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: UV/Visible absorption spectra of WT HRP-C* and the new S167 
variants. Spectra were recorded in 5 mM MOPS buffer, pH 7.0 at 25 oC using 9 μM 
WT HRP-C*, 5 μM S167Y variant and 6.5 μM S167W variant. The inset in the top 
right of the figure is a magnified view of the region between 450 nm and 700 nm, in 
order to highlight the CTI and CTII bands. 
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4.3 BHA binding to WT HRP-C* and the new S167 variants: 
 
Benzhydroxamic acid (BHA) is capable of forming a spectroscopically distinct, 
reversible complex with both free and cyanide-ligated HRP-C (Schonbaum, 1973). In 
general, little selectivity is shown by HRP-C towards aromatic donors, however, BHA 
has become the donor molecule most favoured by researchers as a probe of the binding 
site due to its tight binding and strong spectroscopic effects (Veitch and Smith, 2001). 
The X-ray crystal structure of the BHA complex of the resting state of HRP-C* has 
been solved to 2.0 Å resolution (Henriksen et al., 1998a). The results showed that a 
well-defined electron density for BHA is observed in the peroxidase active site, with a 
hydrophobic pocket surrounding the aromatic ring of the substrate. The aromatic ring of 
the BHA makes hydrophobic contacts with the side chains of His42, Phe68, Gly69, 
Ala140, Pro141 and Phe179 residues, as well as the haem methyl C8 and the haem meso 
proton Cδ, with the shortest distance (3.7 Å) found between the haem C8-methyl and 
BHA. In addition, the residues Arg38, His42 and Pro139, and the distal water molecule 
2.6 Å above the haem iron, contribute to an extensive hydrogen bond network with the 
BHA side chain (Figure 4.2) (Henriksen et al., 1998a). 
 
The dissociation constant (Kd) is a specific type of equilibrium constant that is used to 
describe the affinity between an enzyme and a particular substrate or ligand. For HRP-
C, it has been reported that BHA has a high affinity (Kd = 2.4 μM) for binding with the 
free enzyme (Schonbaum, 1973). Binding also causes a perturbation to the coordination 
state of the haem iron of the enzyme, changing it from a 5-coordinate high spin form to 
a 6-coordinate high spin form (Smulevich et al., 1991). On the other hand, it has been 
found that BHA has a much weaker affinity for the cyanide-ligated form of the HRP-C 
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with a Kd value of 95 μM, 40-fold higher than for the free enzyme (Veitch and 
Williams, 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: The binding mode of BHA to resting state HRP-C*. The donor molecule 
is located on the distal side of the haem plane and makes both hydrogen bond and 
hydrophobic interactions with the enzyme. The hydrogen bonds between the BHA side 
chain and distal residues, plus the structural water molecule above the haem group, are 
shown by dashed green lines. The figure was constructed by Accelrys DS visualizer 
using the coordinates deposited in the PDB (accession code 2ATJ).  
 
 
Site-directed mutagenesis studies have been used to confirm the importance of the distal 
haem amino acid residues in the binding of the enzyme with the hydroxamate group of 
H2O 
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BHA. It was found that the replacement of Arg38 by Lys or Leu, or His42 by Leu or 
Glu leads to a dramatic decrease in the affinity of the mutant enzyme towards BHA, as 
well as, a disruption of the coordination state of the haem iron in the enzyme-BHA 
complex. These findings have led to a clarification of the critical role(s) of His42 and 
Arg38 in the binding of BHA, via the hydrogen bonding network (Smith et al., 1993; 
Rodriguez-Lopez et al., 1996a; Howes et al., 2001b). The significance of the amino 
acid residue Phe179 has also been investigated, by substitution of this residue by Ala, 
His or Ser. All three variants (F179A, F179H and F179S) exhibit a high Kd and 
therefore a significant decrease in affinity for BHA for both the free and cyanide-ligated 
enzymes, when compared to the wild-type enzyme (Veitch et al., 1997; Howes et al., 
2001b). Furthermore, substitution of Phe68 by Ala (F68A) significantly increases the 
dissociation constant, indicating that this amino acid residue also plays a role in the 
binding site of aromatic substrates to the HRP-C (Veitch et al., 1996). 
 
In this section I explore whether the amino acid residue at position 167, chosen as the 
new potential haem-linkage site, has any affect on aromatic substrate binding in HRP-C. 
The effect of mutation of this residue on the affinity of the enzyme for BHA was 
determined. BHA binding assays were carried out for WT HRP-C*, as well as for the 
new S167 variants, by titrating an enzyme sample with successive amounts of BHA 
until there was no further obvious change in the absorbance spectra (Figure 4.3). The 
dissociation constant (Kd) for the BHA-enzyme complex, together with the maximum 
absorbance change of the Soret peak (Amax), was determined by fitting the change in the 
difference spectrum (bound minus unbound) of the Soret region to the quadratic binding 
equation given in section 2.5. The results obtained are shown in Figure 4.4 and Table 
4.2. 
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The absorbance spectra of WT HRP-C* and the S167W variant complexes with BHA 
show the absence of the 380 nm shoulder of the resting enzyme spectra, which gives 
clear evidence of conversion from the 5-coordinate high spin form into the 6-coordinate 
high spin form, this phenomena is typical of formation of a BHA complex (Smith et al., 
1992). The Kd value obtained for WT HRP-C* was 2.4 μM, in excellent agreement with 
the published values: 2.4 μM (Schonbaum, 1973) and 2.5 μM (Smith et al., 1992; 
Rodriguez-Lopez et al., 1996a). The results obtained in Table 4.2 show that the 
dissociation constant of the S167W variant for BHA (2.89 μM) is hardly affected 
relative to that for the wild-type enzyme, whilst it slightly increased (4.36 μM) for the 
S167Y variant implying a small perturbation of the aromatic donor binding site in this 
enzyme. In fact, there was no reason to expect any structural or functional significance 
of the Ser167 residue to the BHA binding site of HRP-C, however the replacement of 
this amino acid residue with the bulkier Trp or Tyr residues may have had an indirect 
affect on the environment of the haem centre leading to disruption of the interaction of 
BHA with the enzyme. 
 
Table 4.2: Dissociation constants (Kd) and the maximum absorbance change of the 
Soret peak (Amax) on the binding of BHA to HRP-C* and the new S167 variants. 
Results were determined by fitting the change in the difference spectrum (bound minus 
unbound) of the Soret region to the quadratic binding equation given in section 2.5. 
 
Enzyme Kd (µM) Amax 
WT HRP-C* 2.40 ± 0.25 0.165 ± 0.004 
S167Y 4.36 ± 0.54 0.256 ± 0.009 
S167W 2.89 ± 0.32 0.142 ± 0.004 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: UV/Visible difference spectra resulting from titration of the S167Y  
(right) and S167W (left) HRP-C* variants with different concentrations of BHA. 
Spectra were recorded in 5 mM MOPS buffer, pH 7.0 at 25 oC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Change in absorption of the Soret peak obtained by titrating 3 μM of 
WT HRP-C*, S167Y and S167Y variants with different concentrations of BHA. 
Wavelength (nm) Wavelength (nm)
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4.4 Treatment of [S167W] and [S167Y] HRP-C* variants with 
hydrogen peroxide: 
 
As mentioned previously, exposure of recombinant LPO and EPO, [F41E] HRP-C*, 
[S167M] HRP-C* and the rpAPX variants S160M and S160Y to a stoichiometric 
excess of hydrogen peroxide results in covalent attachment of the haem to the protein 
through an autocatalytic process (DePillis et al., 1997; Oxvig et al., 1999; Colas et al., 
2002; Colas and Ortiz de Montellano, 2004; Metcalfe et al., 2004; Pipirou et al., 2007a; 
Pipirou et al., 2007b; Cali, 2008). A similar approach has been used in this work in an 
attempt to introduce a novel new covalent linkage into HRP-C. 
 
The new variants [S167W] and [S167Y] HRP-C* were incubated with hydrogen 
peroxide for two hours in sodium phosphate buffer at 25 oC (section 2.6) and in the 
absence of any reducing substrate. Observation by the naked eye noted the 
discolouration of the reaction solution to a pale green colour lasting for a few seconds, 
followed by a red colour. This observation was an indication of the rapid formation of 
the first high oxidation state intermediate Compound I (green) which is then quickly 
converted into the second high oxidation state intermediate Compound II. Repeated 
UV/Visible scans of the S167Y and S167W variants after treatment with H2O2 
confirmed this initial observation (Figures 4.5 and 4.6). The first scan, taken one minute 
after the beginning of the reaction shows that the first intermediate Compound I, is less 
stable and undergoes a more rapid conversion to Compound II for each mutant, when 
compared to WT HRP-C*. The spectra of both variants show the more stable 
intermediate Compound II with spectral features at λmax (nm) = 420, 555 and 523, which 
are consistent with those reported for Compound II of the wild-type enzyme (Dunford, 
1999f). Further scans then show that Compound II decays over a further period of time 
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back to the resting state enzyme. However, it was found that in the case of the S167W 
variant, the return to the resting state was more rapid, after 15 minutes, compared to the 
S167Y variant, which needed 180 minutes to return to the resting state. 
 
Treatment of the S167Y variant with H2O2 gave a final spectrum that was essentially 
identical to that of the pre H2O2 resting state (Figure 4.7); there are no changes in the 
position of the Soret peak or CTI band, which were 403 and 636 nm respectively. The 
only small difference between them appeared to be in the CTII band, where it was 496 
nm for untreated S167Y variant and 499 nm for the treated sample. The results showed 
also that the treated S167Y variant has a molar extinction coefficient value equal to 178 
mM-1 cm-1, again essentially identical to that of untreated S167Y (180 mM-1 cm-1). In 
the case of the S167W variant, the final spectrum after treatment with H2O2 is very 
different from the spectrum of the untreated variant and the wild-type enzyme (Figure 
4.8). Although the Soret peak and CTI band are still at 404 and 638 nm, the CTII band 
appears very weak in the treated variant at 496 nm. Furthermore, the S167W variant has 
lost 40% of its total haem signal as a result of exposure to H2O2, with a lower extinction 
coefficient of 121 mM-1 cm-1 compared to 135 mM-1 cm-1 for the untreated S167W. 
These results give a strong indication that a change in the haem environment, i.e. a 
significant electronic effect, has occurred during exposure to H2O2.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Repeat scan spectra collected during the reaction of [S167Y] HRP-C* 
with H2O2. The reaction was carried out in sodium phosphate buffer, pH 9.5 at 25 oC, 
where 0.5 mM of H2O2 was added to 5 µM of variant. 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 4.6: Repeat scan spectra collected during the reaction of [S167W] HRP-C* 
with H2O2. The reaction was carried out in sodium phosphate buffer, pH 7.0 at 25 oC, 
where 0.6 mM of H2O2 was added to 6 µM of the variant. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: UV/Visible absorbance spectra of 9 μM WT HRP-C*, 5 μM S167Y 
variant treated and untreated with 5 mM H2O2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: UV/Visible absorbance spectra of 9 μM WT HRP-C*, compared to 6.5 
μM S167W treated and untreated with 6.5 mM H2O2. 
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4.5 Evidence for the generation of a covalent linkage between the 
haem and the protein: 
 
4.5.1 Pyridine haemochrome assay: 
 
Pyridine haemochrome spectra are often used to give an indication of the type of haem 
present. These spectra are measured in aqueous alkaline pyridine solutions after 
reduction with sodium dithionite. The high pH of the solution leads to the disruption of 
non-covalent interactions between the haem and the protein, and the haemochrome 
complexes are formed by the coordination of two molecules of a pyridine to the haem 
group. The sharp and characteristic α-bands of the pyridine haemochrome spectra are 
used for identification and determination of the molar absorption coefficient ε, as well 
as the concentration of the haemoproteins (Fuhrhop and Smith, 1975; Kooter et al., 
1997a; Kooter et al., 1999a). 
 
A pyridine haemochrome assay was carried out on WT HRP-C*, and the new S167 
variants, both before and after treatment with hydrogen peroxide. The reduced-oxidized 
difference spectra obtained are presented in Figures 4.9 and 4.10, and the spectral 
features are summarised in Table 4.3. It was observed clearly that the pyridine 
haemochrome spectra of the S167W variant, either treated or untreated with H2O2, are 
identical to the spectra of WT HRP-C*; the maximum α-band appears at 555 nm and a 
Soret band at 419 nm. However, in the case of the S167Y variant, the pyridine 
haemochrome spectra showed a blue shifted maximum for the α-band, at 552 nm, 
beside a similarly shifted Soret band at 415.5 nm. These spectroscopic changes give a 
preliminary indication of the formation of a covalent linkage between the haem and the 
protein in the S167Y variant, since the electronic properties of the haem are modified, 
even before treatment of the enzyme with H2O2. 
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Similar results have been reported previously for rpAPX and HRP-C* mutants (Pipirou 
et al., 2007a; Pipirou et al., 2007b; Cali, 2008). A shift in the maximum α-band from 
556 nm to 553 nm was observed for rpAPX spectrum, after treatment with H2O2, 
presumed to be due to the formation of a haem-tryptophan link in the enzyme (Pipirou 
et al., 2007a). Similarly, the pyridine haemochrome spectrum showed a maximum α-
band at 556 nm for untreated [S160Y] rpAPX, but the peak blue shifted to 551 nm after 
reaction with H2O2 (Pipirou et al., 2007b). Finally, the spectrum observed for the 
[S167M] HRP-C* variant after treatment with H2O2 showed a pronounced blue shift in 
its bands compared to untreated enzyme, indicating a possible sulfonium linkage 
between the haem and the protein (Cali, 2008). 
 
The alkaline pyridine haemochrome spectrum of the MPO variant, [M243Q] MPO, is 
also greatly affected and showed blue shifted bands compared to that of WT MPO. This 
behaviour was attributed to the absence of the sulfonium linkage in the M243Q variant 
which is normally present in the native enzyme (Kooter et al., 1997a; Kooter et al., 
1999a; Kooter et al., 1999b). 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Comparison of the pyridine haemochrome difference spectra for WT 
HRP-C* and the S167W variant, before and after treatment with 100 equivalents 
of H2O2. Spectra were recorded in 5 mM MOPS buffer, pH 7.0, at 25 oC and the haem-
protein species was reduced with disodium dithionite. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: Comparison of the pyridine haemochrome difference spectra for WT 
HRP-C* and the S167Y variant, before and after treatment with 100 equivalents of 
H2O2. Spectra were recorded in 5 mM MOPS buffer, pH 7.0, at 25 oC and the haem-
protein species was reduced with disodium dithionite. 
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Table 4.3: Spectral features of WT HRP-C* and the new S167 variants (both 
treated and untreated with 100 equivalents of H2O2) after treatment with alkaline 
pyridine. Spectra were recorded in 5 mM MOPS buffer, pH 7.0, at 25 oC and the haem-
protein species was reduced with disodium dithionite. 
 
Enzyme 
Soret Peak 
(nm) 
β max (nm) β min (nm) α max (nm)
WT HRP-C* 419 524 540 555 
aTreated WT HRP-C* 418.5 524 540 555 
Untreated S167W 418.5 524 540 555 
Treated S167W 418.5 524 540 555 
Untreated S167Y 415.5 521 536 552 
Treated S167Y 415.5 521 536 552 
 
a(Cali, 2008) 
 
 
 
 
4.5.2 Acid butanone haem extraction: 
 
Acid butanone haem extraction is a simple and fast method used to separate the haem 
from a haemoprotein, by exploiting differences in their relative solubilities in two 
immiscible solvents. However, as a result of the inability of the acid extraction 
technique to remove the haem prosthetic group from MPO because of the covalent 
linkages between the haem and the protein (Wu and Schultz, 1975), acid butanone haem 
extraction (Fuhrhop and Smith, 1975) was carried out in a similar way in this work to 
examine the possibility of the presence of a covalent linkage between the haem and the 
protein in the new S167 variants. This test gives a preliminary indication of a haem-
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protein covalent linkage. It did not remove the haem prosthetic group from the S160M 
and S160Y variants of rpAPX after treatment by H2O2 (Metcalfe et al., 2004; Pipirou et 
al., 2007b), or from [S167M] HRP-C* after H2O2 treatment (Cali, 2008). 
 
Samples of WT HRP-C*, S167W and S167Y variants (before and after reaction with 
H2O2) were subjected to the acid butanone extraction method (section 2.8). In order to 
determine and calculate the haem content for each sample, a pyridine haemochrome 
assay was then carried out on the extracted organic layer and quantitation was achieved 
from the reduced-oxidized difference spectra. The results obtained are presented in 
Table 4.4. 
 
For WT and both the S167W variant samples (before and after H2O2 treatment), 
essentially all the haem was recoverable from the butanone organic layer, which gives a 
strong indication that there is no haem covalently linked to the protein even after 
treatment with H2O2. However, very little or no haem was observed in the organic layer 
for the untreated and treated S167Y variant. These results clearly suggest that the haem 
group of the H2O2 treated S167Y variant is strongly and completely linked to the 
protein (0% recovery). In addition, 81% of the haem of the untreated S167Y variant was 
unrecoverable, suggesting that a haem-protein covalent bond occurs in this variant 
spontaneously. An acid butanone extraction and pyridine haemochrome was also 
applied to a sample of the S167Y variant that had been folded and purified in the 
presence of ferulic acid, a peroxidase substrate; almost all of the haem was then 
recovered in the organic layer, suggesting that the haem is unlinked to the protein when 
oxidation equivalents are scavenged. 
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A previous study from a member of this lab has concluded that the haem group from 
haem-protein cross-linked [S167M] HRP-C* was 100% unrecoverable on acid butanone 
extraction (Cali, 2008). He also reported that some 14% of the haem of the H2O2 
untreated S167M variant was unrecoverable, indicating that a low level of haem-protein 
bonding might have occurred spontaneously (Cali, 2008).  
 
 
Table 4.4: Acid butanone haem extraction of WT HRP-C*, [S167W] HRP-C*and 
[S167Y] HRP-C*. The acid butanone haem extraction technique was carried out for 
WT, S167W and S167Y samples, both before and after treatment with hydrogen 
peroxide. 100 µl of enzyme (using enzyme concentrations as shown below in nmoles) 
were treated with 25 µl of 2M HCl, and then 500 µl of butanone were added, the 
solution was mixed very well and then left on the bench to allow the separation of the 
aqueous layer below and the organic layer above. The pyridine haemochrome technique 
was then performed on the organic layer to measure the haem content. 
 
Enzyme 
Theoretical haem 
content (nmoles) 
Practical haem 
content (nmoles) 
Recovery 
percentage (%)
WT HRP-C* 1.65 1.61 97 
Untreated S167Y 3.30 0.63 19 
Treated S167Y 1.67 Nil 0 
Untreated S167Y-
Ferulic acid 
3.00 2.80 93 
Untreated S167W 2.70 2.60 96 
Treated S167W 0.70 0.65 93 
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4.5.3 High Performance Liquid Chromatography (HPLC) Analysis: 
 
High Performance Liquid Chromatography (HPLC) is a highly improved form of 
column chromatography used frequently in biochemistry to separate, identify and 
quantify biological compounds. It has been successfully applied and widely used for the 
separation of all classes of biochemical molecules such as lipids, steroids, 
carbohydrates, amino acids, proteins and vitamins from complex mixture (Pryde and 
Gilbert, 1979). 
 
Compared to other chromatography systems, HPLC is preferred because it has high 
resolution, fast cycle times, high sensitivity, good accuracy, columns can be reused 
without repacking or regeneration and the system can be automated. The mobile phase 
is often varied during the analysis (gradient elution) to obtain the separation required.  
 
Recently, reverse phase HPLC has been used to distinguish between covalently and 
non-covalently attached haem to protein links in haemoproteins (Reeder et al., 2002; 
Limburg et al., 2005). The term reverse phase refers to a non-polar stationary phase and 
polar mobile phase. Under these conditions, hydrophobic compounds stick to reverse 
phase HPLC columns from highly aqueous mobile phases (usually containing water) 
and are then eluted from the columns with a hydrophobic organic mobile phase (such as 
acetonitrile). Therefore, in reverse phase HPLC compounds are separated based on their 
hydrophobic character, polar solutes separate and elute quickly from the column, while 
less polar and non-polar (hydrophobic) solutes elute with a longer retention time. 
 
This analytical technique was used in the present work in order to detect the formation 
of any new covalent linkages that might have occurred between the protein and the 
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haem prosthetic group for the new S167 HRP-C* variants. Enzyme samples for WT 
HRP-C*, [S167W] and [S167Y] HRP-C*, both before and after treatment with H2O2 
were subjected to reverse phase HPLC analysis, under denaturing conditions, using an 
analytical C4 column and a water/acetonitrile mobile phase under acidic conditions 
(0.1% v/v TFA). The haem group was monitored at 400 nm while protein was 
monitored at 280 nm during elution by an acetonitrile gradient (section 2.9.4). In a 
separate control experiment (data not shown) HPLC analysis was performed for free 
haem under the same conditions; the results showed that haem elution was 23 minutes. 
Representative chromatograms obtained for WT HRP-C*, [S167W] and [S167Y] HRP-
C* variants are presented in Figures 4.11, 4.12, 4.13 and 4.14 respectively. 
 
Chromatograms of WT HRP-C* and the S167W variant, both treated and untreated with 
H2O2, show two distinct peaks, one for the haem at 23 minutes and the other for the 
protein at 26 minutes, when monitored at 280 nm (Figures 4.11A, 4.11B, 4.12A and 
4.12B). However, only one major peak at 23 minutes corresponding to elution of the 
haem group is observed at 400 nm for these same samples, suggesting that the haem is 
not linked covalently to the protein. In the case of the S167W variant after treatment 
with H2O2, a small peak at 17 minutes is observed along with the haem peak at 23 
minutes and no absorbance is associated with the protein component, when monitored at 
400 nm (Figure 4.12B). This indicates degradation of the haem group of [S167W] HRP-
C* after exposure to H2O2. 
 
Surprisingly, for the H2O2 untreated S167Y variant sample monitored at 400 nm, 
besides the previously described haem peak which elutes at 23 minutes, a significant 
and a clear fraction of the haem co-elutes with the protein peak at 26 minutes (Figure 
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4.13A), giving a clear indication that a haem-protein linkage had occurred 
spontaneously in this enzyme during preparation. On the other hand, for the S167Y 
variant after treatment with H2O2, it can be seen that the haem group is completely 
attached to the protein and therefore co-eluting at 26 minutes (Figure 4.13B). Another 
sample of the S167Y variant, which was expressed, refolded and purified in the 
presence of ferulic acid, was also subjected to analysis by reverse phase HPLC. The 
resultant chromatograms show only one peak observed at 23 minutes when monitored at 
400 nm related to the free haem group. In addition, two peaks are observed at 23 and 26 
minutes respectively when monitored at 280 nm (Figure 4.14). These results prove that 
this sample of the S167Y variant was completely unlinked. Presumably the presence of 
ferulic acid functioned as an antioxidant preventing cross-linking from occurring during 
preparation of the enzyme. 
 
Previous work by a member of the group (Cali, 2008), showed similar cross-linking for 
[S167M]HRP-C* after incubating overnight with H2O2, when the haem group 
completely co-eluted with the protein, confirming the formation of a protein-haem 
covalent linkage. It has been confirmed that a covalent bond is formed between the 
haem and the protein as a result of an autocatalytic process in the CYP4A, CYP4F and 
CYP4B1 families of cytochrome P450 enzymes (Henne et al., 2001; Hoch and Ortiz de 
Montellano, 2001; Lebrun et al., 2002a; Lebrun et al., 2002b; Baer et al., 2007). 
Similarly, HPLC analysis provided clear evidence of an auto-catalytically haem-protein 
covalent linkage formation in LPO when exposed to H2O2 (DePillis et al., 1997; Colas 
et al., 2002; Colas and Ortiz de Montellano, 2003). Replacement of Ser 160 by Met 
(S160M) and Tyr (S160Y) in Ascorbate Peroxidase leads to the formation of a covalent 
haem-protein attachment after reaction with hydrogen peroxide, as judged by co-elution 
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of the haem and the protein when the product was subjected to the HPLC analysis 
(Metcalfe et al., 2004; Pipirou et al., 2007a; Pipirou et al., 2007b). Furthermore, HPLC 
experiments provided clear evidence that the covalent attachment of the haem to an 
engineered cysteine residue can also occur in the S160C variant of APX (Metcalfe et 
al., 2007). It has been reported that the haem group of F41E mutant in HRP-C* also co-
elutes with the protein at the same retention time when the treated enzyme with H2O2 
was examined by HPLC analysis (Colas and Ortiz de Montellano, 2004). The same 
process was used to confirm the formation of a covalent link between Trp51 and the 
haem in Cytochrome c Peroxidase (Pipirou et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: HPLC chromatograms of WT HRP-C* before and after treatment 
with H2O2. Left scale represents the absorbance at 400 nm while right scale represents 
at 280 nm, (A) WT HRP-C* before, and (B) WT HRP-C* after treatment with 100 
equivalents of H2O2. 
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Figure 4.12: HPLC chromatograms of [S167W] HRP-C* before and after 
treatment with H2O2. Left scale represents the absorbance at 400 nm while right scale 
represents at 280 nm, (A) the S167W mutant before, and (B) the S167W mutant after 
treatment with 100 equivalents of H2O2. The unexpected elution peak at 17 minutes is 
due to degradation of the haem after exposure to H2O2.  
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Figure 4.13: HPLC chromatograms of [S167Y] HRP-C* before and after 
treatment with H2O2. Left scale represents the absorbance at 400 nm while right scale 
represents at 280 nm, (A) Untreated S167Y mutant, and (B) Treated S167Y with 100 
equivalents of H2O2. 
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Figure 4.14: HPLC chromatogram of [S167Y] HRP-C* folded and purified in the 
presence of ferulic acid. Left scale represents the absorbance at 400 nm while right 
scale represents at 280 nm. 
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4.5.4 Protein analysis by Mass Spectrometry: 
 
Mass spectrometry is an analytical technique which is used to determine the mass of a 
sample by measuring the mass-to-charge (m/z) ratio of the sample once ionized. In fact, 
it is generally considered one of the most powerful analytical techniques for both 
qualitative and quantitative analysis, because of its great power in identification by both 
molecular weight and structural information. The first stage of mass spectrometry is the 
introduction of a sample into an ionization source. The analyte is ionized and 
accelerated to pass into the analyzer region of the mass spectrometer instrument, where 
ions are separated according to their mass-to-charge (m/z) ratios. The separated ions are 
then detected and presented as a mass spectrum displayed with m/z values on the x-axis 
and ion abundances on the y-axis (Johnstone and Rose, 1996).  
 
Among all types of mass spectrometry, soft ionization mass spectrometry, in particular 
matrix assistant laser desorption ionization (MALDI) and electrospray ionization (ESI), 
is ideal for the analysis of high molecular weight bio-molecules. Commercial 
availability of these MS instruments has made the analysis of bio-molecules such as 
peptides, proteins and many other compounds that were previously not accessible to 
mass spectrometric investigations, as routine. One of the greatest advantages of 
MALDI-TOF and ESI mass spectrometry is the sensitivity; the picomole to femtomole 
sensitivity range allows the investigation of bio-molecules even at very small quantities. 
Microgram quantities of sample are generally more than enough to do an analysis with a 
high accuracy up to ± 0.01 % (Daniel et al., 2002). Indeed, the accuracy of MS analysis 
is quite sufficient to detect the mass changes that would occur in peptides and protein 
molecules as a result of the substitution of one amino acid by another. 
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ESI and MALDI-TOF mass spectrometry studies have been widely used to look for 
increases in protein molecular weights due to haem to protein covalent bonds. During 
previous work in this lab, these techniques clearly showed that formation of a sulfonium 
linkage in [S167M] HRP-C* can be achieved by incubation of the enzyme overnight 
with hydrogen peroxide (Cali, 2008). ESI-MS in conjunction with HPLC analysis was 
used to investigate the cross-linking process of the amino acid residues Asp225 and 
Gly375 with the prosthetic haem group of Lactoperoxidase (Colas et al., 2002). 
 
MS analysis results provided strong evidence that a thioether bond formation between 
haem and an engineered cysteine residue at position 160 can occur easily under 
reducing conditions in the S160C variant of ascorbate peroxidase (Metcalfe et al., 
2007). MALDI-TOF and ESI mass spectrometry analysis also confirmed that 
introduction of an engineered methionine residue at the position 160 (S160M variant) 
and tyrosine residue at the same position (S160Y variant), led to the autocatalytic 
formation of a haem-methionine sulfonium linkage (the mass recorded was 629 Da 
higher than the predicted value) and a haem-tyrosine covalent linkage (the mass was 
632 Da higher than the predicted value) respectively in ascorbate peroxidase when 
treated with hydrogen peroxide (Metcalfe et al., 2004; Pipirou et al., 2007b). Mass 
spectrometry clearly showed that the exposure of ascorbate peroxidase to a sufficient 
quantity of hydrogen peroxide leads to the formation of a covalent linkage between the 
haem and the distal Trp 41 residue (Pipirou et al., 2007a). 
 
Recently, mass spectrometry studies indicated that the reaction of cytochrome c 
peroxidase with hydrogen peroxide leads to the formation of a covalent link with the 
distal tryptophan (Trp51) (Pipirou et al., 2009). Furthermore, the presence of a covalent 
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linkage between the protein and the haem prosthetic group was confirmed for many 
members of cytochrome P450 enzymes particularly CYP4A, CYP101, CYP4B and 
CYP4F superfamilies, using mass spectrometry analysis (Henne et al., 2001; Hoch and 
Ortiz de Montellano, 2001; Lebrun et al., 2002a; Lebrun et al., 2002b; Limburg et al., 
2005; Baer et al., 2007). MS analysis was also used to detect the presence of a single 
Tyr-Trp cross-link in M255I mutant of Catalase peroxidase, which is postulated to be an 
intermediate generated during formation of the Met-Tyr-Trp cross-link (Ghiladi et al., 
2005a; Ghiladi et al., 2005b). More recently, a combination of MALDI-TOF and ESI 
mass spectrometry analysis has been used in order to study the characteristics of the 
glycans of the glycopeptides from horseradish peroxidase (Chen et al., 2010). 
 
MALDI-TOF and ESI mass spectrometry were used in this work to investigate mass 
changes that may or may not occur in different HRP-C* samples after treatment with 
H2O2. The masses of WT, [S167Y] and [S167W] HRP-C* (treated and untreated with 
H2O2) were determined from MALDI-TOF mass spectra, and were also calculated from 
ESI-MS mass spectra shown in Figure 4.15, using the equation mentioned in section 
2.10.4.2, as well as auto-calculated directly from the ESI-MS apparatus using 
MassLynx V4.1 (Figure 4.16). The collective results are presented in Table 4.5, where 
the theoretical masses were calculated from the gene sequences. ESI mass spectrometry 
gave an experimental mass for WT HRP-C* of 34,041 Da (Table 4.5) which 
corresponds closely to the theoretical calculated mass of 34,048 Da. The experimental 
mass for the untreated S167W variant is 34,142 Da, and this increase in mass over WT 
is consistent with the replacement of a serine residue with tryptophan; the molecular 
masses for these amino acids are 105 Da and 204 Da respectively. For peroxide treated 
[S167W] HRP-C* the mass spectrum gave a mass of 34,168 Da. which is 26 Da higher 
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than the mass of untreated S167W; the origin of this mass increase seems to be less 
clear. However, the results clearly indicate that there is no linkage formed between the 
haem and the protein in the S167W variant even after H2O2 treatment. The experimental 
masses for untreated and treated [S167Y] HRP-C* are both 34,730 Da, corresponding 
to an increase in mass of 614 Da over the predicted mass of 34,117 Da (the predicted 
mass is 76 Da higher than WT, consistent with the replacement of a serine residue with 
tyrosine, 105 Da and 181 Da, respectively). This increase in mass of 614 Da is 
consistent with the covalent attachment of haem (616 Da) to the protein. The MS data 
are therefore in agreement with the HPLC analysis, and provide further evidence of the 
formation of the covalent cross-link between the haem and the protein in the S167Y 
variant. However, the spontaneous cross-linking of untreated S167Y was unexpected. 
Therefore, protein folding and purification of [S167Y] HRP-C* was performed in the 
presence of ferulic acid as an antioxidant scavenger and examined by mass 
spectrometry. The MS results showed no difference in mass between the calculated and 
the expected values, at 34,117 Da, respectively. 
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Table 4.5: Comparison of the molecular masses of WT, [S167W] and [S167Y] 
HRP-C* treated and untreated with H2O2, as well as [S167Y] HRP-C* purified in 
the presence of ferulic acid. The molecular masses were calculated from the MALDI-
TOF and ESI mass spectra. 
 
Enzyme 
Calculated mass 
(Da) 
Experimental 
mass (Da) 
Difference (Da) 
WT HRP-C* 34,048 34,041 7 
Untreated S167W 34,140 34,142 2 
Treated S167W 34,140 34,168 28 
Untreated S167Y 34,117 34,731 614 
Treated S167Y 34,117 34,731 614 
Untreated S167Y-
Ferulic acid 
34,117 34,117 0 
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4.6 Crystal growth for [S167Y] HRP-C*: 
 
The hanging drop method was used to grow crystals of the S167Y variant, as described 
in section 2.12. In this method, the concentration of protein in a drop is gradually 
increased as water is lost to a reservoir solution by vapour diffusion (Branden and 
Tooze, 1991). The crystals form and grow as the protein solution is brought to a 
supersaturated state as the protein concentration exceeds protein solubility. After one 
week, and in order to accelerate crystallization, the S167Y mutant protein solution was 
seeded with WT HRP-C* micro-crystals to serve as nucleation centres for rapid growth 
of larger crystals. The resultant S167Y crystals were visible to the naked eye and in 
about one third of the wells of the crystal tray used (Table 2.2). They were a few 
millimetres in length after 3-4 weeks, and are shown in Figure 4.17. The crystals were 
bathed in cryo-protective solution, i.e. reservoir solution containing 22% glycerol, and 
then frozen in liquid nitrogen prior to X-ray data collection. The same crystallization 
procedure was attempted for S167W mutant; unfortunately, unlike S167Y, all attempts 
to get S167W crystals were unsuccessful.  
 
 
 
 
 
 
 
 
 
Figure 4.17: Selected crystals of the S167Y mutant of HRP-C*. The crystal were grown 
using hanging drop method and they were a few millimetres in length after 3-4 weeks. 
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4.7 Conclusions: 
 
Spectroscopic characterisation of [S167W] and [S167Y] HRP-C* variants showed the 
absence of the shoulder at 380 nm on the Soret peak seen for WT HRP-C*, and a 
substantial increase in molar extinction coefficients. These changes can be attributed to 
an increase in the 6-coordinate high spin character of the haem at the expense of 5-
coordinate high spin character. Studies on the effect of the mutations on the affinity of 
the HRP-C* enzyme for BHA, gave a dissociation constant (Kd) for the S167W variant 
that was only slightly higher than the WT. However, the Kd doubled for the S167Y 
variant, implying a small but significant perturbation of the aromatic donor binding site 
of the enzyme and / or the associated haem-linked hydrogen bonding network (Smith et 
al., 1992; Veitch et al., 1997). 
 
Incubation of the new HRP-C* variants S167W and S167Y with hydrogen peroxide, in 
the absence of any reducing substrate, for two hours in sodium phosphate buffer at 25 
oC showed changes in the individual catalytic reactivity of the enzymes compared to 
WT. Repeat UV/Visible scans demonstrated clearly that the first intermediate 
Compound I is less stable and undergoes a rapid conversion to the Compound II for 
both mutants, when compared to the WT enzyme. The spectroscopic properties of the 
more stable intermediate, Compound II (λmax at 420, 555 and 523 nm) were consistent 
with those for WT HRP-C*. In the case of the S167W variant the return to the resting 
sate was more rapid, with complete loss of Compound II after 15 minutes, compared to 
the S167Y variant, which needed 180 minutes to return to the resting state. 
 
The reduced, pyridine haemochrome spectrum of the S167Y variant only showed a blue 
shifted α-band at 552 nm in addition to a blue shifted Soret band at 415.5 nm, compared 
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to the 555 nm and 419 nm for WT HRP-C*. These spectroscopic changes, by analogy 
with MPO (Kooter et al., 1997a), indicated the formation a covalent linkage between 
the haem and the protein in the [S167Y] HRP-C* enzyme even before treatment with 
H2O2. 
 
The most important result from the reaction of the new variants with hydrogen 
peroxide, is the finding that the haem in [S167Y] HRP-C* is attached to the protein by 
covalent linkage. This was confirmed in three ways. Firstly, acid butanone haem 
extraction did not remove the haem from the protein, 100% of the haem of H2O2 treated 
S167Y variant was unrecoverable, compared with 97% of untreated WT and 96% of 
H2O2 treated S167W variant being recoverable. Interestingly, 81% of haem was also 
unrecovered from the non H2O2 treated [S167Y] HRP-C* sample. 
 
Secondly, HPLC analysis of the S167Y variant after treatment with H2O2 clearly 
showed that the haem group was strongly attached to the protein as it co-eluted with the 
protein peak at 26 minutes in the HPLC elution profile. Again untreated S167Y samples 
were also substantially cross-linked, with a significant and a clear fraction of haem 
again co-eluting with the protein peak at 26 minute. Thirdly, ESI and MALDI-TOF 
analysis of both untreated and H2O2 treated [S167Y] HRP-C* showed a mass of 34,731 
Da, corresponding to an increase in mass of 614 Da over the predicted mass of 34,117 
Da. This increase is consistent with the covalent attachment of haem (616 Da) to the 
protein. Again this gives a clear indication that the majority of the haem is already 
covalently linked to the protein before [S167Y] HRP-C* is reacted with H2O2, 
suggesting that the haem-protein linkage is spontaneous. No clear evidence was found 
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for a haem-protein cross-link in the [S167W] HRP-C* variant even after treatment with 
H2O2. 
 
The results obtained therefore show that a Tyr residue at position 167 close to the 2-
vinyl of the porphyrin of the haem is sufficient to allow formation of the haem-protein 
covalent linkage in HRP-C, even before treatment with H2O2. One likely scenario is that 
the enzyme turns over during isolation, folding or purification with an oxidant, forming 
radicals (either Compound I or a radical on the haem 2-vinyl) that enable the reaction 
with tyrosine to occur. Therefore, protein folding and purification for a sample of 
S167Y variant was performed in the presence of ferulic acid, as an antioxidant 
scavenger. Acid butanone extraction, HPLC and MS analysis then showed no evidence 
of a spontaneous haem-protein cross-link in the variant. It is important to mention that 
from this time, the UmS167Y refers to the unlinked mutant while mS167Y refers to the 
haem-tyrosine covalent link mutant. 
 
The S167Y variant has been successfully crystallised and data collected at the Diamond 
Light Source by Dr. Mark Roe (X-Ray Crystallography Collaborative Research Facility 
Manager, University of Sussex, UK). The structure was subsequently solved to 1.7 Å 
resolution. A more detailed account of the structural aspects of this mutant is given in 
chapter 7. 
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Chapter Five: 
Steady-state enzyme kinetics 
 
 
5.1 Introduction: 
 
Enzyme kinetics is the study of the rates of enzyme-catalyzed reactions. The rate of 
catalysis is defined as the number of moles of product formed per second and this value 
rises linearly with increasing substrate concentration, then begins to level off and 
approach a maximum at higher substrate concentrations (Berg et al., 2002). In 1913, 
Leonor Michaelis and Maud Menten proposed a classic model that describes an enzyme 
reaction (Michaelis and Menten, 1913). The model proposed is the simplest one that can 
be used to account for the kinetic properties of enzymes: 
 
 
 
In this equation E is an enzyme that combines with the substrate S to form an ES 
complex, with a rate constant of k1. The ES complex has two possible fates, it either 
dissociates back to E and S with a rate constant of k-1 or proceeds to form product P 
with a rate constant of k2. Michaelis and Menten established from this model a basic 
equation (equation 5.1), called the Michaelis-Menten equation, to describe the kinetic 
data of this enzyme reaction: 
 
ܸ ൌ ௠ܸ௔௫ ሾܵሿܭ௠ + ሾܵሿ            (݁ݍݑܽݐ݅݋݊ 5.1) 
                     (1)        
k1 
k-1 
k2 
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In this equation V is the rate of catalysis at any given substrate concentration and Vmax is 
the maximum attainable rate of catalysis from the enzyme-catalyzed reaction (unit M s-
1). Km is an important characteristic of enzyme kinetics and is called the Michaelis 
constant. Km is expressed by the following equation: 
 
ܭ௠ ൌ
݇ିଵ + ݇ଶ
݇ଵ             (݁ݍݑܽ݅݋݊ 5.2) 
 
Km indicates the affinity between the enzyme and substrate, it is a measure of the 
strength of the ES complex (see model 1 above), where a high value of Km indicates 
weak binding while a low value of Km indicates strong binding. The maximum rate of 
catalysis Vmax also leads to the turnover number of an enzyme (Berg et al., 2002), which 
is the number of substrate molecules converted into product by an enzyme molecule in 
unit time, when the enzyme is fully saturated with substrate (unit s-1). It is often called 
kcat. When the total concentration of enzyme [E]o is known, the Vmax is related to the 
turnover number kcat by the following equations: 
 
௠ܸ௔௫ ൌ ݇௖௔௧ሾܧሿ଴            (݁ݍݑܽݐ݅݋݊ 5.3) 
ܽ݊݀ ݐ݄ݑݏ     ݇௖௔௧ ൌ ௠ܸ௔௫ ሾܧሿ௢⁄             (݁ݍݑܽݐ݅݋݊ 5.4) 
 
Under physiological conditions, the [S]/Km ratio is typically between 0.01 and 1.0 
(Campbell and Farrell, 2009). However, when the substrate concentration is small 
compared to Km, the enzymatic rate is much less than kcat because not all the active sites 
of the enzyme molecules are filled with substrate. Under these conditions, the ratio 
value of kcat/Km behaves as the rate constant for the interaction between the substrate 
and the enzyme. The ratio kcat/Km is thus a measure of catalytic efficiency because it 
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takes into account both the rate of catalysis with a particular substrate (kcat) and the 
strength of the enzyme-substrate interaction (Km). Therefore, by using kcat/Km values, it 
is easy to compare an enzyme’s preferences for different substrates. Enzymes that have 
kcat/Km values at the upper limits have attained kinetic perfection (Berg et al., 2002). 
 
Most enzymatic reactions in biological systems are more complicated than the classical 
Michaelis-Menten model and include two substrates (Berg et al., 2002). Nevertheless, it 
is still possible to obtain data that conform to the Michaelis-Menten equation (equation 
5.1), and determine the steady-state kinetic parameters for each substrate in vitro, by 
treating the catalysis as if it is a single substrate reaction. This is achieved by varying 
the first substrate concentration, at a constant concentration of the second substrate, and 
vice versa. The parameters obtained by this method are termed ‘apparent’ and may 
change if the concentration of the constant substrate is altered (Cornish-Bowden, 2004). 
 
5.2 Initial steady-state kinetics of ABTS oxidation: 
 
In order to study the effects of mutation at position 167 on the catalytic efficiency of 
HRP-C*, steady-state kinetic parameters for the reaction of WT HRP-C* and the new 
S167 variants were determined with hydrogen peroxide and using 2, 2´-azino-di-(3-
ethyl-benzthiazoline-6sulphonic acid) (ABTS) as reducing substrate. ABTS is a 
relatively large molecule (Figure 5.1), with a sulphate oxygen to sulphate oxygen 
distance of 17.2 Å, and structurally is essentially a planar substrate (Mousty et al., 
1997). It is utilized as a convenient, low cost, commercially available substrate to assay 
peroxidase activity, as it is known as one of the most efficient electron donors for HRP 
(Childs and Bardsley, 1975; Smith et al., 1990; Heering et al., 2002). The chemical 
properties of ABTS and its oxidation by HRP-C have been extensively studied (Childs 
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and Bardsley, 1975; Wolfenden and Willson, 1982; Scott et al., 1993; Campos and 
Lissi, 1997; Aliaga and Lissi, 1998). In the presence of HRP-C and hydrogen peroxide 
this substrate readily undergoes a single electron oxidation to produce a cation radical 
species with distinctive green colour (Figure 5.1). Accordingly, ABTS assays involve 
the measurement of the accumulation of this cation radical by following the colour 
production spectrophotometrically as a function of time (Childs and Bardsley, 1975). 
 
The catalytic oxidation of ABTS by HRP-C is of course a two substrate reaction. The 
sequence of this reaction firstly involves interaction of the enzyme with hydrogen 
peroxide to produce the Compound I intermediate. This is followed by the oxidation of 
one molecule of ABTS concomitant with the reduction of Compound I to the second 
intermediate Compound II, and then, the oxidation of a second molecule of ABTS 
concomitant with the reduction of Compound II to the resting state of the enzyme 
(Childs and Bardsley, 1975). 
 
 
 
 
 
 
 
 
 
Figure 5.1: Chemical formula of ABTS and its oxidation product. Colourless, 
reduced ABTS undergoes a single electron oxidation in the presence of HRP-C and 
H2O2 to give a green, long-lived cation radical (Childs and Bardsley, 1975).  
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In this work, activity assays were carried out using varying concentrations of ABTS and 
a constant concentration of H2O2. The initial rates, expressed as turnover numbers, were 
measured by monitoring the increase in absorbance at 414 nm resulting from the 
oxidation of the ABTS. Figure 5.2 shows the calculated initial rates against ABTS 
concentration and the plots of the Michaelis-Menten equation (equation 5.1) to the 
experimental data (SigmaPlot). The apparent kinetic parameters Km and kcat determined 
from each fit are listed in Table 5.1. The values of kcat/Km, the catalytic efficiency 
constant for ABTS oxidation by HRP-C, or KABTS, are also included in this table as a 
measure of the specific enzymes effectiveness.  
 
The kinetic parameters obtained show a number of important differences between the 
new mutants and the WT HRP-C*. The largest difference between the parameters for 
the S167W variant and WT HRP-C* is the higher apparent Km for the former; 366 µM 
for [S167W] HRP-C* and 184 µM for WT, meaning there is a two-fold decrease in the 
affinity of the mutant towards ABTS compared with the wild-type enzyme. Moreover, 
the apparent kcat of the mutant is also reduced, to approximately 75% of that of WT. 
These results indicate that replacement of the Ser167 residue by Trp has created an 
enzyme mutant with a somewhat reduced affinity towards ABTS and lower activity 
when compared to wild-type. Calculating the efficiency constant KABTS shows that the 
mutant has only 39% of the effectiveness of WT HRP-C* (Figure 5.3). 
 
The UmS167Y variant, compared to the S167W variant, displayed different behaviour 
during the steady-state oxidation of ABTS (Table 5.1). This variant has a decreased 
apparent Km value of 73 µM compared to 184 µM for WT (i.e. approximately 2.5-fold 
less) but also a reduction in the apparent kcat value to 18% of the WT enzyme. These 
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results mean, in contrast to the S167W variant, that the replacement of Ser167 by Tyr 
has created an enzyme mutant with a higher affinity towards ABTS, but a much lower 
catalytic activity kcat. As a result, the efficiency constant KABTS for Um[S167Y] HRP-C* 
is decreased to 45% of that of WT enzyme (Figure 5.3). 
 
As with UmS167Y, the m[S167Y] HRP-C* also has decreased apparent Km value to 
approximately half that of the wild-type enzyme (Table 5.1). However, the activity of 
mS167Y, as judged by the kcat value, is almost 3-fold higher than that of UmS167Y but 
still nearly 2-fold lower than that of the wild-type enzyme. These results therefore give 
a value of KABTS for m[S167Y] HRP-C* over twice the value of UmS167Y and equal to 
that of WT HRP-C*. It can therefore be concluded that the creation of the haem-protein 
cross-linkage in the S167Y mutant, has led to an enzyme with a similar effectiveness to 
WT HRP-C* (Figure 5.3), presumably due to the linkage causing an adventitious 
perturbation of the structure. 
 
In a previous study by a member of the group (Cali, 2008), it was observed that the Km 
value for UmS167M HRP-C* with ABTS was similar to that of WT HRP-C*, but the 
kcat value was 3-fold lower. Therefore, the S167M mutation decreased the enzyme’s 
effectiveness (KABTS) by approximately 2.5-fold compared to WT. However, the 
formation of the sulfonium linkage in this mutant (mS167M) had a larger negative 
effect on efficiency, as it reduced the KABTS value of the enzyme towards ABTS by a 
factor of 15 (Cali, 2008). 
 
From the present results, in conjunction with the findings of Cali (Cali, 2008), it seems 
clear that although Ser167 does not have any essential role in the catalytic function of  
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Plots depicting the initial rates (expressed as turnover numbers) 
against ABTS concentration. (a) WT HRP-C* and [S167W] HRP-C* and (b) 
Um[S167Y] and m[S167Y] HRP-C*. The assays were carried out in phosphate-citrate 
buffer, pH 5, using 0.5 nM of enzyme, 1 mM H2O2, in a final volume of 1 ml at 25 oC. 
a 
b 
  
Table 5.1: Steady-state parameters of the oxidation of ABTS by WT HRP-C* and 
the new S167 variants. Data obtained from Figure 5.2. 
 
Enzyme Km (µM) kcat (s-1) KABTS (M-1s-1) 
WT HRP-C* 184 ± 18 699 ± 16 3.8 x 106 
S167W 366 ± 22 524 ± 13 1.4 x 106 
UmS167Y 73 ± 12 126 ± 4 1.7 x 106 
mS167Y 95 ± 11 363 ± 8 3.8 x 106 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Histogram illustrating the effects of mutations at position 167 of HRP-
C* on kcat/Km values for the oxidation of ABTS. Data obtained from Figure 5.2.
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the enzyme, its mutation can affect indirectly either the substrate binding to the binding 
site or the rate of substrate turnover causing an alteration in the effectiveness of the 
enzyme towards ABTS. Interestingly, the only enzyme with the same effectiveness ratio 
as WT HRP-C* is the cross-linked S167Y variant. 
 
5.3 Activity screening towards a panel of substrates: 
 
HRP-C is characterized by having the capacity to oxidize a wide variety of substrates, 
albeit with varying efficiencies, e.g. aromatic amines, indoles, phenols and sulfonates 
(Veitch and Smith, 2001). In order to determine further the functional properties of the 
S167 enzyme mutants and whether the effects on the rate of ABTS oxidation already 
seen are replicated with other substrates, the new mutants were also studied against a 
panel of twelve further peroxidase substrates. Activity assays were carried out using 
varying concentrations of each substrate and a constant concentration of H2O2 (section 
2.11.2). The results obtained are presented as specific activities in Table (5.2). 
 
The S167W variant generally displays an impaired activity toward all substrates used 
compared to WT HRP-C*, although the degree of impairment varies considerably, 
ranging between 40-75% of the wild-type enzyme. While the specific activities for 
guaiacol and orange II oxidation are similar to those of the wild-type enzyme, most 
interestingly the S167W mutant exhibits an approximately 3-fold increase in luminol 
oxidation, under the conditions used. 
 
The ability of the UmS167Y variant to oxidize substrates was also found to generally be 
decreased when compared to WT HRP-C*, with the exception of guaiacol and orange 
II. The specific activities measured were also more severely impaired than for S167W, 
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except for pyrogallol. This is consistent with the ABTS oxidation results reported in the 
last section. These results give an indication that the active site of the enzyme has been 
more modified when the Ser167 residue is replaced by Tyr, than when it is replaced by 
a Trp, perhaps surprisingly giving the amino acid structures involved.  
 
 
Table 5.2: Substrate activity screening of WT HRP-C* and the new S167 variants. 
The assays were carried out in phosphate-citrate buffer, pH 5.0, at 25 oC. The results 
represent the specific activity of the enzyme in units (µmole. min-1. mg-1). 
 
 
Substrate WT S167W UmS167Y mS167Y 
ABTS 824 ± 8 389 ± 3 264 ± 4 805 ± 8 
Ferulic acid 3723 ± 33 1465 ± 12 1237 ± 38 3658 ± 141 
Caffeic acid 3742 ± 101 2030 ± 66 1312 ± 22 3648 ± 66 
p-Coumaric acid 2216 ± 64 1626 ± 75 1063 ± 11 2244 ± 19 
Potassium ferrocyanide 1247 ± 60 301 ± 2 260 ± 27 856 ± 42 
Guaiacol 387 ± 4 433 ± 11 338 ± 22 969 ± 40 
Pyrogallol 2931 ± 62 1055 ± 15 1172 ± 28 3853 ± 37 
o-Phenylenediamine 1672 ± 35 764 ± 10 598 ± 23 1655 ± 14 
Chlorpromazine 12 ± 1 5 ± 1 4 ± 1 13 ± 1 
Luminol 71 ± 2 201 ± 4 49 ± 1 163 ± 3 
Orange I 442 ± 14 305 ± 9 266 ± 8 755 ± 6 
Orange II 0.12 ± 0.01 0.12 ± 0.01 0.10 ± 0.01 0.17 ± 0.01 
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The most interesting observations were found for m[S167Y] HRP-C*, which displays 
an overall increase in specific activity of 2-4 fold towards all the substrates used, when 
compared to the unlinked enzyme. This increase in activity also leads to equivalent or 
higher activities compared to the WT enzyme (Figure 5.4), except for the potassium 
ferrocyanide. Of particular note is the approximately 2.5-fold increase in activity 
compared to WT for guaiacol and luminol. Again this is generally consistent with the 
previous results for ABTS. Presumably the perturbation of the structure brought about 
by the initial S167Y mutation is again altered by the production of the linkage so that 
the active site and substrate binding site are once more like the wild-type arrangement, 
although for a few substrates a small change must still be present that allows for the 
increased activities. It is interesting that the linked S167Y mutant has higher activities 
against all substrates tested than the linked S167M mutant (Cali, 2008), which were all 
lower than the unlinked S167M mutant. Presumably in this mutant the formation of the 
sulfonium linkage increases the perturbation of either, or both, the active and substrate 
binding sites. On the other hand, it has been reported that the specific activity of F41E 
HRP-C* towards guaiacol was significantly increased 10-fold after treatment with H2O2 
and creation of a haem-protein covalent bond (Colas and Ortiz de Montellano, 2004). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Figure 5.4: Histogram of specific activities for the oxidation of a panel of 
peroxidase substrates by Um[S167Y] and m[S167Y] HRP-C* expressed as a 
percentage of the values obtained for WT HRP-C*. Data obtained from Table 5.2. 
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5.5 Steady-state kinetics of Luminol oxidation: 
 
The oxidation reaction of 5-amino-2,3-dyhydrophthalazine-1,4-dione (Luminol), 
mediated by HRP-C, to yield 3-aminophthalate and light is called chemiluminescence 
and is considered one of the many important applications of HRP (Thorpe and Kricka, 
1986; Veitch and Smith, 2001). This reaction produces light and has been used 
frequently in clinical applications, for immunoassays, metabolic pathway monitoring, 
detection of inorganic and organic compounds, determination of enzymatic reaction and 
detection of blood at crime scenes (Briheim et al., 1984; Radi et al., 1993; Lundqvist 
and Dahlgren, 1996). 
 
The chemiluminescence assay involves the normal catalytic cycle of HRP-C with both 
its intermediary complexes, Compound I and Compound II, being able to rapidly 
remove an electron from luminol to form a luminol cation radical. Then, the luminol 
radicals enter a complex chemical pathway to produce diazoquinione, luminol 
endoperoxide and finally, the light emitting excited state of a 3-aminophthalate ion and 
nitrogen gas. In the final step of the reaction the excited 3-aminophthalate ion yields a 
3-aminophthalate dianion and light (Bhandari et al., 2010). 
 
One disadvantage of the conventional chemiluminescence assay with HRP-C is the 
inefficiency of the luminescence reaction due to its low quantum yield (Tanaka et al., 
1999). Therefore, and in order to detect and measure smaller amounts of analytes in 
clinical assays, many efforts have been made to enhance the luminol activity of HRP-C. 
It has been found that the sensitivity of the luminol assay can be increased by addition 
of enhancers, such as 4-Iodophenol and 4-Iodophenylboronic acid but this can be costly 
(Kricka et al., 1988; Kricka et al., 1996). An attempt has been made to enhance the 
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direct luminol oxidation activity of HRP, by mimicking in HRP-C a possible binding 
site for luminol from Arthromyces ramosus peroxidase (ARP); the results showed a 
significant increase in enzyme activity towards luminol, with some HRP variants 
prepared having 500-fold higher activity for luminol than the wild-type enzyme (Tanaka 
et al., 1999). 
 
As mentioned before, from the specific activity screening against a panel of substrates, 
the luminol oxidation results showed that there was an interesting increase in activity of 
the S167W and mS167Y mutants relative to the wild-type enzyme. Therefore, apparent 
steady-state parameters were determined for these two mutants this time using luminol 
as reducing substrate, instead of ABTS, and conditions as described in section 2.6.3. 
 
The initial rates obtained, expressed as turnover numbers, were plotted against luminol 
concentration and were fitted to the Michaelis-Menten equation using SigmaPlot 
software (Figure 5.5). Apparent kinetics parameters obtained (Km and kcat) for WT HRP-
C*, S167W, UmS167Y and mS167Y are compiled in Table 5.3. The efficiency constant 
(kcat/Km) for each enzyme was calculated and is also included in this table. In order to 
facilitate visual comparison between WT HRP-C*, and the S167W, UmS167Y and 
mS167Y mutants, the efficiency constants are illustrated graphically in Figure 5.6. 
 
The results obtained for the S167W mutant show a significantly decreased apparent Km 
value by a factor of 7-fold and a kcat value decreased by a factor of 1.5-fold compared to 
the wild-type enzyme. These results lead to a clear increase in the efficiency of this 
enzyme variant towards luminol, with the kcat/Km for luminol being 5-fold higher than 
that of WT HRP-C* (Figure 5.6). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: Plots depicting the dependence of initial rates of luminol oxidation on 
luminol concentration during steady-state HRP-C assays. The data were fitted to the 
Michaelis-Menten equation and the values determined are given in Table 5.3. (a) WT 
HRP-C* and S167W mutant, and (b) Um[S167Y] and m[S167Y] HRP-C*. The assays 
were carried out in phosphate-citrate buffer, pH 5.0, using 20 nM of enzyme, 1 mM 
H2O2 and varying concentrations of luminol in a final volume of 1 ml at 25 oC. 
a 
b 
  
Table 5.3: Steady-state parameters of the oxidation of luminol by WT HRP-C* and 
the new S167 mutants. Data obtained from Figure 5.5. 
 
 
Enzyme Km (μM) kcat (s-1) kcat/Km (M-1s-1) 
WT HRP-C* 1425 ± 93 275 ± 10 1.93 x 105 
S167W 199 ± 24 190 ± 9 9.56 x 105 
UmS167Y 2030 ± 163 130 ± 7 0.65 x 105 
mS167Y 541 ± 49 170 ± 5 3.14 x 105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Histogram illustrating the effects of mutations at position 167 of HRP-
C* on kcat/Km values for the oxidation of luminol. Data obtained from Figure 5.5.
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The UmS167Y variant displays very different behaviour to that of the S167W variant. It 
has an increased apparent Km value of 2030 μM compared to 1425 μM for WT HRP-
C*, accompanied by a 2-fold decrease in apparent kcat value. The efficiency constant for 
this mutant is therefore decreased by a factor of 3-fold compared to that of wild-type 
enzyme. However, the results for the mS167Y enzyme are again different to those of 
Um[S167Y] HRP-C*. For this linked mutant the decrease is 2.5-fold in Km and 1.6-fold 
in kcat compared to values for WT HRP-C*, leading to an overall 1.6-fold higher 
catalytic efficiency (kcat/Km) than the wild-type enzyme and 5-fold higher than the 
Um[S167Y] HRP-C*. The increase in catalytic effectiveness for both S167W and 
mS167Y enzymes is achieved by a decrease in the apparent Km value, which reflects a 
higher binding affinity for luminol. 
 
5.6 Conclusion: 
 
The changes in the kinetic parameters of the S167Y and S167W variants, relative to WT 
HRP-C*, are interesting. It can be concluded that the replacement of Ser167 by either a 
Tyr or Trp, leads to an indirect effect on the active and substrate binding sites of HRP-C 
and as a result modulates the activity of the enzyme towards certain substrates. The 
nature of this modulation seems to be substrate specific to some extent. In general, the 
introduction of a Tyr or Trp in position 167, leads to an enzyme with lower activity 
towards most substrates. However, surprisingly, and in contrast to other substrates, there 
is a significant enhancement in the oxidation activity of the S167W variant towards 
luminol leading to an enzyme efficiency approximately 5-fold that of WT HRP-C*. For 
the S167Y mutant formation of the haem-protein covalent linkage leads to an enzyme 
that has much more WT-like levels of activity against all substrates tested. This is very 
different to that previously found for the S167M mutant (Cali, 2008), where the 
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formation of the sulfonium linkage between the heam and protein leads to a further 
decrease in enzyme activity by approximately 12-16 fold. This is presumably due to an 
increase in the perturbation to the HRP-C* active site for m[S167M] HRP-C* but for 
m[S167Y] HRP-C* the linkage in some way compensates for the perturbations already 
caused by the mutation itself. A further discussion of the steady-state kinetic results and 
the functional changes accompanying the mutations of the HRP-C will be presented in 
chapter 7. 
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Chapter Six: 
Pre steady-state kinetic characterisation of HRP 
S167 variants and effect(s) of haem-protein 
covalent linkage 
 
 
6.1 Introduction: 
 
The term pre steady-state kinetics is usually applied to the observation of rates of 
reaction that occur in very short time intervals (usually fractions of a second) and at 
very low product concentrations. In enzyme kinetics, this period covers the time from 
the enzyme encountering its target substrate, up to the point that the system reaches an 
equilibrium state. Figure 6.1 illustrates the changes in concentration observed for the 
reaction participants, with time, during the pre steady-state and steady-state (Berg et al., 
2002). 
 
 
 
 
 
 
 
 
Figure 6.1: The concentration changes in reaction participants in an enzyme-
catalyzed reaction with time. Concentration changes under (A) steady-state 
conditions, and (B) pre steady-state conditions. This figure is adopted from Berg et al., 
2002.  
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The figure demonstrates that, from the beginning of the reaction, the concentration of 
Enzyme-Substrate complex (ES) rises from zero to its steady-state value. The steady-
state approximation is therefore not valid during this early stage and for this reason it is 
called the pre steady-state or transient-phase. The pre steady-state of an enzyme-
catalyzed reaction usually occupies a very brief period of time (milliseconds), therefore 
special rapid techniques have to be used for investigation. One of the most frequently 
used techniques is stopped-flow, in which a spectroscopic signal is observed during the 
pre steady-state stage (Wang, 2007). Pre steady-state kinetic experiments with 
peroxidases are often carried out using the stopped-flow apparatus, as it permits the 
direct monitoring of the kinetic behaviour of the resting enzyme and intermediates 
Compounds I and II (Dunford, 1999h). Stopped-flow spectroscopy was developed by 
Britton Chance in the 1950's (Chance, 1952) and allows the measurement of pre steady-
state rate constants for the formation of enzyme intermediates, which is not possible 
using steady-state methods. 
 
As mentioned in Chapter 5, the rate of an enzyme reaction is the quantity of reactants 
that disappear, or quantity of products that appear, in a specified unit of time. It is 
directly related to the concentration of reactants by a proportionality constant, called the 
rate constant (k). The number of reactant concentration terms which need to be 
considered when determining the rate of reaction is called the order of reaction (Berg et 
al., 2002). The pre steady-state reactions between the catalytic species of HRP and 
substrates are first-order with respect to each reactant, and second-order overall. 
Therefore, the rate of these reactions is dependent on the concentration of both the 
enzyme species and the substrate used. In general, the rate of such a second-order 
reaction is described by the following equation. 
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ܸ ൌ ݇ሾܧሿሾܵሿ            (݁ݍݑܽݐ݅݋݊ 6.1) 
 
where k is the second-order rate constant governing the reaction, [E] the concentration 
of enzyme and [S] the concentration of the substrate (Atkins and Paula, 2009). The rate 
constant (k) has the unit M1-n s-1, where n is the order of the reaction. A first-order rate 
constant has unit s-1 and second-order rate constant has the unit M-1 s-1 (Berg et al., 
2002). 
 
Direct kinetic measurement of second-order reactions with two reactants can be 
problematic and less precise if the concentrations of the two reactants are followed 
simultaneously, or if one is measured and the other calculated as a difference. 
Therefore, in order to minimise the complexities arising from dealing with two 
reactants, the reactions are forced to operate under pseudo first-order conditions (Job 
and Dunford, 1976). Maintaining a small concentration of the enzyme, reacting with a 
large excess of substrate (at least 5-fold greater than enzyme concentration), will allow 
the rate of the reaction to be first-order, because the relatively small changes in substrate 
concentration during the reaction will not contribute to the total order, as it is in excess 
and can be viewed as a constant (Berg et al., 2002). These reaction conditions are called 
pseudo first-order and can be described by the following equation: 
 
ܸ ൌ ݇௢௕௦ሾܧሿ           (݁ݍݑܽݐ݅݋݊ 6.2) 
 
where: kobs is the pseudo first-order rate constant, that has the unit s-1 (Job and Dunford, 
1976). 
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Valuable information can be obtained when the pseudo first-order rate constant is 
measured directly as a function of substrate concentration (Dunford, 1999h), including 
an apparent second-order rate constant (kapp) for a given reaction. A plot of kobs against 
substrate concentration gives a linear relationship, and from equation 6.3 the slope of 
the plot gives the most accurate determination of kapp in units of M-1 s-1 (Dunford, 
1993). A linear plot passing through the origin indicates that, in practical terms, the 
reaction is irreversible (Dunford, 1999h). 
 
݇௔௣௣ ൌ
݇௢௕௦
ሾܵሿ             (݁ݍݑܽݐ݅݋݊ 6.3) 
 
In the previous chapter, steady-state data showed that the kinetics of luminol oxidation 
were different for cross-linked [S167Y] HRP-C* compared to unlinked. Therefore, in 
order to determine the rate constants k1, k2 and k3 directly (see section 1.5.4) for the 
reaction of HRP-C with luminol, the pre steady-state kinetic experiments described in 
this chapter were carried out under pseudo first-order conditions, maintaining the 
substrate concentrations at 5-10 times greater than the enzyme. Linear plots obtained 
from the observed pseudo first-order rate constants against corresponding substrate 
concentration confirmed that the respective partial reactions were really second-order 
overall with respect to the substrate used and the enzyme. 
 
6.2 Stopped-flow rapid scan photodiode array: 
 
As mentioned before in section 4.2, the main feature of the resting state spectrum of 
HRP-C is the presence of a Soret band at 403 nm, with two other bands at 642 nm (CTI) 
and 498 nm (CTII) related to charge transitions (Dunford, 1999f). Upon exposure to 
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H2O2, the resting enzyme is rapidly converted to the Compound I intermediate, 
concomitant with a decrease in the molar absorptivity of the Soret peak by a factor of 
approximately two (Dunford, 1982; Dunford, 1999i). After this, over a period of time, 
the spectrum of the second intermediate Compound II is observed as the result of a slow 
auto-reduction of Compound I. A comparison of the resting enzyme spectrum with the 
typical spectrum of Compound II shows that the maximum peak in the Soret region is 
red shifted from 403 nm to 420 nm and the peak intensity is increased slightly. A double 
peak in the visible region of the spectrum, with maxima at 527 nm and 554 nm, is also 
considered a characteristic feature of Compound II (Dunford, 1999i). In fact, Compound 
II is more stable than Compound I, and hence is easier to characterize. 
 
In order to have an overview on the nature of the changes that occur in the UV/Vis 
spectrum during the first part of the catalytic cycle of the S167W and S167Y HRP-C* 
variants upon reaction with hydrogen peroxide, rapid scan photodiode array absorption 
spectrometry was used, in the presence of 10 equivalents of H2O2 and the absence of 
reducing substrate, using a stopped-flow spectrophotometer equipped with an attached 
diode-array detector (section 2.12.2). 500 data points were collected on a logarithmic 
scale over a total time of 1000 s. The results are presented in Figures 6.2a, 6.3a, 6.4a 
and 6.5a. These figures show selected spectra obtained from 64 milliseconds to 992 
seconds for WT HRP-C*, and S167W, UmS167Y (unlinked enzyme) and mS167Y 
(linked enzyme) variants, respectively. In addition, data analysis was performed using 
the Pro-K Global Analysis Program (Applied Photo-Physics), to fit the time-dependent 
spectra collected and obtain computer modelled enzymatic species. Figures 6.2b, 6.3b, 
6.4b and 6.5b show the obtained intermediate species spectra from computer modelling 
141 
 
 
of the original data, and there is an inset in each figure indicating the relative abundance 
of each species as a function of time. 
 
The predominant species of WT HRP-C* (Figure 6.2b) agree well with those reported 
previously (Dunford, 1982), with the only slight difference being that the Compound II 
Soret peak appears less intense than that of the resting state; this is attributed to not fully 
converting the enzyme to Compound II. For all four enzyme samples studied, it was 
found that the initial decrease in the Soret absorption of the resting state on conversion 
to Compound I was almost the same, i.e. approximately a factor of two. The original 
spectra of Um[S167Y] and m[S167Y] HRP-C* (Figures 6.4a and 6.5a) show clearly 
that the formation of Compound I occurs more rapidly than for WT HRP-C* (Figure 
6.2a). However, and at the same time, the relative abundance of the enzyme species 
shows that the Compound I is of UmS167Y and mS167Y are also unstable compared to 
WT Compound I and quickly convert to Compound II. Computer modelling simulation 
of the raw data confirms this rapid formation and reduction of Compound I, where a 
three species model (A  B  C) for both UmS167Y and mS167Y (Figures 6.4b 
and 6.5b) could not detect the resting state of the enzyme that is clearly indicated for 
wild-type enzyme (Figure 6.2b). The first species found (A) is approximately 90% 
Compound I, the second species (B) seem to be a 50/50 mixture of Compounds I and II, 
and the third species (C) represents Compound II. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2: Rapid scan absorption spectra of WT HRP-C* reaction with H2O2. 3.6 
µM of enzyme were treated with 40 µM of H2O2 in 10 mM sodium phosphate buffer, 
pH 7.0, at 25 oC. (a) Rapid scan absorption spectra from 64 ms to 992 s. (b) Enzyme 
intermediate species spectra obtained from computer simulation of the raw data by 
global analysis (APP Pro-K) software, the figure in the top right represents the relative 
abundance of each one of the enzyme intermediates as a function of time. 
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Figure 6.3: Rapid scan absorption spectra of [S167W] HRP-C* reaction with 
H2O2. 4 µM of enzyme were treated with 40 µM of H2O2 in 10 mM sodium phosphate 
buffer, pH 7.0, at 25 oC. (a) Rapid scan absorption spectra from 64 ms to 992 s. (b) 
Enzyme intermediate species spectra obtained from computer simulation of the raw data 
by global analysis (APP Pro-K) software, the figure in the top right represents the 
relative abundance of each one of the enzyme intermediates as a function of time. 
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Figure 6.4: Rapid scan absorption spectra of Um[S167Y] HRP-C* reaction with 
H2O2. 4 µM of enzyme were treated with 40 µM of H2O2 in 10 mM sodium phosphate 
buffer, pH 7.0, at 25 oC. (a) Rapid scan absorption spectra from 64 ms to 992 s. (b) 
Enzyme intermediate species spectra obtained from computer simulation of the raw data 
by global analysis (APP Pro-K) software, the figure in the top right represents the 
relative abundance of each one of the enzyme intermediates as a function of time. 
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Figure 6.5: Rapid scan absorption spectra of m[S167Y] HRP-C* reaction with 
H2O2. 4 µM of enzyme were treated with 40 µM of H2O2 in 10 mM sodium phosphate 
buffer, pH 7.0, at 25 oC. (a) Rapid scan absorption spectra from 64 ms to 992 s. (b) 
Enzyme intermediate species spectra obtained for computer simulation of the raw data 
by global analysis (APP Pro-K) software, the figure in the top right represents the 
relative abundance of each one of the enzyme intermediates as a function of time.  
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Analysis of the rapid scan absorption spectra of the S167W mutant shows only a good 
fit to the experimental data when using a model of four species (A  B  C  
D) instead of the three species model of the WT enzyme, where A represents the resting 
state, B Compound I, C Compound II and D a new form of the enzyme. The rapid scan 
spectra show clearly another decrease in the Soret peak intensity (Figure 6.3), beginning 
150 s after the start of the reaction, where instead of reduction of Compound II back to 
the resting state enzyme (the normal process that occurs in the wild-type enzyme) it 
appears to suffer from a bleaching process. This phenomenon gives an indication that 
destruction, i.e. methylene breakage, may occur to the haem because of increased 
sensitivity of this mutant to H2O2 in the absence of reducing substrate. More chemical 
analyses, such as NMR analysis, need to take place in order to prove this, although a 
similar possibility was seen in chapter 4 results from HPLC analysis. 
 
6.3 Pre steady-state enzyme kinetics: 
6.3.1 Determination of the rate constant (k1) for the reaction of resting 
enzyme with H2O2: 
 
The reaction cycle of HRP-C starts with the formation of the first intermediate, 
Compound I, by reaction of resting enzyme with H2O2 (equation 6.4). In this reaction 
the ferric haem group undergoes a two equivalent oxidation to an oxyferryl, FeIV, 
porphyrin π-cation radical state (Hasinoff and Dunford, 1970), with a second-order rate 
constant (k1) equal to 1.6 × 107 M-1 s-1 for the wild-type enzyme (Shiro et al., 1986).  
 
 
In order to examine the effects which may be caused by the mutations introduced into 
HRP-C* at position 167, on the rate of formation of Compound I, the second-order rate 
k1E + H2O2                                Compound I + H2O            (equation 6.4) 
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constant (k1) for the reaction of WT enzyme and the new variants with H2O2 was 
determined under pseudo first-order conditions at pH 7.0 (section 2.12.3). Upon mixing 
of the enzyme sample and a known concentration of H2O2 in the stopped-flow system, a 
decrease in absorption due to the formation of Compound I was monitored at 395 nm. 
When measuring k1 for HRP-C, the wavelength of 395 nm is generally used as this is 
the isosbestic wavelength between Compound I and Compound II (Smith et al., 1992). 
As the Compound I species is forming it is also unstable and will be auto-reduced 
slowly to Compound II even without the addition of any reductants (Dunford and 
Stillman, 1976). However, interference to the data caused by this reduction can be 
avoided, as there is no change in the A395 during the reduction of Compound I to 
Compound II. 
 
The pseudo first-order rate constants (kobs) at a number of H2O2 concentrations were 
determined by fitting the traces obtained, i.e. a decrease in A395 as a function of time, to 
a single exponential decay function (Figures 6.6 - 6.9). In order to then calculate the 
value of the second-order rate constant for each enzyme sample used, the obtained 
values for kobs were plotted against the corresponding hydrogen peroxide concentrations 
using a weighted least square linear regression analysis (Figures 6.10 and 6.11). The 
slope of the resultant graph in each case represents the k1 value (see equation 6.3) for 
the relevant enzyme, values obtained presented in Table 6.1.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6: Stopped-flow trace of Compound I formation of WT HRP-C*. The 
trace shows the change in A395 for one second after 3.6 µM of enzyme was mixed with 
40 µM of H2O2 in 10 mM sodium phosphate buffer, pH 7.0, at 25 oC. (a) original trace, 
(b) single exponential fit (in red) of the A395 versus time progress curve. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7: Stopped-flow trace of Compound I formation of [S167W] HRP-C*. The 
trace shows the change in A395 for one second after 4 µM of enzyme was mixed with 40 
µM of H2O2 in 10 mM sodium phosphate buffer, pH 7.0, at 25 oC. (a) original trace, (b) 
single exponential fit (in red) of the A395 versus time progress curve. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8: Stopped-flow trace of Compound I formation of Um[S167Y] HRP-C*. 
The trace shows the change in A395 for one second after 4 µM of enzyme was mixed 
with 40 µM of H2O2 in 10 mM sodium phosphate buffer, pH 7.0, at 25 oC. (a) original 
trace, (b) triple exponential fit of the trace, but that this likely reflected non-specific 
absorption drift over the longer timescale, the values used in Figures 6.11 come from a 
single exponential fit of the data over the first 0.2 seconds of the reaction.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9: Stopped-flow trace of Compound I formation of m[S167Y] HRP-C*. 
The trace shows the change in A395 for one second after 4 µM of enzyme was mixed 
with 40 µM of H2O2 in 10 mM sodium phosphate buffer, pH 7.0, at 25 oC. (a) original 
trace, (b) single exponential fit (in red) of the A395 versus time progress curve. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10: Pseudo first-order rate constant plots for Compound I formation for 
WT HRP-C* and [S167W] HRP-C*. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11: Pseudo first-order rate constant plots for compound I formation for 
m[S167Y] and Um[S167Y] HRP-C*. 
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As mentioned before, the linear nature of the pseudo first-order rate constants versus 
H2O2 concentration plot passing through the origin (Figure 6.10), indicates that the 
formation of Compound I is an essentially irreversible process for wild type HRP-C* 
(Dunford, 1999h). The similar linear behaviour, and going through the origin, of the 
plots for the mutants, Figures 6.10 and 6.11, shows that the introduction of a tryptophan 
or tyrosine residue at position 167, instead of serine, also does not affect the mechanism 
of Compound I formation, i.e. the formation of Compound I has remained much faster 
than the rate of dissociation of the hydroperoxide complex (see scheme 1.3). 
 
 
Table 6.1: Second-order rate constants (k1) for Compound I formation by WT, 
Um[S167Y], m[S167Y] and [S167W] HRP-C*. All assays were carried out in 10 mM 
Na-Phosphate buffer, pH 7.0, at 25 oC. The k1 values were determined from the slopes 
of regression line plots of the pseudo first-order rate constants against hydrogen 
peroxide concentration. Data analysis and processing were carried out using Sigmaplot 
software.  
 
 
  Enzyme k1 (M-1 s-1) 
WT HRP-C* 1.59 ± 0.10 × 107 
S167W 9.0 ± 0.07 × 106 
UmS167Y 1.84 ± 0.20 × 107 
mS167Y 2.12 ± 0.10 × 107 
 
 
 
 
 
145 
 
 
The k1 value obtained for WT HRP-C* is 1.59 ± 0.10 × 107 M-1 s-1 and is in very good 
agreement with the published value, which is 1.64 × 107 M-1 s-1 (Smith et al., 1992). The 
results show a small but significant decrease in the k1 value of the S167W mutant 
compared to wild type enzyme, its value is reduced to almost half the value of WT 
HRP-C*. In the case of the UmS167Y mutant, a small but significant increase by a 
factor of 1.2-1.3 fold in the second-order rate constant for the formation of Compound I 
is observed relative to the wild-type enzyme. The production of the haem-protein 
covalent bond in this mutant (mS167Y) can be seen to have little effect on this value. 
 
Examination of the influence of haem pocket residues on the mechanism of Compound 
I formation in HRP-C, and their relative contribution to the k1 rate constant, has been a 
major focus of site directed mutagenesis studies. A study has been presented by Veitch 
and Smith that summarizes the haem pocket mutations of HRP-C on the rate of 
formation of Compound I (Veitch and Smith, 2001); this study shows the relative 
contributions of the distal and proximal haem pocket residues Arg38, Phe41, His42, 
Glu64, Asn70 and His170 of HRP-C. 
 
For enzymes engineered to be able to introduce a haem-protein covalent linkage, the k1 
rate constant of Compound I formation for the unlinked [F41E] HRP-C* variant showed 
a value 100 times lower than that of the wild-type enzyme, presumably a result of either 
an ionic or steric interaction between His42 and Glu41. However, interestingly, after 
treatment with hydrogen peroxide and formation of the covalent bond between the 
glutamic acid and the 3-methyl group of the haem, this mutant exhibited a rate of 
Compound I formation, equivalent to that of wild-type enzyme (Colas and Ortiz de 
Montellano, 2004). It has also been reported that, neither the S167M mutation alone, 
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nor the covalent modification of this enzyme, has any drastic affect on the basic 
mechanism for Compound I formation. The k1 value obtained of Compound I formation 
for the Um[S167M] HRP-C* was 1.32 × 107 M-1 s-1, while for m[S167M] HRP-C* it 
was 1.64 × 107 M-1 s-1 (Cali, 2008). 
 
6.3.2 Auto-reduction and life time of Compound I: 
 
Compounds I of the S167W and S167Y variants, formed by the addition of hydrogen 
peroxide to the enzyme at pH 7.0, were found to be unstable, and in a manner similar to 
Compound I of WT HRP-C* reverted to the resting state of the enzyme even in the 
absence of reducing agents (Figures 6.2-6.5). Therefore, in order to determine the life-
time of the Compound I species for each enzyme, the auto-reduction was monitored at 
412 nm in the stopped-flow system over a total time of 1000 s. This wavelength was 
chosen as it is the isosbestic point between Compound II and resting enzyme and 
therefore interference from the reduction of Compound II is avoided. The time traces 
obtained at 412 nm were found to be biphasic for all enzymes (Figure 6.12). The first 
phase is more rapid compared to a second slower phase. The traces were fitting to a 
double exponential equation using the curve fitting application in the Pro-Data Viewer 
software (Applied Photo-Physics), and two life times were determined using the 
reciprocal of the rate constants associated with both exponential rise phases of the traces 
(Table 6.2). 
 
The stopped-flow traces show that the amplitude changes associated with the two 
phases differ for each enzyme, Figure 6.12 and Table 6.2. The trace for WT HRP-C* 
has a fast phase with a small amplitude change of 15% and a slow phase with a much
  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.12: Stopped-flow traces of Compound I auto-reduction followed at 412 
nm. The double exponential fits of the traces show a biphasic change in absorbance. A 
4 µM of enzyme sample was mixed with 10 equivalent of H2O2 in 10 mM sodium 
phosphate buffer, pH 7.0, at 25 oC. (a) WT HRP-C*, (b) [S167W] HRP-C*, (c) 
Um[S167Y] HRP-C* and (d) m[S167Y] HRP-C*. 
 
 
Table 6.2: Life times for Compound I of WT HRP-C*, [S167W] HRP-C*, 
Um[S167Y] HRP-C* and m[S167Y] HRP-C*. Values were calculated from the 
reciprocal of the rate constants obtained for the two phases of the traces in Figure 6.12. 
 
Enzyme 
Life Time of Compound I Intermediate 
Fast phase Slow phase 
WT HRP-C* 850 ± 17 ms (15%) 89 ± 13 s (85%) 
S167W 2.4 ± 0.2 s (37%) 22.6 ± 4.3 s (63%) 
UmS167Y 135 ± 8 ms (72%) 9.3 ± 0.2 s (28%) 
mS167Y 40 ± 3 ms (76%) 3.7 ± 0.2 s (24%) 
Time (s) 
Time (s) Time (s) 
Time (s) 
Absorbance 
Absorbance 
Absorbance 
Absorbance 
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larger amplitude change of 85%. In the case of the S167W variant, the trace shows an 
increase in the amplitude change of the fast phase (37%) at the expense of the slow 
phase, when compared to the wild-type enzyme. The traces of Um[S167Y] and 
m[S167Y] HRP-C* both show a dramatic change in the amplitude changes, with the 
early fast phase associated with a large amplitude change, of 72% and 76% respectively. 
 
The life times obtained show that the Compound I auto-reduction for the S167W mutant 
was 3-4 times faster overall than for wild-type enzyme; this result is in good agreement 
with the rapid scan diode array observations (Figures 6.2 and 6.3). The most interesting 
results are for the S167Y mutant, where over 70% of Compound I of both Um[S167Y] 
and m[S167Y] HRP-C* is auto-reduced in the fast phase within only 135 ms and 40 ms, 
respectively (Table 6.2) and then only another 4 or 10 seconds is needed to completely 
reduce Compound I to Compound II. The overall reduction is therefore 10 times and 25 
times, respectively, faster than for WT HRP-C* Compound I reduction. However, the 
majority of the effect is from the mutation itself and only a small further instability is 
introduced by the presence of the cross-link. A previous study in this laboratory showed 
that the Compound I of Um[S167M] HRP-C* has an overall life time 1.5 times shorter 
than the wild-type enzyme, while m[S167M] HRP-C* is 2.5 times shorter (Cali, 2008), 
i.e. there is clearly less effect on the stability of Compound I from the S167M mutation 
than the S167Y mutation. 
 
 
6.3.2 Determination of the second-order rate constants (k2 and k3) for 
the HRP-C catalysed oxidation of luminol: 
 
The normal HRP-C reaction cycle is via the sequence: resting enzyme  Compound 
I  Compound II  resting enzyme (see section 1.5.4), so that after the 
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formation of Compound I, two sequential single electron reductions of Compound I by 
the reducing substrate occur and the resting enzyme is regenerated via Compound II; the 
rate constants k2 and k3, respectively, describe the reductions of Compounds I and II. 
Compound I and Compound II usually react with the same reducing substrate, i.e. once 
the reaction between Compound I and reducing substrate is initiated and some 
Compound II is formed, the Compound II begins to react with the substrate as well 
(Dunford, 1999h). It has been found that wild-type Compound I reacts more rapidly 
with reducing substrates than does Compound II, i.e. Compound II reduction is the rate 
limiting step. 
 
In this study, in order to determine the rate constant (k2) for reduction of Compound I, 
or formation of Compound II, and the rate constant (k3) for reduction of Compound II 
by luminol at the same time, approximately 3 µM of WT HRP-C* and the S167 variants 
were treated with 2.7 µM of H2O2. Then, directly, the reaction mixture was reacted 
under pseudo first-order conditions with a range of luminol concentrations. The kinetic 
measurements were performed in 10 mM sodium phosphate buffer, pH 7.0, at 25 oC and 
were monitored by a change in absorbance at 424 nm (at this wavelength both k2 and k3 
can be measured) using the stopped-flow instrument. This wavelength is the isosbestic 
point between Compound I and resting enzyme (Smith et al., 1992). It has been found 
that any excess of hydrogen peroxide in the reaction mixture would recycle some of the 
enzyme and cause interference with accurate measurement (Dunford, 1999h). For this 
reason, a slightly less than stoichiometric amount of hydrogen peroxide was used. 
 
The traces obtained of change in absorbance at 424 nm as a function of time were 
biphasic (Figure 6.13), where the rise in absorbance represents the Compound I 
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reduction stage (Compound II production), and the decay in absorbance represents 
Compound II reduction. The pseudo first-order rate constants (kobs) for Compounds I 
and II reduction were determined by fitting the traces obtained to a double exponential 
function. The slope of a plot of kobs from the rise phase against luminol concentration 
was used to calculate the second-order rate constant k2 for Compound I reduction 
(Figure 6.14), while the slope of a plot of kobs from the decay phase against luminol 
concentration was used to calculate the second-order rate constant k3 for Compound II 
reduction (Figure 6.15). The calculated k2 and k3 values are presented in Table 6.3. 
 
For the k3 determination, the plots of kobs against luminol concentration all show the 
presence of a small positive intercept on the x-axis (Figure 6.15). This intercept is due 
to a reduction of the concentration of luminol by one equivalent of enzyme through its 
initial reaction with the Compound I intermediate. 
 
In general, the results show that the rates of Compound I reduction are much faster (50-
360 times greater) than the rates of Compound II reduction, for all enzymes, and that the 
rates of Compound II reduction vary only over a two-fold range. However, the results 
do reveal that the rate of Compound I reduction (k2) for [S167W] HRP-C* is increased 
to approximately 4 times that of WT HRP-C*. This suggests that the substitution of the 
Ser residue for Trp at position 167 has a substantial effect on the way that the luminol 
molecule is able to interact with the Compound I intermediate, resulting in an 
enhancement in the reaction rate. However, as the rate limiting step for the overall 
reaction with luminol is the reduction of Compound II this will not result in an increase 
in steady-state activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.13: Stopped-flow traces of Compound II formation and reduction with 
luminol as reducing substrate. The traces show the change in absorbance at 424 nm 
for five seconds after reaction of Compound I (mixture of 3 μM enzyme and 2.7 μM 
H2O2) with 10 μM of luminol in 10 mM sodium phosphate buffer, pH 7.0, at 25 oC for 
each of (a) WT HRP-C*, (b) [S167W] HRP-C*, (c) Um[S167Y] HRP-C* and (d) 
m[S167Y] HRP-C*. The rise in absorbance represents the Compound I reduction stage, 
while the decay in absorbance represents the Compound II reduction stage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.14: Plots of the pseudo first-order rate constants for Compound I 
reduction by luminol. (a) WT HRP-C* and [S167W] HRP-C*, and (b) Um[S167Y] 
and m[S167Y] HRP-C*. 
a 
b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.15: Plots of the pseudo first-order rate constants for Compound II 
reduction by luminol. (a) WT HRP-C* and [S167W] HRP-C*, and (b) Um[S167Y] 
and m[S167Y] HRP-C*. 
a 
b 
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Table 6.3: The pre steady-state kinetic parameters k2 and k3 obtained for WT 
HRP-C* and S167 variants, using luminol as reducing substrate. Rate constants k2 
and k3 were calculated by weighted least square regression analysis using SigmaPlot 
software, from the slopes of plots of the pseudo first-order rate constants (kobs) against 
luminol concentration (Figures 6.14 and 6.15). 
 
Enzyme k2 (M-1 s-1) k3 (M-1 s-1) 
WT HRP-C* 2.8 × 106 5.6 × 104 
S167W 1.07 × 107 5.2 × 104 
UmS167Y 1.7 × 106 2.2 × 104 
mS167Y 9.7 × 106 2.7 × 104 
 
 
The results obtained for Um[S167Y] HRP-C* show that there is a small decrease in the 
k2 value by a factor of 0.6 fold when compared with wild-type enzyme. However, after 
incubation with hydrogen peroxide and creation of the haem-protein covalent linkage, 
m[S167Y] HRP-C* shows an enhancement in the rate of reduction of Compound I with 
a value 3.5 times faster than that of WT HRP-C*. These results indicate that while the 
replacement of the Ser residue by Tyr at position 167 initially causes a slight weakening 
of the interaction between the Compound I intermediate and luminol, formation of the 
haem-protein covalent linkage by treatment with H2O2, leads to a conformation where 
Compound I is able to oxidize luminol more rapidly. However, as k3 is still the rate 
limiting step for the overall HRP-C* reaction in this mutant the slight decrease in k3 will 
lead to an approximately 2-fold slower steady-state rate for both the cross-linked and 
unlinked S167Y mutant. 
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6.4 Conclusion: 
 
The use of pre steady-state kinetic methods has revealed that the mutation of HRP-C at 
position 167 causes some modulation in the rate of Compound I formation, compared to 
WT. It has been observed that there is a small decrease in the rate of Compound I 
formation for [S167W] HRP-C* and a small increase for [S167Y] HRP-C*, with no 
significant difference between linked and unlinked enzyme. Additionally, it was shown 
that the auto-reduction of Compound I occur in two phases, fast and then slow. The 
amplitude changes of the slow and fast phases reveal that the majority of WT 
Compound I auto-reduction is in the slow phase (85%), while the majority of UmS167Y 
and mS167Y Compound I auto-reduction is in the fast phase (72-76%). The S167W 
mutation has an intermediate effect. Interestingly therefore the S167Y mutation leads to 
a 10-fold greater overall instability of Compound I. this instability is enhanced further 
by 2.5-fold if the haem-protein covalent linkage is formed.  
 
Despite of the small negative effect on both the k2 and k3 rate constants for Um[S167Y] 
HRP-C* with luminol as reducing substrate compared to wild-type, m[S167Y] HRP-C* 
shows a 3.5-fold increase in the rate of Compound I reduction when compared with the 
wild-type enzyme, suggesting that the formation of the haem-protein covalent linkage 
has resulted in more favourable conditions for the electron transfer step between 
luminol and the porphyrin π-cation radical of Compound I. Approximately the same 
enhancement in the rate of reduction of Compound I has also been observed for the 
S167W variant. However, although both S167W and mS167Y variants have increased 
Compound I reduction by luminol, neither shows an increase in Compound II reduction, 
which is the rate limiting step of the reaction, under the pre steady-state conditions. 
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Chapter Seven: 
Final discussion 
 
 
 
The mammalian peroxidases are distinguished, in contrast to plant peroxidases, by the 
presence of two or three covalent bonds between the haem porphyrin and the protein. 
The available information about these linkages, such as how they are formed and what 
their functional advantages, is limited. Therefore, efforts have been made recently to 
attempt to understand the mechanism of linkage formation and the effects on the 
enzyme containing them, by introducing equivalent bonds into plant  peroxidases, e.g. 
HRP or APX, using site-directed mutagenesis (Colas and Ortiz de Montellano, 2004; 
Metcalfe et al., 2004; Pipirou et al., 2007a; Pipirou et al., 2009). Previous work in this 
laboratory involved the identification of a residue, Ser167, in HRP-C in a similar 
position relative to the haem as Met243 in the mammalian peroxidase MPO, which is 
involved in a sulfonium linkage to the haem porphyrin. The mutant [S167M] HRP-C* 
was therefore produced and was found to contain a sulfonium bond between the protein 
and haem after treatment with hydrogen peroxide (Cali, 2008). However, the linkage 
was found to be unstable and broke down after a few days. 
 
In this work, the same residue, Ser167 of HRP-C, has been replaced by both Tyr and 
Trp using a PCR-based site-directed mutagenesis. Both enzyme variants have been 
successfully expressed in E. coli as inclusion bodies, refolded and characterized. 
Resting state spectra of both enzyme variants suggest that, in contrast to WT HRP-C*, 
the haem iron exists predominantly in a six-coordinate high spin form, similar to that 
found in Lip and MnP (Blodig et al., 2001). Consistent with this, the Soret peak 
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extinction coefficient of the variants is much more than that of the wild-type enzyme. 
These results indicate that replacement of Ser167 residue by a bulky residue leads to a 
perturbation in the environment of the haem, so that the sixth coordination position of 
the iron is occupied by a weak ligand, probably a water molecule. Binding studies have 
also revealed that the affinity of the enzyme towards BHA has been impaired as a result 
of the mutagenesis. This effect is most likely caused indirectly by a perturbation in the 
aromatic donor binding site and / or the associated haem-linked hydrogen bonding 
network of the enzyme, rather than suggesting a direct role of Ser167 in substrate 
binding. 
 
The most important conclusion of the current work is the finding that on exposure of the 
S167Y mutant to an adequate amount of hydrogen peroxide, a covalent attachment of 
the haem to the protein is formed autocatalytically. Different analytical techniques have 
been used to confirm the formation of the covalent cross-linkage. The inability to 
remove the haem prosthetic group by the acid butanone haem extraction technique, the 
coelution of the protein and the haem together during HPLC analysis and the increase in 
mass of 614 Da over the predicted mass of the protein by MS analysis, all provide 
strong evidence for the formation of the haem-protein covalent bond in the S167Y 
variant. In addition, the results indicate that the positioning of a Tyr residue at position 
167 near to the haem 2-vinyl side chain is sufficient to form the haem-protein covalent 
linkage, even in the absence of H2O2, this requires formation of radical species on the 
iron (e.g. compound I) and/or on the 2-vinyl group to initiate reaction with the tyrosine. 
Again, this likely happens as a consequence of turnover of the HRP-C during its 
isolation, folding or purification. In contrast to the sulfonium linkage formed in the 
[S167M] HRP-C* mutant (Cali, 2008), which was found to be unstable and broke down 
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after few days, the haem-protein cross linking in [S167Y] HRP-C* was found to be very 
stable. The linkage was followed up after a period of 14 days at 4 oC and room 
temperature, and using MS and HPLC analysis the results were the same as 
immediately after formation of haem-protein covalent bond. Opposite to the results for 
the [S167Y] HRP-C* variant, no protein-haem linkage could ever be detected for the 
[S167W] HRP-C* variant. 
 
Results from kinetic studies on the two new S167 variants indicate that, even though 
there is no major functional role of Ser167 in the catalytic activity of HRP-C, the 
catalytic properties of the mutants somewhat altered. Generally, the reactivity of both 
mutants is significantly reduced against reducing substrates, with the exception of 
luminol and guaiacol, for the S167W variant. However, after treatment with hydrogen 
peroxide and formation of the covalent linkage, the S167Y mutant has a higher 
reactivity towards all enzyme substrates, equivalent to or higher than WT HRP-C*. This 
suggests that, as a result of covalent linkage formation, a favourable conformational 
change has occurred in either the haem environment and / or substrate binding site. 
 
The two new S167 variants were also examined by pre steady-state kinetics. 
Measurement of Compound I formation showed a 2-fold reduction for S167W and a 
small increase for either unlinked or linked S167Y. In addition, Compound I was found 
to be much more unstable for both unlinked and linked [S167Y] HRP-C*. However, 
unlike the increased activity towards luminol shown by the S167W and linked S167Y 
variants under steady-state conditions, only Compound I reduction showed an increased 
rate constant for these two mutants under pre steady-state conditions; the rate 
determining step of Compound II reduction is not increased. This apparent contradiction 
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is explained by the different pH’s used for the two different experiments, pH 5.0 for 
steady-state and pH 7.0 for pre steady-state assays. 
 
Indeed, unlike Compound I reduction, the rate of reduction of Compound II to resting 
enzyme is highly dependent on the pH. It has been reported that Compound II is easiest 
to reduce at low pH, while at high pH it becomes less and less reactive (Dunford, 
1999h). It was also found that the kcat value for the oxidation of ABTS by HRP-C* is 
drastically affected and decreased by changes in the pH value form pH 5.0 to pH 7.0 
(Rodriguez-Lopez et al., 1996b). An attempt has been made to do a comparison 
between steady-state and pre steady-state enzyme kinetics results, but unfortunately this 
was not possible due to the differences in the pH used in each case which has led to a 
change in the activity of enzyme Compound II.  
 
7.1 X-ray crystal structure: 
 
X-ray data collection, generation of electron density maps and structure refinement for 
the S167Y variant were all carried out in collaboration with Dr. Mark Roe (X-Ray 
Crystallography Collaborative Research Facility Manager, University of Sussex). The 
data were collected at the Diamond Light Source, beamline I03, and refined to 1.7 Å 
resolution using the PHENIX software suite. [S167Y]HRP-C* structural coordinates 
have been deposited in the protein data bank under the accession code 2YLJ. 
Superposition of the crystal structure of the S167Y mutant on that of the wild-type 
enzyme showed that the overall folds of the two enzymes are very similar. The structure 
also indicates that the new Tyr167 residue occupies a position similar to that of Met243 
in MPO, i.e. in a potential position to form a covalent linkage with the haem vinyl 
group. 
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In fact, the crystal structure obtained was found to be a mixture of both linked and 
unlinked S167Y mutant (Figure 7.1). The linked structure reveals a highly unusual five 
member ring linkage from Tyr167 to the haem that has never been seen before, 
supported by the increase of 614 Da seen from ESI mass measurements of the linked 
S167Y protein, compared to the unlinked enzyme. In addition, it was observed that the 
haem porphyrin ring is considerably distorted from its planarity in the linked structure. 
This distortion in the haem planarity has been reported previously in the MPO structure 
as a result of the sulfoinum linkage, giving a bow-shaped structure of the haem (Fiedler 
et al., 2000). The X-ray crystal structure of the unlinked S167Y mutant shows that the 
distance between the engineered Tyr167 hydroxyl and the haem vinyl β carbon is 2.43 
Å, while the distance between the O-carbon of the phenyl ring and the haem vinyl β 
carbon is 1.64 Å (Figure 7.2), while there is 3.82 Å between the Ser167 hydroxyl and 
the haem vinyl β carbon in the wild-type enzyme. Therefore, for a cross-linked S167Y 
protein to be formed it is easier to initially form a C-C bond between the haem vinyl β 
carbon and the phenyl ring; then the five member ring linkage is constructed as 
described in the following proposed mechanism (Scheme 7.1). 
 
The mechanism involves the following steps: (1) Initial reaction of the S167Y mutant 
with H2O2 to form Compound I, (2) oxidation of Tyr167 by Compound I associated 
with removal of its hydroxyl proton to form a Tyr radical. The phenoxy radical of Tyr 
(i) readily rearranges to the benzyl radical (ii), (3) the benzyl radical of Tyr167 is then 
added to the Cβ of the 2-vinyl group of the haem leading to breakage of the double bond 
and resulting in a radical on Cα, (4) the ferryl haem is reduced by the radical on Cα 
leading to release of a water molecule and formation of a carbocation on the Cα and (5) 
finally, elimination of the proton occurs in concert with resonance arrangement and 
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attack on the electrophilic carbocation, resulting in the creation of a five member ring 
linkage giving a haem structure consistent with the mass spectrometry results. The 
mechanism for the formation of a covalent linkage between an engineered methionine at 
position 160 (S160M) and the haem in ascorbate peroxidase has been proposed 
(Metcalfe et al., 2004). This mechanism includes in the final step addition of a hydroxyl 
group to the Cα of the vinyl group of the haem resulting in the loss of the double bond. 
On the other hand, a proposed mechanism for the formation of the vinyl-sulfonium 
linkage in MPO suggests the loss of a proton from the Cβ of the vinyl group and 
retention of the double bond (Colas and Ortiz de Montellano, 2003). The typical MPO 
spectroscopic characteristics, especially the red shift in the Soret peak, have been 
attributed to the conjugation of the sulfonium ion with the haem group via this double 
bond (Kooter et al., 1999b). Metcalfe and co-workers therefore suggest that the loss of 
the double bond in [S160M] APX is the reason of why the UV/Visible spectrum does 
not show the significant red shift in the Soret peak as in MPO (Metcalfe et al., 2004). 
The results in this work, where no significant change in the Soret peak position of 
linked [S167Y] HRP-C* is seen to strongly support this reasoning. 
 
7.2 Finally to summarise the main results of this thesis: 
 
Although the [S167W] HRP-C* variant does not form a covalent linkage between the 
haem and protein on treatment with H2O2, it exhibits an enhanced luminol turnover 
which might be interesting commercially, as an alternative to the WT enzyme in 
chemiluminescence assays. However, the reason(s) for haem degradation in this mutant 
after exposure to H2O2 should be further investigated; analytical techniques such as LC-
MS and Fourier Transform Infrared Spectroscopy (FTIR) analysis would be useful. 
FTIR is an analysis technique that provides information about the molecular structure 
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and chemical bonding of materials. It can be utilized to study the chemical changes that 
might occur in the haem structure after exposure to H2O2. 
 
Most interestingly, this work has shown that a haem-protein covalent linkage can be 
formed either autocatalytically on the addition of hydrogen peroxide, or indeed 
spontaneously in the absence of H2O2, in the [S167Y] HRP-C* mutant. The X-ray 
crystal structure reveals an unanticipated linkage structure, containing an additional 
ring, between the engineered Tyr and the haem; a structure not seen before. This linkage 
seems to be much more stable than the sulfonium linkage previously investigated in 
[S167M] HRP-C*. In contrast to the S167M variant, however, in which formation of 
the linkage significantly lowers the activity of the enzyme against all substrates tested, 
the activity of [S167Y] HRP-C* is enhanced by linkage formation, even to levels 
greater than WT enzyme for some substrates. This retention of good levels of activity 
after the covalent bond formation shows that it should be possible to use this mutant as 
an alternative to WT in commercial and clinical applications of HRP-C. If, as it is 
hoped, the linked mutant displays increased stability over the WT enzyme, e.g. at high 
temperature, then it’s use in diagnostic kits would be a great advantage, particularly in 
areas of the world where there is less access to refrigeration.  
 
The results obtained in this work show that the presence of a haem-protein covalent 
bond significantly alters the electronic and catalytic properties of a haem enzyme. This 
suggests that the reason for the existence of the haem-protein covalent linkages in 
mammalian peroxidases, in addition to possible contributions to the stability of the 
enzymes, might well be related to the catalytic properties required. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1: Ribbon representation for the structure of [S167Y] HRP-C* mutant. 
The figure was constructed by the VMD molecular visualization programme using the 
molecular coordinates of the X-ray crystal structure of [S167Y] HRP-C* mutant, 
accession code 2YLJ.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2: Five member ring linkage between Tyr167 and the haem vinyl group in 
the structure of the [S167Y] HRP-C* mutant. The figure shows the positions of 
Tyr167 molecules both unlinked and covalently linked to the haem vinyl group. The 
distance between the engineered Tyr167 hydroxyl and the haem vinyl β carbon is 2.43 
Å, and the distance between the O-carbon of the phenyl ring of Tyr167 and haem vinyl 
β carbon is 1.64 Å. The figure was constructed by VMD molecular visualization 
programme using the molecular coordinates of the X-ray crystal structure of [S167Y] 
HRP-C* mutant, accession code 2YLJ. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 7.1: Proposed mechanism for formation of a five member ring linkage 
between Tyr167 and 2-vinyl haem group in HRP-C*. Reactions 1-5 are described in 
the text. The results also indicate that the linkage is formed even before treatment with 
H2O2. Therefore, another possible route to initiating the reaction is that during catalysis 
a 2-vinyl radical species appears transiently on the haem, and this (and not Compound I) 
is responsible for hydrogen abstraction from the tyrosine side chain to initiate the 
covalent link formation. 
(i) 
(ii) (ii) 
(i) 
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